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Abstract  
 
Background: Respiratory disorders manifest themselves with chest symptoms including 
shortness of breath and decline in lung function. An innovative cost-effective therapy is needed 
and there is a growing body of evidence to suggest that singing in a group may have health and 
wellbeing benefits for these patients.  
 
Method: The key objectives of this research were to review current knowledge and to evaluate 
the potential impact of group singing as an intervention for health and wellbeing. The research 
is divided into three components which aimed to: 
-  Review, synthesise and consolidate current research in the area of singing for COPD. 
-  Evaluate the impact of group singing on health and wellbeing for a group of COPD patients  
-  Evaluate the usability of specially designed resources for home practice for respiratory 
patients. 
 
Results: A broad systematic review showed that availability of high quality evidence that 
singing for COPD improves physical health, dyspnoea or respiratory-specific quality of life is still 
very limited. This is due to the low number of high quality studies and small sample sizes. The 
study reported here found statistically significant positive changes in both total mean Warwick-
Edinburgh Mental Wellbeing Scale (WEMWBS) and COPD Assessment Test (CAT) scores for 
twenty-one COPD participants of two community singing groups over a twelve-week period.  
These changes were maintained up to thirty-weeks for sixteen participants that continued. The 
research also successfully piloted the use of resources designed for self-management.   
 
Conclusion: There are promising findings from this and other studies on the impact of singing 
for COPD on health and wellbeing. However, the outcomes of this research are consistent with 
those outlined in recent reviews and it is recommended that larger randomised controlled trials 
with longer durations are conducted. 
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Chapter 1 - Introduction 
 
Background  
 
Respiratory Diseases 
 
Hundreds of millions of people suffer each day from Chronic Respiratory Diseases (CRDs). 
These chronic diseases of the airways and other structures of the lung are among the leading 
causes of death worldwide according to the World Health Organization (WHO) (WHO, 2017a) 
and these make up five of the thirty most common causes of death with more than one billion 
people suffering from either acute or chronic respiratory conditions (FIRS, 2017). 
 
The World Health Organisation (WHO) use the term 'Respiratory Illness' to encompass 
developmental and pathological conditions affecting the organs and tissues, that make gas 
exchange possible in higher organisms. This includes conditions of the upper respiratory tract, 
trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of 
breathing (WHO, 1978). Respiratory illness in this context refers to the disorders outlined in a 
collective list of common chronic respiratory diseases identified by the WHO classification 
(Bousquet et al., 2007) which were detailed in the initial protocol (Appendix A, sub-appendix I) 
along with their related symptoms. Respiratory disorders generally manifest themselves with 
chest symptoms including shortness of breath and decline in lung function. These in turn lead to 
further symptoms such as weakening of muscles, pain and other related complications. 
 
It is estimated that CRDs accounted for four million deaths (almost eleven percent of non-
communicable disease deaths) in 2012 (WHO, 2015) and it is expected pulmonary diseases are 
likely to remain a major burden for decades to come. Prevention and treatment will need to be 
improved if their impact on longevity and quality of life of individuals and their economic burden 
on society are to be reduced.  
 
Chronic obstructive pulmonary disease (COPD) is the term used for a subset of these illnesses, 
which generally includes two main conditions; emphysema and chronic bronchitis. World Health 
Organisation estimates (WHO, 2017b) that more than three million deaths were caused globally 
in 2015 by COPD alone, which represented approximately five percent of all deaths globally in 
that year. 
 
COPD is characterised by poorly reversible airflow obstruction and an abnormal inflammatory 
response in the lungs, which represents the innate and adaptive immune responses to long-
term exposure to noxious particles and gases (MacNee, 2006). The main section of the GOLD 
2013 diagnostic criteria states that a clinical diagnosis of COPD should be considered in any 
patient who has dyspnoea, chronic cough or sputum production, and a history of exposure to 
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risk factors for the disease. Spirometry is required to make the diagnosis in this clinical context; 
the presence of a post-bronchodilator FEV1/FVC <0.70 confirms the presence of persistent 
airflow limitation and thus of COPD (Vestbo et al., 2013).  
 
The concept of COPD as a syndrome with specific entities has evolved over time. Several 
definitions of COPD currently exist the first arising from working groups of the major respiratory 
societies i.e. the American Thoracic Society (ATS) and the European Respiratory Society 
(ERS). The definitions have not always been particularly precise and may easily have included 
disease entities that would not usually be regarded as COPD (cystic fibrosis, bronchiectasis 
etc.) (Vestbo, 2014). Significant national guidelines have subsequently adopted and modified 
these definitions, which can add further complexity to research in this area. Whether other 
concepts such as phenotypes will evolve and be included in future standards for diagnosis and 
management of COPD still remains to be seen (Vestbo, 2014). 
 
The diseases which make up COPD are progressive and therefore long-term treatment options 
are currently limited and usually involve relieving the symptoms with medication (or surgery in a 
very small number of cases) (NHS UK, 2016), but significant efforts now focus on pulmonary 
rehabilitation (PR) for these patients. This generally involves therapies to help strengthen the 
respiratory muscles and limbs through exercise (which in turn improves exercise tolerance). 
This aims to slow the progression of the disease and to help educate patients to prepare for the 
challenges of living with the disease and help support them in managing their related 
symptoms.  
 
Dyspnoea 
 
Dyspnoea, or shortness of breath, is perhaps the most common accompaniment of lung 
disease (Burki and Lee, 2010). Patients with chronic respiratory disease are often limited in 
their activities by respiratory discomfort of this kind (Meek et al., 1999). A reduction in functional 
status and quality of life of these patients, along with disability are frequent consequences. 
Diseases producing this symptom may leave patients with significant breathlessness despite 
maximal therapy and they are estimated to debilitate millions of people worldwide (Herigstad et 
al., 2010).  
 
The American Thoracic Society (Meek et al, 1999) describe respiration as being unique to all 
other vital functions, in that it is not only regulated by automatic centres located in the brainstem 
but also by voluntary signals initiated in the cortex. Individuals have some control over their 
breathing in that sensations arising from respiratory activity affect the rate and pattern of their 
breathing, as well as their functional status. Therefore, derangements or disturbances in the 
mechanics of this respiratory system and in overall oxygenation process may underlie the 
uncomfortable breathing sensations generally referred to as dyspnoea.  
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Since breathlessness is often perceived as a threat to survival, researchers (Ryan et al., 2014) 
propose that episodic breathlessness may also engage the human stress-response, as 
regulated by the hypothalamic–pituitary–adrenal (HPA) axis. It can be considered that chronic 
breathlessness can cause excessive stimulation of this axis, resulting in dysfunctional 
regulation, along with associated neuropsychological, metabolic and immunological outcomes. 
 
Rehabilitation programs in patients with CRDs have been shown to relieve dyspnoea and 
reduce hospitalisations, but the understanding of mechanisms by which they succeed continues 
to be controversial (Celli, 1995, Killian et al., 1992, Burki and Lee, 2010). The specific 
mechanism contributing to dyspnoea (Meek et al., 1999) and the symptoms of the dyspnoea 
(Herigstad et al., 2010) will both vary within an individual patient and from patient to patient, 
confounding the isolation of a definitive mechanism of action. 
 
More than one process may contribute to the patients’ functional ability and the patients’ own 
emotional response to the illness could also exacerbate their response to the respiratory 
discomfort (Meek et al, 1999). The symptoms of dyspnoea are not fully explained by the 
differences in disease severity in regard to lung function either. Patients suffering from 
dyspnoea often have very different pathologies, and it is likely that the psychological 
components of these conditions are also not identical (Herigstad et al., 2010). 
 
A Cochrane review of randomised control trials of Pulmonary Rehabilitation (PR) for COPD 
(Lacasse et al., 2006) found that while rehabilitation (i.e. exercise training) in patients with 
COPD showed clinically significant results for relief of dyspnoea and fatigue, and emotional 
function improvement, it did not indicate clinical significance for lung function improvement 
(Functional (FEC) and Maximal (MEC) Exercise Capacity). Lung function was not considered as 
a primary endpoint for the review and it focussed on health-related quality of life and exercise 
capacity. This would support the concept that dyspnoea and other related symptoms of the 
disease may not be directly related simply to the lung function alone.  
 
In one documented case study (Davies et al., 1987) a patient experienced exertional dyspnoea 
after pulmonary surgery. Investigation excluded other key causes of dyspnoea and exercise 
studies demonstrated activity consistent with excess vagal nerve stimuli to the respiratory 
centre. Vagal nerve interruption via surgery markedly altered the patient’s respiratory pattern 
and improved their functional status. While this finding is not relevant to respiratory patients 
specifically, it does highlight that excess vagal nerve fibre or ‘afferent’ activity caused the 
dyspnoea in this case and these mechanisms are would likely be interrelated to the complex 
underlying causes of this sensation in respiratory patients.  
 
While the mechanism(s) and pathways of the sensations of dyspnoea remain unclear, it is 
speculated (Burki and Lee, 2010) that dyspnoea occurs when there is an increase of reflex 
information above usual levels from the peripheral sensors, provided by the pulmonary stretch 
and other receptors stimulated by the vagal nerve and chest wall mechanoreceptors. When 
                                                                          
 
  10  
 
processed, these generate a neural output to the respiratory system, which suggests that when 
a patient’s central neural output has unexpected results (i.e. via airflow or ventilation) either 
because of muscle paralysis or abnormal lung mechanics, a sensation of dyspnoea is 
experienced. 
 
When an imbalance is perceived between the current or future ability to meet respiratory 
demand, but where airflow into and out of the lungs is still occurring, ‘‘work-of-breathing’’ 
dyspnoea develops. This is where various stimuli give rise to a perceived need for increased 
ventilation. Increased metabolic activity, production of CO2, a lowered pH, increase in body 
temperature, perhaps anxiety or panic and increased sympathetic tone, among other things, 
signal the respiratory centre to increase respiration (Hallenbeck, 2012). 
 
A diagram summarising the short-term and longer-term factors impacting the respiratory 
systems for patients with COPD related illness and involved the sensation of dyspnoea is 
illustrated in figure 1 below.  
 
 
Figure 1 - Respiratory Stimuli Impacting Dyspnoea in COPD (created by author)  
 
One study used functional MRI scanning and psychological and physiological assessments to 
indicate that breathlessness in COPD is associated with altered cognitive processing in the 
medial prefrontal cortex of the brain (i.e. differing brain activation patterns occurred in response 
to dyspnoea related 'word cues') between COPD patients and a control group (Herigstad et al., 
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2013). In this study the control group displayed a similar activation pattern observed in previous 
functional MRI studies of breathlessness in healthy volunteers, while COPD patients displayed 
significantly greater activation in the medial prefrontal cortex (emotion control and memory 
consolidation). The behavioural data demonstrates that there may be a greater psycho-
morbidity in the COPD patients (Herigstad et al., 2013). 
 
Imaging and behavioural findings indicate that in COPD, engagement of the medial prefrontal 
cortex may distort the processing of breathlessness sensations towards greater reliance or 
dependence on fear memories and expectations, contributing to a vicious cycle of fear and 
avoidance (Herigstad et al., 2013). It has further been reported that distractive auditory stimuli 
decrease the level of exercise-induced dyspnea in patients with COPD by reducing their 
perceived unpleasantness of dyspnoea (Von Leupoldt et al., 2007). 
 
The data obtained in a very recent study in animals suggest that star-shaped glial cells called 
astrocytes, characteristic in the brain and spinal cord, may also play a role in providing ‘tonic 
excitation’ of pre-Bötzinger complex (preBötC) circuits that generate the inspiratory rhythm 
(Sheikhbahaei et al., 2018). The preBötC or pre-Bötzinger complex is a cluster of interneurons 
in the ventral respiratory centre of the brain, proven to be essential for the generation of 
respiratory rhythm and although this complex has not been definitively identified in humans, it is 
clearly identified and well-studied in animals (Hallenbeck, 2012). 
 
The role of preBötC astrocytes may be especially important in conditions where homeostatic 
adjustments of breathing are critical to support physiological and behavioural demands 
(Sheikhbahaei et al., 2018) and while this research is still in its infancy and the understanding 
of the physiologic mechanisms of dyspnoea and mechanisms of therapeutic action remains 
remarkably primitive (Hallenbeck, 2012), it illustrates significant complexities. It is clear that 
there is still much to learn and understand about the engagement of the brain and respiratory 
systems and the mechanisms that might impact the links between exercise and breathlessness. 
 
Inflammation and Depression 
 
It is understood that untreated comorbid anxiety and depression in patients with COPD has 
devastating consequences and may increase healthcare utilisation. Depression and anxiety are 
challenging to identify and treat in this group because their symptoms often overlap with those 
of COPD. It is estimated that less than one-third of COPD patients with comorbid depression or 
anxiety symptoms are receiving appropriate treatment. The evidence for the efficacy of 
antidepressant drug therapy in patients with COPD with comorbid depression and anxiety is 
inconclusive (Yohannes and Alexopoulos, 2014). There are however, promising findings 
regarding pulmonary rehabilitation, psychological therapy, and the collaborative care model in 
reducing depression and anxiety symptoms in patients with COPD, but these findings are 
currently limited by short-term follow-up periods (Yohannes and Alexopoulos, 2014).  
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It is well established that a number of inflammatory cell types are involved in the 
pathophysiology of COPD including macrophages, neutrophils and T-cells (which are found in 
all tissues including the lungs). These cells release a variety of mediators in response to 
noxious particles and gases which orchestrate and perpetuate the inflammatory response in 
COPD (Austin et al., 2016). In addition to an increase in the number of macrophages and 
neutrophils, these cells appear to have an impaired phagocytic function, resulting in impairment 
in clearance of apoptotic (dead or no longer needed) cells and potentially contributing to the 
chronic inflammatory state in the lungs of patients. 
 
Those who develop COPD also have an enhanced or abnormal response to inhaling toxic 
agents. This amplified response may result in mucous hypersecretion as in chronic bronchitis 
patients, tissue destruction seen in emphysema, and disruption of normal repair and defence 
mechanisms causing small airway inflammation and fibrosis (bronchiolitis). These pathological 
changes result in increased resistance to airflow in the small conducting airways, increased 
compliance of the lungs (i.e. ‘highly compliant’ refers to lungs where elastic tissue is damaged 
by enzymes), air trapping, and progressive airflow obstruction (MacNee, 2006).  
 
Depressive symptoms are common in patients with COPD and both diseases are believed to be 
associated with inflammation. Those patients with severe COPD have a 2.5 times greater risk of 
developing depression than controls i.e. people without COPD (van Manen et al., 2002). 
Evidence suggests that pro-inflammatory cytokines and cortisol in particular, play a crucial role 
in the causes of COPD and depression. (Du et al., 2014) and depression is a disorder which 
remains easily undiagnosed due to under-presentation and because the symptoms are not very 
specific. It is important to consider this disorder in patients with COPD and research 
underscores the importance of reducing symptoms and improving physical functioning in 
patients with COPD rather than focusing on pulmonary function alone (van Manen et al., 2002). 
 
A previous study (Du et al., 2014) investigated further the associations between depression, 
sputum cytokines and salivary cortisol in COPD patients. Diurnal rhythms of sputum biomarkers 
and salivary cortisol were measured in COPD patients with depression compared to those with 
depression alone, COPD alone and healthy controls. The combination of various sputum 
biomarkers and salivary cortisol VAR (relative diurnal variation) were found to perform best as a 
potential biomarker in the diagnosis of depression in COPD patients.  
 
There is early ongoing laboratory research which indicates that the role of the immune system 
in depression could be due to T-cells protecting against stress and depression. These very early 
findings suggest that therapies that boost such T-cell responses could be used in some patients 
with depression. Decreased numbers of peripheral blood T-cells and reduced concentrations of 
anti-inflammatory cytokines in the blood have also been reported in depression. Thus, it 
appears that patients with depression may have impairments in neuroprotective and anti-
inflammatory T-cell responses (Miller and Raison, 2016). This research could also hold 
potential importance for COPD patients with depression. 
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There are ongoing efforts to understand and build on these known links between depression 
and inflammation, which could have relevance for COPD patients and their treatment.  A recent 
study (Cattaneo et al., 2016) expanded on previous findings that depressed patients, resistant 
to conventional antidepressant therapies, appear to have higher concentrations of inflammatory 
biomarkers and that successful antidepressant treatment has been associated with a reduction 
in the levels of pro-inflammatory cytokines. This study looked in further detail at certain 
inflammatory biomarkers and found results that may support faster prediction of antidepressant 
response in particular patients. This could hold further implications for other research areas, 
such as COPD where inflammation and depression are key components.  
 
Singing, Respiration and Science  
 
Breathing, Stress and Wellbeing 
 
It is accepted that breathing behaviour is an important area of study with implications for stress 
research (Grossman, 1983). Specific breathing techniques are regularly recommended for 
relaxation, stress management, control of psycho-physiological states and to improve organ 
function (via improved circulation). Yogic breathing, defined as a manipulation of breath 
movement, has been shown to positively affect immune function, autonomic nervous system 
imbalances and psychological or stress-related disorders (Zope and Zope, 2013). The slow-
paced respiratory rate exercise has been found to have a strong tendency of improving or 
balancing the autonomic nervous system through enhanced activation of the parasympathetic 
system and thus can be practised for mental relaxation and reduction of stress of in daily life. 
This respiration and heart rate variability has been linked to physiological benefits, for example, 
lowered blood pressure (Pramanik et al., 2009). It is speculated that this may act similarly to 
mechanical hyperventilation and electronic unilateral vagal nerve stimulation (VNS), resulting in 
quieting of the frontal cerebral cortex (Brown and Gerbarg, 2005) the area of the brain involved 
in feelings of anxiety and stress.  
 
There is building evidence globally that singing, which is highly dependent on controlled 
breathing holds similar implications. A report showed that 71% of singers in a university choral 
society agreed that singing was beneficial for their ‘mental wellbeing’ (Clift and Hancox, 2001). 
The results of a study conducted in Germany (Kreutz et al., 2004) supports the hypothesis that 
choir singing positively influences emotions as well as immune functions in humans, findings 
previously discussed by other researchers (Unwin et al., 2002, Beck et al., 1999). The analysis 
of saliva samples taken at baseline and post group singing or listening indicated specific 
changes in the levels of secretory Immunoglobulin A (S-IgA), cortisol and emotional state 
(Kreutz et al., 2004) which collectively support the idea that choir-singing positively influences 
both emotional status and immune competence.  
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The results of a systematic review of the psychoneuroimmunological effects of music (Fancourt 
et al., 2014), also demonstrates an apparent sensitivity of hormones to musical stimulation. 
Immunoglobulin A (S-IgA) has been revealed to be particularly responsive to music, increasing 
following exposure to a range of styles of music, as well as for both active involvement and 
simply listening to recorded music. Similarly, strong patterns can be noted with respect to 
cortisol, and response of epinephrine (adrenaline) and norepinephrine (non-adrenaline). The 
review indicated that more studies will be needed to confirm this pattern though, as previous 
studies have not managed to achieve statistical significance. A meta-analysis would have been 
useful in providing a balanced judgement across all studies. However, this was not possible, 
due to the variation in methods used by the studies selected.  
 
There is also evidence from recent research in Cancer patients and their carers that greater 
improvements in mood, as a result of singing are associated with lower pro-inflammatory 
response, which appeared to be independent of stress levels. In this study, those with the 
lowest levels of mental wellbeing and highest levels of depression experienced the greatest 
short-term improvement in mood across the singing sessions and these larger mood changes 
were associated with lower levels of inflammation (Fancourt et al., 2016).  
 
It is unclear whether the increase in Immunoglobulin A holds any significance to physical 
functionality, but inflammation and depression are key factors in the pathophysiology of COPD, 
so this finding could hold important implications in further understanding the processes by which 
group singing might support the health and wellbeing of COPD patients.  
 
The effects of stress and emotion are often measured using respiratory parameters (Wientjes, 
1992), with psychological distress generally leading to increases in respiration rate and a 
change over from diaphragmatic or 'deep' breathing to thoracic or 'shallow' breathing. In 
extreme cases, a lowering of partial pressure of carbon dioxide (pCO2) values can be seen, with 
concomitant symptoms of hyperventilation (Hibbert and Pilsbury, 1989). However, attention 
has focused more recently on relationships between respiration and vagal control over the 
heart. This direct cardiorespiratory interaction is reflected in a phenomenon known as 
respiratory sinus arrhythmia (RSA) (de Geus et al., 1995).  
 
Respiratory Sinus Arrhythmia and Heart Rate Variability 
 
Respiratory sinus arrhythmia (RSA) is a cardiorespiratory phenomenon characterized in 
mammals by heart rate (HR) or R-R interval (RRI) fluctuations (i.e. cardiac beat-to-beat ECG 
intervals) that are in phase with inhalation and exhalation. RSA is defined as the coherence 
between respiration depth and heart rate. Typically, heart rate accelerates during inspiration 
and slows down during expiration, but the exact phase relationship, between respiratory and 
heart rate oscillations, is dependent upon the prevailing respiration rate (Eckberg, 1983). 
Respiratory sinus arrhythmia has been shown to reflect rhythmic waxing and waning of cardiac 
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vagal efferent effects upon the sinoatrial node (i.e. the carrying of impulses from the central 
nervous system to an effector) and thus on heart rate (Eckberg, 2003).  
 
Vagus Nerve Stimulation (VNS) (a technique providing targeted electrical therapy to the left 
cervical vagus nerve to control refractory epilepsy and treatment resistant depression) has also 
been seen to cause side effects involving the upper airway, lower respiratory tract, and upper 
gastrointestinal tract. These VNS devices can decrease airflow, oxygen saturation, and 
respiratory amplitude during sleep (Ghanem, 2006). Electronic stimulation of left vagus nerve 
afferent fibres, which carry impulses to the central nervous system (at the current levels 
required to provide therapy in this patient population) has been seen to cause adverse events of 
vocal cord dysfunction, laryngeal spasm, cough, dyspnoea, nausea, and vomiting. Specific 
Vagus Nerve Stimulation (VNS) of this kind has been seen to cause an increase in respiratory 
rate, decrease in respiratory amplitude, decrease in tidal volume (volume of air inspired or 
expired in a single breath during regular breathing) and decrease in oxygen saturation during 
periods of device activation, (Parhizgar et al., 2011). This further supports the concept that 
vagal tone might have key implications for the sensations of dyspnoea and other related 
respiratory and vocal functions. 
 
In summary, vagal tone (and specifically its influence on heart rate) represents a measure of the 
functional state of the parasympathetic nervous system, which is the division of the autonomic 
nervous system which acts to conserve energy. Vagal tone is most commonly measured by 
analysing the rhythmical variations in heart rate period or RSA, due to the respiratory cycle. 
Increases in vagal tone slow the heart and make heart rate more variable and although ‘vagal 
tone’ itself cannot be measured, changes in the heart rate due to RSA can be found by 
measuring periodic changes in the heart rate due to breathing and can be used to index 
autonomic vagal activity (Thayer et al., 2011). This process is referred to as the heart rate 
variability (HRV). 
 
Early research examined synchronization of respiration and HRV among choir members during 
singing (Muller and Lindenberger, 2011) and it was further investigated how singing, as a form 
of guided breathing, affects heart rate variability and respiratory sinus arrhythmia in healthy 
patients (Vickoff et al., 2013). It was concluded that singing produces slow, regular and deep 
respiration which in turn triggers respiratory sinus arrhythmia. Respiratory sinus arrhythmia is 
associated with vagal influence and self-reported well-being, so researchers suggest that 
singing can be viewed as initiating the work of a vagal pump, sending relaxing waves through 
the choir. The singing itself guides respiration, resulting in compliances of frequencies and 
phases of respiration cycles and heart rate variability cycles between singers. This could hold 
implications for patients with a respiratory illness and may help researchers in understanding 
which aspects of group singing in particular, may have been effective in those trials (Clift et al., 
2013) where encouraging results for COPD patients have been noted. 
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The influence of the inspiratory muscle weakness in COPD patients on cardiac autonomic 
control is as yet unknown. One study (Reis et al., 2010) evaluated the influence of respiratory 
muscle strength on autonomic control and found COPD patients demonstrated impaired cardiac 
autonomic modulation at rest and during RSA-M when compared with healthy subjects (p < 
0.05). Patients with COPD presented impaired sympathetic-vagal balance at rest. In addition, 
cardiac autonomic control of heart rate was associated with inspiratory muscle weakness in 
COPD. It is speculated based on this evidence that future research applications of respiratory 
muscle training may bring to light a potentially valuable target for rehabilitation. 
 
Group Singing for Respiratory Illness 
 
Researchers have studied the effects of emotion induction on total respiratory resistance in 
asthma patients and the relationship with cardiac vagal activity and facial muscle activity (Ritz 
et al., 2001). Significant increases of respiratory resistance in asthmatic patients were observed 
following ‘depressing stimulation’ (i.e. presentation of coloured pictures depicting scenes of 
hospital patients, scenes of catastrophe, soldiers in action, dead animals). Resistance increases 
were positively correlated with respiratory sinus arrhythmia and researchers concluded that the 
respiratory resistance increases in asthmatics following observation of these ‘depressing 
stimulations’ are dependent on vagal activity. Greater facial muscle activation during emotional 
stimulation is seen to reduce vagal activation too. 
 
Evidence further suggests that singing has the potential to improve health outcomes in patients 
with other chronic respiratory diseases. A feasibility study on the health benefits of a community 
singing programme for older people with COPD (Clift et al., 2013), strongly support this. The 
measures of lung function and health-related quality of life significantly improved over a ten-
month period of the singing programme (Clift et al., 2013) further supported by qualitative data 
collected from the same study (Skingley et al., 2014). 
 
Group singing is an activity that may support lung function and enhance quality of life in people 
with certain respiratory disorders. The current literature and research though, has mixed and 
inconclusive findings, suggesting that several different but interrelated processes could 
potentially be active in differing degrees. 
 
The key mechanism appears to be the active engagement of the muscles of the entire 
respiratory system and an increase in respiratory muscle strength, leading to increased lung 
volume and effective cough (Kang et al., 2006, Wiens et al., 1999). Poor posture 
(hyperkyphosis) is often common in COPD patients and can restrict the expansion of the rib 
cage and movement of the diaphragm. Since singing requires the development of skills in 
controlling posture this may be transferable to activities in daily life in people with COPD (Lord 
et al., 2010).  
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In addition, group singing includes a strong element of education by singing facilitator to help 
support patients with their breathing control. It is well accepted that teaching respiratory patients 
to breathe slowly and deeply during exercise, and avoid rapid upper thoracic patterns of 
breathing, should help to lessen dyspnoea and improve performance (Macklem, 2010). 
Respiratory patients indicate that a crucial element in improvement to their breathing during 
group singing is the aspect of learning how to breathe correctly and to control their own 
breathing (Skingley et al., 2018). It is also considered an important benefit that the action of 
breathing more slowly allows patients lungs more time to empty, thus reducing the acute effect 
of air trapping in the lungs (Lord et al., 2010) which impacts the mechanism of dyspnoea. 
 
There are other mechanisms active that may potentially impact this population. One of these is 
mucus clearance. This could be due to the vibrations caused by the physical activities of 
singing, as the techniques used in singing itself follow similar scientific pathways that form the 
basis of successful chest physiotherapy, airway clearance, and airway clearance devices 
(Goldenberg, 2018).  
 
It was initially demonstrated in an animal model, that pressure oscillations at the chest wall 
cause the release of acetylcholine (King et al., 1990) stimulating cilia beating and helping to 
increase mucus flow. In singing, the frequency of the pressure oscillations will vary according to 
the pitch being sung, but any vibrations less than 350Hz can be felt at the chest wall 
(Sundberg, 1992). These pressure oscillations during singing may also change the rheological 
properties of the mucus. The increasing shear rates from oscillating airflow in vitro were seen to 
reduce mucous viscoelasticity, making movement and thus clearance easier (Tomkiewicz et 
al., 1994, Sturgess et al., 1970). Inspiration during singing would usually be around 5 l/s 
(Sundberg, 1987) and peak expiratory flow rates above 0.5 L/s can effectively shear and pull 
mucus within the airway (Kim et al., 1987), so although inspiratory airflow is not in the direction 
for expulsion of mucus the mucus would still be loosened such that it is easier to expel upon 
coughing. 
 
It is common during singing sessions for COPD patients that the activity of singing induces a 
high prevalence of coughing and sputum expectoration (Bonilha et al., 2009), indicating this 
expected mobilisation of mucus. Studies of singing in cystic fibrosis patients in particular have 
observed participants coughing during singing though not during conversation (Goldenberg, 
2012), which supports an understanding that singing not only improves respiratory muscle 
strength but as the physiology of singing resembles the principles behind airway clearance, it 
facilitates the mobilisation of mucus. 
 
The other mechanisms that may have significance include a reduction of fear, anxiety and pain 
perception (Kenny and Faunce, 2004) possibly by increased breath control improving the 
autonomic nervous system through enhanced activation of the parasympathetic system, leading 
to higher vagal tone (Pramanik et al., 2009, Kok and Fredrickson, 2010, Vickoff et al., 2013); 
This in turn and in combination with the improvements in a patient’s overall improved 
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consciousness of their own breathing due to the singing training, may reduce the occurrence or 
severity of dyspnoea episodes; Improvement of mood (Unwin et al., 2002) positively impacted 
by socialising and meeting people, thus combating isolation. Finally, immunoglobulin A (S-IgA) 
levels have been revealed to be particularly responsive to music (Fancourt et al., 2014) and 
there is evidence that greater improvements in mood as a result of singing were associated with 
lower pro-inflammatory response (Fancourt et al., 2016). This leads to consideration of a 
potential link, still to be more rigorously examined, between regular singing and more 
sustainable improvements in mood and positive impact on depression and inflammation. This in 
turn would be a particularly important outcome for COPD patients specifically, where depression 
is more prevalent.  
 
These multiple complex processes are thought likely to be interrelated, thus enhancing the 
overall potential benefit by form of a virtuous circle, combating the ‘spiral of decline’ (Jones, 
2009) associated with the condition. It can be hypothesised that singing as an enjoyable pursuit, 
may help to prolong the continued engagement and retention of patients in regular activities 
which support their condition longer term. The variety of cost effective and self-sustaining 
options available for patients within this area needs to be explored further both in regard to 
longer treatment and follow-up periods, overall healthcare utilisation and particularly to 
understand further the mechanisms and processes employed. 
 
Research Importance 
 
The WHO European health report (WHO, 2012) indicates that the main specific causes of death 
from respiratory diseases are chronic obstructive pulmonary disease (COPD), pneumonia, 
influenza and asthma and that the interventions to prevent such respiratory diseases often 
reflect wider social determinants of health that require some inter-sectorial action to ensure an 
impact that lowers disease incidence and severity.  
 
The research outlined here is in line with this analysis and also with existing UK Chronic 
Obstructive Pulmonary Disease (COPD) outcomes strategy discussions (UK DH, 2012) 
particularly objectives identified in the companion document, which outline directions for 
enhancing quality of life for these patients. It is also aligned more broadly with a general 
movement away from past models of health care which formally placed the patient in the role of 
a passive recipient. Many chronic disease patients now require more active involvement in 
managing their conditions, whereby responsibility for day-to-day disease management gradually 
shifts away from health care professionals to the individual (Barlow et al., 2002).  
 
Research suggests that specific theoretical work is required to link the nature, process and 
experiences of ‘singing’ with the nature, processes and experiences of wellbeing and health 
(Clift et al., 2008). It considers that the key questions needing to be addressed are ‘What?’ and 
‘How?’ What effects, if any, does active involvement in group singing have on wellbeing and 
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health? And how does singing have these effects – what mechanisms are at work? What 
mechanisms, for example, link the physicality of singing with the physical wellbeing of the body? 
What mechanisms link the psychological and social processes at work during singing with 
senses of emotional wellbeing and mental health?  
 
There is indication from the research literature available that the potential mechanisms and 
interactive aspects of this intervention may support health outcomes in respiratory challenged 
patients more generally e.g. positively influencing both emotional status and immune 
competence (Kreutz et al., 2004). It can also be hypothesised that, depending on the nature of 
the underlying respiratory illness in question, differing aspects of the activity of singing may be 
more or less impactful to patients and their symptoms too i.e. The overall effect of singing may 
be variable dependant on the pathology of the disease, the area of the human respiratory 
system impaired or the respiratory apparatus impacted by the treatment. e.g. vocal training may 
reduce snoring or Obstructive Sleep Apnoea (OSA) by improving the pharyngeal muscle tone 
(Ojay and Ernst, 2000) or it may support cystic fibrosis by providing rigorous exercises for the 
whole respiratory system as well as a means for emotional expression, in turn enhancing quality 
of life (Irons et al., 2010a). This suggests that understanding the impact of singing on specific 
symptoms within a single disease group or population may prove an important step forward, in 
addition to further understanding the holistic effects on wellbeing in general. 
 
The implications of group singing on respiratory sinus arrhythmia and other psycho-
physiological functions of patients with a respiratory disorder and on related symptoms such as 
dyspnoea in particular, are still not fully understood. However, group singing has the potential to 
be an innovative, cost-effective, low risk therapy which helps participants to engage in physical 
and social activities and which can serve to support independence and improved quality of life. 
This planned research intends to provide additional knowledge in this area and enhance the 
impact of singing for patients with a respiratory illness. 
 
Objectives 
 
The aims of this research were to add to the growing body of evidence in the area of singing for 
wellbeing and health, particularly for patients with COPD, to help answer the following research 
questions.  
 
1) What has been established so far by research regarding the effects of group singing for 
COPD patients? 
 
2) What are the potential health and wellbeing benefits of regular participation in group singing 
for a small cohort of COPD patients? 
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3) What is the potential feasibility and usefulness of developing and implementing novel singing 
resources in a group of COPD patients, in addition to regular group singing? 
 
The key objectives were to review current research systematically and evaluate the potential 
mechanisms, processes and effects of group singing as an intervention for pulmonary function 
and health status. The research was divided into three discrete components: 
 
-  Review, synthesise and consolidate current research in the area of group singing for COPD 
patients and use this information to support the design of an empirical research study 
 
-  Evaluate the impact of group singing on health and wellbeing for a cohort of COPD patients 
using patient reported outcomes measures (WEMWBS, CAT, ACQ-5) and provide 
recommendations to inform and support future study design and planning. 
 
-  Evaluate the feasibility and usability of specially designed resources for home singing practice 
for respiratory patients. 
 
The initial planning for the systematic review was conducted during 2013 with an initial protocol 
completed in August 2013. Initial searches and data extraction started at that point. In 
December 2015 the Cochrane review title ‘Singing for Adults with COPD’ was registered and 
the Cochrane review protocol ‘Singing for Adults with COPD’ published in July 2016.  
 
It was recognised at this point that the initial planned protocol closely aligned to the Cochrane 
methodology and as such this separate planned systematic review was largely replicating the 
planned Cochrane review. It was decided at that point that it would add more value to this 
research if the scope of the systematic review be broadened to incorporate the review of design 
and execution aspects of the available studies. This planned review would remain in close 
alignment with the Cochrane review but there would be no restriction on the types or quality of 
the studies to be included. 
 
The first version of this broad systematic review was completed in December 2016 and this was 
used to inform the design of the Empirical study. Recruitment planning and taster sessions for 
planned COPD singing groups were initiated in spring and summer 2016 prior to the finalisation 
of the study design. This was to ensure the singing groups, resources and venues could be 
arranged during winter 2016 allowing for group sessions to be conducted in the following 
summer period. The protocol for the empirical study was completed in March 2017 and received 
Ethics approval in April 2017. The study was successfully conducted at two COPD singing 
groups during the summer 2017.  
 
It was further decided during the ongoing study conduct in September 2017 that there would be 
value in continuing the study and collecting further data for these singing groups, so the protocol 
and study plans were revised to enable the collection of data for one additional visit timepoint. A 
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request was submitted and further ethics approval granted. The study then completed in 
November 2017 and all final data was analysed in winter 2017. The final thesis was completed 
and submitted in June 2018. 
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Chapter 2 – Background: Systematic Review of Current 
Literature 
 
Systematic Review: Introduction 
 
The Cochrane Collaboration has completed systematic reviews for singing in patients with 
certain specific respiratory disorders, for example ‘Singing for Cystic Fibrosis’ (Irons et al., 
2010a) and ‘Singing for Bronchiectasis’ (Irons et al., 2010b), however these were ‘empty’ 
reviews and did not lead to any conclusions. A good quality collective review of ‘Singing for 
chronic respiratory disorders’ or ‘Singing for COPD’ had not been published by Cochrane or 
other recognised organisation at the onset of this project in 2014. However a Cochrane review 
protocol was published for ‘Singing for Adults with COPD’ in 2016 (McNamara et al., 2016) and 
the full review and subsequent publication (McNamara et al., 2017) competed in parallel with 
this project. However, the total number of randomised controlled trials (RCTs) in this area, 
eligible for inclusion, was small and the total sample sizes used and follow-up periods employed 
did not provide enough robust information to provide significant conclusions. 
 
Two other systematic reviews were published during this project which similarly agreed with the 
overall outcome of the Cochrane review ‘Singing for Adults with COPD’ (McNamara et al., 
2017). The first, (Gick and Nicol, 2015) considers studies of singing for both COPD and other 
respiratory conditions and indicates that improvements are not shown in respiratory health 
directly for most studies. It shows instead that improvements in quality of life or well-being have 
a positive, immediate impact and might further affect respiratory health over time. The other 
review (Lewis et al., 2017) provides a detailed and critical review of the existing literature on 
singing for lung health and concludes that further, larger-scale and more robust studies are 
needed to test the therapeutic effects of singing, but it does acknowledge that there is 
considerable qualitative data to support participation in singing groups as a safe and potentially 
valuable strategy for these patients.  
 
In addition to the more rigorous Cochrane review and these further highly specific systematic 
reviews, a broader systematic review is still considered important. The aim is to research all 
study designs, methodology and outcomes published in the area of singing for adults with 
COPD to date, with the intent of consolidating existing evidence in one place, to support future 
research methodology and practice development. A further aim of this review is to explore 
whether there are any insights to be gained from currently published research that concern any 
additional aspects that group singing as an intervention may have for COPD symptoms 
specifically, which have not previously been considered.  
 
The recently completed Cochrane review ‘Singing for Adults with COPD’ certainly holds more 
significance and impact in regard to the analysis of the previous data obtained, but since it 
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focuses exclusively on randomised controlled studies, there remains valuable qualitative 
information to be provided by an extended review of all ‘Singing for COPD’ related studies. A 
collective review of all studies including those that were not randomised controlled trials from 
any additional publications will provide a comprehensive review of current information. The 
researcher for this systematic review and project was also a contributing author for the ‘Singing 
for adults with COPD’ Cochrane review (McNamara et al., 2017) so these two reviews remain 
sympathetic and consistent. 
 
This broader review aims to add context and compliment the Cochrane review. It focuses on the 
nature, methodologies and quality of all current work to date, including all studies in this area, 
i.e. mixed model, quantitative and qualitative. The intent of this is to supplement the outcome of 
a Cochrane review conducted in parallel and to help shape agenda for future research.  
 
This extended review completed alongside the Cochrane review focuses on the following areas: 
 
1. The quality, design and settings employed in execution of the studies, including the frequency 
and duration of the singing intervention.  
 
2. The health and wellbeing measures used, data collected and the overall research problems 
identified by researchers.  
 
3. The discussion and consideration of any general findings in this area with particular focus on 
any outcomes which may clarify further the aspects or mechanisms which group singing may 
employ for COPD patients  
 
Systematic Review: Method 
 
The design criteria outlined in the original protocol, ‘Singing for Chronic Obstructive Pulmonary 
Disease: A Systematic Review of Currently Published Literature’ as shown in Appendix A, was 
followed. The initial version of this protocol acted as the framework for a review of all work to 
date however, the scope for this protocol included research for singing for all patients with a 
respiratory disease and it was decided, following the initial database searches, to narrow this 
review criteria to focus more specifically on COPD related disease i.e. ‘singing for adults with 
COPD’ and to exclude studies on singing for other non-COPD respiratory illnesses. This also 
enabled the review to remain closely aligned with the Cochrane review protocol ‘Singing for 
Adults with COPD’ (McNamara et al., 2016), developed in parallel, and to ensure direct 
comparability with the specific patient populations. 
 
The scope for the broader systematic review was expanded both in its intent to review all 
aspects of study design and execution and also in regard to inclusion of all study types and 
designs. It aimed to include all papers to date for singing and COPD, without exclusion. All 
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studies that contained pertinent content for an expanded review of the methodology, 
implementation, practice implications and findings for group singing and COPD were 
incorporated. The initial searches had been deliberately conducted so as not to specify or 
exclude any particular study type, as the intent was for the researcher to procure all studies 
available for singing in COPD in their entirety and manually filter those with the required study 
type. Hence the original searches remained valid as they were designed to capture all 
randomised controlled trials, quasi-experimental designs, qualitative, quantitative and mixed 
model designs, recorded in any language containing the intervention and population terms as 
outlined in the original protocol. 
 
Systematic Review: Results 
 
Database Searches 
 
The initial protocol was developed with the aim to focus on singing in all Chronic Respiratory 
Diseases (CRD). Hence the planned search strategy for this systematic review included all 
papers relating to Chronic Respiratory Diseases (CRD) as identified per WHO ICD10 by the 
Global Alliance against Chronic Respiratory Diseases (Bousquet et al., 2007) where singing 
was included as the intervention. The search criteria were very broad and thus the searches 
included studies which had less strict design criteria and a wide range of respiratory illnesses. 
 
The initial searches based on this early strategy were completed in August 2014 and all papers 
were procured and the characteristics of each study were collated and databased as per 
protocol over the following year. This produced 2055 titles of which there were 165 duplicates 
leaving a total of 1963 unique studies. The titles were reviewed for relevance and all those 
meeting the specific criteria of singing for respiratory illness extracted and reviewed.  
 
There were found to be a number of relevant studies including some that were excluded from 
previous Cochrane reviews. Studies were found to be highly variable over a number of 
parameters both within the design, respiratory illness type and in the quality of execution and 
reporting.  
 
The results from the initial searches and identification of relevant papers led to the protocol 
being revised to narrow the focus to those studies involving COPD alone, and also to review 
studies with a more robust design methodology i.e. randomised design, feasibility and pilot 
studies in line with more distinct criteria. It was decided that studies with a high risk of bias or 
with confounding factors in the population (e.g. patients and carers, population bias, 
stratification by gender etc.) should be excluded. 
 
The original key database searches (completed in 2014) plus additional manual searches and 
review of references within all relevant studies produced a total of twenty-six papers that met all 
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the original protocol inclusion criteria i.e. singing as an intervention for respiratory illness. A total 
of four titles were registered studies only without a full paper (which were all excluded) and one 
title was an abstract with no other information available. The remaining twenty-four papers detail 
relevant studies where diseases of interest could be more simply categorised into six groups by 
their pathology: Asthma; Sleep Apnoea/Snoring; Lung Cancer; Cystic Fibrosis; Emphysema; 
COPD/CRD. 
 
These database and manual searches were performed using broad criteria from the original 
protocol and then this full list of studies and papers manually pared further to include only those 
where patients were specifically noted as having COPD or a related illness (e.g. Emphysema). 
This produced a total of sixteen papers from eleven unique studies. Updated searches were run 
in fourth quarter of 2015 and first quarter of 2016 but produced no further studies of relevance.  
 
The Cochrane review title ‘Singing for Adults with COPD’ was registered December 2015 and 
the protocol published in July 2016. Database and manual searches were completed for this 
protocol in August - September 2016 and while Cochrane’s methodology for effectiveness 
reviews requires that only randomised controlled trials (RCT) are included, the searches were 
much wider and acted as further important quality check for studies to be included in this 
review. 
 
These searches in 2016 surfaced one additional more recently published study (Canga et al., 
2015) along with a clinical trials registration abstract (Canga et al., 2014) for the same study, 
which met the criteria for this systematic review. These searches also identified additional 
conference abstracts for the study by Bonilha et al. (2009) (i.e. Martinez et al., 2008), for the 
Lord et al. (2010) study (i.e. Lord et al., 2010b) and an abstract and an erratum paper for the 
Lord et al. (2012) study (i.e. Lord et al., 2012a, Lord et al., 2012e). These studies had 
already been included in searches for this review and selected, but these five additional papers 
were included for completeness. 
 
One further study was noted to be registered in the ANZCTR database of clinical trials i.e. 
(McNaughton, 2014) ‘Sing Your Lungs Out: Effect of participation in weekly community singing 
group for 1 year, on lung function, anxiety and depression and health care use in patients with 
COPD who have completed pulmonary rehabilitation: a quantitative and qualitative study’ but 
this study data was not available at the time of the initial review.  
 
In March 2018 further manual and database searches were conducted to ensure all updated 
information was captured. The study mentioned previously (McNaughton, 2014) was traced 
and two papers had since been published documenting this study. One paper was published in 
2016 (McNaughton et al., 2016) and then a further updated paper was published in 2017 
(McNaughton et al., 2017) both for the same study. These were both subsequently assessed 
and included along with the additional six papers surfaced in 2016. 
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Seven further published papers from six unique studies became available within this time and 
were subsequently added (BLF, 2017, Clift et al., 2017, Liu et al., 2016, Jamaly et al., 2017, 
Skingley et al., 2018, Thomas et al., 2015, Trivedi, 2017). The outcome is that a total of 
sixteen additional eligible papers were identified between mid-2016 and spring 2018 and 
sourced from nine unique studies. These were subsequently added to the systematic review 
and detailed in figure 2 below: 
      
 
Figure 2 – Systematic Review - Flow of Papers and Studies through the Review  
 
Study Selection 
 
There were thirty key papers identified from the initial and subsequent searches and full reviews 
as detailed in Table 1 below, which reported on nineteen unique studies in total. All the papers 
by Clift et al. (2013), Morrison et al. (2013) and Skingley et al. (2014) present different 
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aspects of a single study, as do Clift et al. (2017) and Skingley et al. (2018). Lord et al. 
(2010a) and Lord et al. (2010b) papers both present abstracts of the study as detailed by Lord 
et al. (2010). The paper by Lord et al. (2012a) describes an abstract of the study presented in 
full in Lord et al. (2012), and Lord et al. (2012e) also provides an erratum to this same study. 
McNaughton et al. (2017) is a later update (including quantitative findings) from the same study 
detailed by McNaughton et al. (2016) which detailed the initial qualitative findings. Martinez 
(2008) is a conference abstract of the study of Bonilha et al. (2009). The details described in 
these papers, are grouped and collectively presented under a single study within subsequent 
tables and text, for simplicity i.e. Clift et al. (2013), Lord et al. (2010), Lord et al. (2012), 
McNaughton et al. (2017) and Bonilha et al. (2009). If data is referenced uniquely only in one 
of the papers within the group, then that specific paper may be referenced. These papers are 
noted with an additional unique alphanumeric identifier relating it to the main study paper in the 
table, as appropriate. 
 
Three papers (Miyahara et al., 2001, Jamaly et al., 2017 and Liu et al., 2016) were 
conference abstracts for relevant studies. The full study paper for each was not available during 
this systematic review despite attempts to follow up to obtain information, however key 
information available in the abstract was still utilised for the purpose of the extended review. 
The information in these studies appears to contain potentially important outcome data. This 
review will be updated should information become available at a later date. 
  
The majority of the studies selected were conducted in Europe (UK, France, Germany and 
Portugal) with four studies in North America (US, Canada), four in Asia Pacific (New Zealand, 
India, China and Japan) and one in Brazil. No further publications were available for studies 
conducted in any other languages or further countries worldwide from the global databases that 
were searched or from the further manual searches. 
 
The studies that have been published to date were, for the most part, conducted in higher 
income countries, with a bias overall to educated participants, where this information was 
recorded. 
 
Demographic Information 
 
In the majority of studies selected the demographic measurements for patients, as noted in 
Table 1 below, was limited to ‘Age’ and ‘Gender’. Fifteen of the unique studies captured age 
data in various formats while thirteen captured gender. The majority presented the average age 
rather than providing more detailed age data or any further analysis by age group.  
 
The age or mean age of patients was presented for fifteen of the unique studies. The studies 
which captured this data, included participants aged between 48-91 years old. There is clearly a 
large differential within this age range both within the total sample and within the samples of the 
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individual studies. Since COPD has mostly been seen to affect people more often beyond 
retirement age (BTS/BLF, 2002) this sample is consistent with the target population.  
 
Gender information was only collected for thirteen of the unique studies. Study samples 
generally included a higher proportion of females than males. Race and ethnicity data was 
rarely mentioned in any of the reviewed studies and only one study (McNaughton et al., 2017) 
made clear record of this. 
 
Weight was captured in four studies (Lichtenschopf et al., 2014, Lord et al., 2010, Lord et al., 
2012, Pacheco et al., 2014) and height and clinical history by one of these (Pacheco et al., 
2014), though again only the average weight or average height was presented, but no analysis 
was carried out on this data, so little can be deduced from this.  
 
Several studies captured smoking history (Grasch, 2015, McNaughton et al., 2017, Thomas 
et al., 2015), or smoking and alcohol history (Lichtenschopf et al., 2014) but the total amount 
of data examined in these studies was limited and was not analysed in regard to current 
smoking and alcohol usage so again, nothing can be clearly deduced from this information.  
 
Unique 
identifier 
(First Author/ 
Date 
Published) 
(Country) 
Publication title Condition Age 
range 
Gender N = Total 
patients 
evaluable  
Bonilha 2009** 
(Brazil) 
Effects of singing classes 
on pulmonary function 
and quality of life of 
COPD patients 
COPD 69.8 
±7.4  
73.6 
±7.5 
Male/ 
Female 
43 
BLF 2017  
(UK) 
British Lung Foundation 
Singing Project Report 
2015-2017 
CRD Not 
Known 
Male/ 
Female 
80 
Canga 2014* 
(Canga 2015a) 
(US) 
Music therapy in the 
treatment of chronic 
pulmonary disease 
(CT.gov registration entry 
- NCT02146235) 
COPD Not 
Known 
Not 
Known 
Not 
Known 
Canga 2015* 
(US) 
AIR: Advances in 
Respiration - Music 
therapy in the treatment of
chronic pulmonary 
disease 
COPD 70.1  
(48-88) 
Male/ 
Female 
68 
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Clift 2013 
(UK)  
An evaluation of 
community singing for 
people with Chronic 
Obstructive Pulmonary 
Disease (COPD) 
COPD 69.5 
(SD 
7.64)  
Male/ 
Female 
1:2 
126 
Clift 2017 
(UK) 
Findings from the 
Lambeth and Southwark 
Singing and COPD 
Project 
COPD 68.64 
(SD 
9.01) 
Male/ 
Female  
8:23 
42 
Engen 2005  
(US) 
The Singer's Breath: 
Implications for Treatment 
of Persons with 
Emphysema 
COPD M av. 81 
F av. 72 
Male/ 
Female 
7  
Goodridge 
2013* 
(Canada) 
Therapeutic singing as an 
adjunct for pulmonary 
rehabilitation participants 
with COPD: Outcomes of 
a feasibility study 
Advanced 
COPD 
Average 
age ~70 
Male/ 
Female 
14 
Grasch 2013 
(US) 
Daily Singing Practice as 
a Means of Improving 
Pulmonary Function and 
Quality of Life in 
Emphysema Patients 
COPD  69.44 
+/- 9.43 
(47-84) 
Male/ 
Female 
(9:16) 
25  
Herer 2013 
(France) 
Outcomes of a pulmonary 
rehabilitation program 
including singing training 
37 COPD + 
8 CRDs 
60 +/-10 Male/ 
Female 
45 
Jamaly 2017 The effect of singing 
therapy compared to 
standard 
physiotherapeutic lung 
sport in COPD 
COPD  63 ± 6 Not 
Known 
22 
Lichtenschopf 
2014 
(Germany) 
Singing as a new therapy 
in treating COPD patients: 
A pre-study. [German] 
(Singen Als erweiterung 
des therapeutischen 
spektrums bei der 
behandlung der COPD) 
COPD  Not 
Known 
Not 
Known 
119 
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Liu 2016 
(China) 
Effect of Singing Therapy 
on Anxiety and 
Depression in Patients 
with Chronic Obstructive 
Pulmonary Disease at 
Stable Stage in 
Community 
COPD Not 
Known 
Not 
Known 
56 
Lord 2010** 
(UK) 
Singing teaching as a 
therapy for chronic 
respiratory disease - a 
randomised controlled 
trial and qualitative 
evaluation 
CRD  67.3 
(8.1) 
Not 
Known 
28 
Lord 2010a 
(UK)** 
Effect Of Singing Lessons 
In Patients With COPD A 
Randomised Controlled 
Trial [Abstract] 
COPD 67.3 
(8.1) 
Not 
Known 
28 
Lord 2010b 
(UK) ** 
Singing for breathing™ 
effects of singing lessons 
in patients with COPD – A 
randomised control trial 
[Abstract] 
COPD Not 
Known 
Not 
Known 
28 
Lord 2012** 
(UK) 
Singing classes for 
COPD: A randomised 
controlled trial 
COPD 68.3 
(9.7) 
Not 
Known 
24 
Lord 2012a 
(UK)** 
Effects Of "Singing for 
breathing”™ In Patients 
With COPD - A 
Randomized Control Trial 
[Abstract] 
COPD NK NK 24 
Lord 2012e 
(2014) 
(UK)** 
Erratum to: Singing 
classes for COPD: A 
randomized controlled 
trial <correction of trial 
number to 
ISRCTN39714922>  
COPD Not 
Known 
Not 
Known 
Not 
Known 
Martinez 2008 
(Bonilha 2009a) 
(Brazil)** 
Effects of singing on 
pulmonary function and 
quality of life of COPD 
patients [Abstract] 
COPD M: 69.8 
±7.4  
F: 73.6 
±7.5 
Male/ 
Female 
Not 
Known 
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McNaughton 
2014 
(McNaughton 
2017a) 
(New Zealand) 
Sing Your Lungs Out: 
Effect of participation in 
weekly community singing 
group for 1 year, on lung 
function, anxiety and 
depression and health 
care use in patients with 
COPD who have 
completed pulmonary 
rehabilitation: a 
quantitative and 
qualitative study’ WHO 
registration entry - 
ACTRN12615000736549) 
COPD Not 
Known 
Not 
Known 
Not 
Known 
McNaughton 
2016 
(McNaughton 
2017b) 
(New Zealand) 
Sing Your Lungs Out: a 
qualitative study of a 
community singing group 
for people with COPD 
COPD 51–91 Male/ 
Female 
1:1.3  
21 
McNaughton 
2017 
(New Zealand) 
Sing Your Lungs Out: a 
community singing group 
for chronic obstructive 
pulmonary disease: a 1-
year pilot study 
COPD 68.8 
(9.8)  
(51- 91) 
Male/ 
Female  
8:13 
21  
Miyahara 2001 
(Japan)** 
Benefits of singing 
training in chronic 
obstructive pulmonary 
disease patients 
COPD Not 
Known 
Not 
Known 
20 
Morrison 2013 
(Clift 2013a) 
(UK) 
A UK feasibility study on 
the value of singing for 
people with Chronic 
Obstructive Pulmonary 
Disease 
COPD 69.5  
(SD 
7.64) 
Male/ 
Female 
1:2 
106 
Pacheco 2014 
(Portugal)* 
Singing in chronic 
obstructive pulmonary 
disease patients: A pilot 
study in Portugal 
COPD 2M= 68 
1F=42 
1F=50 
Male/ 
Female 
1:1 
6/8 
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Thomas 2015 
(UK) 
‘I really live for coming 
here’. The effect of a long-
term singing group on 
control of breathlessness, 
social empowerment and 
psychological wellbeing of 
patients with respiratory 
disease: a qualitative 
study 
CRD 72.6  
(50–92) 
(Mean) 
Male/ 
Female 
1:3 
16 
Trivedi 2017 
(India) 
Effect of Singing along 
with Pulmonary 
Rehabilitation on Quality 
of Life and Dyspnea in 
Patient with Chronic 
Obstructive Pulmonary 
Disease 
COPD 54 
(Mean) 
(All <65) 
Male/ 
Female 
15:7 
56 
Skingley 2014 
(Clift 2013b) 
(UK) 
“Singing for Breathing”: 
Participants’ perceptions 
of a group singing 
programme for people 
with COPD 
COPD 69.5 
(SD 
7.64) 
Male/ 
Female 
1:2 
97 
Skingley 2018 
(Clift 2017a) 
(UK) 
Community singing 
groups for people with 
chronic obstructive 
pulmonary disease: 
participant perspectives 
COPD Not 
Known 
Male/ 
Female   
37 
 
Table 1 – Systematic Review – Study Demography Details 
 
An a or b noted after the year of study denotes that the paper is a study registration title, a 
subsequent abstract title or an additional paper related to the original study and an e following 
the year of study denotes an erratum paper. 
 
NB Those studies included in the Cochrane review are noted with two asterisks (**) and those 
discussed but excluded from the Cochrane review are noted with one asterisk (*).  
 
Study populations and eligibility 
 
The study populations i.e. sample size, study setting, eligibility and enrolment criteria are 
identified and presented in summary in Table 2 below. The majority of the information within this 
table is provided verbatim from the studies and papers. 
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Unique 
identifier  
(Country)  
Participant 
eligibility 
Participant 
population and 
enrolment 
details 
Study 
Setting  
Randomisation 
Method/ 
Control 
Total 
Patient 
No. 
Bonilha 2009 
(Brazil) 
- COPD 
diagnosis 
according to 
‘GOLD’ criteria  
- Former 
smokers  
- Stable clinical 
conditions for at 
least two 
months  
- Excluded: 
Patients with 
severe 
comorbidities, 
still smoking, or 
using oxygen 
therapy 
Patients invited 
to participate in 
the study during 
regular 
consultations at 
the University 
Hospital, or after 
answering a 
radio 
advertisement  
Hospital 
(2008) 
Randomisation 
– method not 
specified 
Control – Craft 
classes 
 
30  
 
n=15 
singing 
group 
BLF 2017 
(UK) 
- Participants 
experiencing a 
range of 
diagnosed lung 
conditions 
- There is a 
variety of 
diagnoses 
although the 
majority had 
COPD 
A total of 32 
leaders were 
trained, 29 
groups were 
set-up with 26 
self-sustaining 
singing groups 
delivering 
classes to over 
300 people with 
a lung condition 
across England, 
Scotland and 
Wales. 70/80 
enrolled patients 
evaluated 
Community 
Groups 
(2016-17) 
Pilot study 
 
Mixed method, 
No 
randomisation 
or control 
70 
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Canga 2015 
(US) 
- COPD 
diagnosis 
according to the 
‘GOLD’ criteria 
- Attending 
pulmonary 
rehabilitation 
sessions 
- Able to attend 
music therapy 
sessions once a 
week for 6 
weekly sessions 
- Medically 
stable 
simultaneously 
allowing them to 
participate in PR 
Patients newly 
enrolled in PR 
sessions 
randomly 
allocated to 
treatment or 
control group.  
30 excluded as 
required number 
of sessions 
were not 
completed (due 
to time 
commitment or 
personal/ 
medical 
concerns) 
Hospital 
(2008 - 
2013) 
Pilot study 
pulmonary 
rehabilitation 
plus musical 
instrument 
playing and 
singing - No 
randomisation 
or control 
60 
Clift 2013  
(UK) 
- COPD 
diagnosis 
defined by the 
FEV1% 
following GOLD 
(2010) and 
NICE (2010) 
guidance. 
- COPD pts with 
15% mild, 45% 
mod% severe 
and 10% very 
severe. 
- 126 patients 
recruited via all 
routes, 5 did not 
attend for 
baseline 
assessments. 
15/121 (12.3%) 
did not meet 
formal COPD 
inclusion criteria  
COPD patients 
from COPD 
practices. 106 
Pts Mean age 
69.5 (SD 7.64) 
1:3 (M:F) 75.1% 
Retired 13.5% 
due to COPD. 
69.5% previous 
smokers; 11.4% 
current smokers 
99% white, 
51.4% 
continued in 
education, with 
> 1/3 holding a 
degree. 
106 enrolled, 35 
discontinued 
(33%) 71 
followed up 
216 comments 
from 97 
Community 
Groups 
(2011-12) 
 
Six groups 
in a 
community 
setting with 
family, 
carers + 
supporters 
Pilot study 
 
Mixed method 
six groups - No 
randomisation 
or control 
106  
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Clift 2017 
(UK) 
- Participants 
with breathing 
difficulties 
- 31/42 met 
GOLD criterion 
and diagnosis of 
COPD (i.e. 
FEV1\FVC <0.7) 
at baseline 
- Six had mild 
severity, fifteen 
moderate, nine 
severe and one 
very severe.  
- 18 were 
recruited in Sep. 
and 13 in Jan. 
44/ 60 CRD 
participants 10 
males and 34 
females 
recruited with 
breathing 
difficulties. 31 
COPD patients 
8 males and 34 
females. Two 
cohorts from 
four groups 
comparable on 
all baseline 
measures, 
combined for 
the purpose of 
the evaluation 
Community 
Groups 
(2015-16) 
 
 
Pilot study 
 
Mixed method – 
No 
randomisation 
or control 
44 
Engen 2005 
(US) 
- Physician's 
diagnosis of 
emphysema or 
COPD. 
- Patient 
agreement to 
participate in 
10/12 group 
lessons.  
- Screened for 
smoking and 
respiratory 
related 
hospitalisation.  
- Tested for FEV 
>35% <75% of 
predicted values  
Emphysema or 
COPD 
outpatients in 
Gerontology 
clinic and 
pulmonary 
rehabilitation 
clinic 
 
Classroom  
(2002) 
Assigned to 
small group 
based on patient 
schedule 
preference 
(day/time) - No 
randomisation 
or control 
7 
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Goodridge 
2013 
(Canada) 
- Advanced 
COPD attending 
a PR program 
targeted to 
address 
symptoms 
- Participation in 
program for > 3 
months  
- Clinically 
stable  
- Able to 
complete ICD 
and speak/read 
English 
Exclusions - 
concomitant 
medical 
conditions 
significantly 
limiting exercise 
tolerance 
COPD patients 
attending a PR 
program offered 
through the local 
health region in 
Western 
Canada 
Private 
room at the 
PR facility 
following 
regularly 
scheduled 
PR 
session. 
Participants 
consecutively 
assigned to the 
therapeutic 
singing 
intervention up 
to a capacity of 
14. Remaining 
participants 
continue normal 
standard of care 
14 
Grasch 2013 
(US) 
- COPD or 
emphysema 
without any 
other major 
concomitant 
respiratory 
illnesses  
COPD and 
Emphysema 
patients 
participating in 
pulmonary 
rehabilitation 
program 
Hospital PR 
program. 
 
PR study with 
singing alone 
daily as add on 
activity - No 
randomisation 
or control 
13  
Herer 2013 
(France) 
- COPD (n=37) 
or other chronic 
respiratory 
disorders (n=8) 
COPD and CRD 
 
Hospital Open study - No 
randomisation 
or control 
45 
Jamaly 2017 
(Germany) 
- COPD FEV1 
1.65 ± 0.65 
- exacerbation-
free 
COPD patients 
Height 172 ± 10 
cm, Weight 84 ± 
24 kg 
Hospital Single centre 
Open, 
prospective, 
randomized, 
pilot study  
22 
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Lichtenschopf 
2014 
(Germany/ 
Austria) 
- COPD (n=92) 
or other chronic 
respiratory 
disorders (n=27) 
COPD and CRD 
Patients 
requiring oxygen 
or recorded with 
global 
insufficiency 
were excluded 
Rehab. 
Centre  
Pilot study 
design - No 
randomisation 
or control 
119 
Liu 2016 
(China) 
- COPD patients 
 
COPD patients Hospital Randomisation 
according to a 
digit table 
56 
Lord 2010 
(UK) 
- COPD 
diagnosis 
according to the 
‘GOLD’ criteria 
at the Royal 
Brompton 
Hospital 
 
COPD patients. 
183 people 
approached 
initially 150 
declined (82%) 
Total n=33 
randomised, 8 
discontinued 
(i.e. 24% 
attrition).  
n=24 completed 
- attending at 
least 8/12 
sessions 
Hospital Randomisation - 
singing or 
control - block 
randomization 
with consecutive 
sealed 
envelopes 
Control - normal 
standard of care 
28 
n=15 
singing 
group  
n=13 
control 
group 
Lord 2012 
(UK) 
- COPD 
diagnosis 
according to the 
‘GOLD’ criteria 
attending 
respiratory 
clinics at the 
Royal Brompton 
and Harefield 
NHS Foundation 
Trust 
Invitation to 
patients 
attending 
respiratory 
clinics at Royal 
Brompton and 
Harefield NHS 
Foundation 
Trust. 
Control - group 
film discussion 
Hospital 
clinic 
Randomisation - 
baseline blocks 
of 4 via 
consecutive 
sequentially 
numbered 
sealed 
envelopes  
24 
 
n=13 
singing 
group  
n=11 
control 
group 
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McNaughton 
2017 
(New 
Zealand) 
- COPD or other 
chronic lung 
disease 
diagnosis 
- Attended 8-
week, hospital-
based PR 
programme. 
- Attending 
weekly 
maintenance 
community PR 
exercise class 
Patients 
selected by a 
PR nurse from 
group attending 
weekly 
maintenance 
community PR 
exercise class. 
COPD patients 
with a wide 
range of disease 
severity and 
comorbidities 
Urban 
community 
 
Mixed methods 
feasibility study 
Qualitative 
description from 
interview 
transcripts and a 
focus group 
21 
Miyahara 
2001 
(Japan) 
- COPD 
moderate to 
severe - FEV1 
40+/-15% 
COPD patients Hospital Randomisation - 
singing vs. 
control standard 
of care 
Not 
Known 
Pacheco 2014 
(Portugal) 
- Stable clinical 
condition for at 
least 6 weeks 
before 
admission to the 
study 
- COPD 
according to 
‘GOLD’ criteria 
COPD Patients 
attending a 
maintenance P 
programme (90 
min, 2x week) at 
Physical 
Medicine and 
Rehabilitation 
Dept. in Hospital 
Hospital 
Clinic 
Pilot study - No 
randomisation 
or control 
6 
Thomas 2015 
(UK) 
- Singing group 
led by a music 
therapist and 
open to all 
patients with 
respiratory 
disease  
Total n=16 
COPD (11), 
Asthma (2), 
Bronchiectasis 
(2) and Fibrosis 
(1) All non-
smokers 
(ex-smokers 
12); 75% had 
previously 
attended PR. 10 
lived alone, 8 
had a history of 
mental health 
comorbidity  
Hospital Pilot study - No 
randomisation 
or control 
16 
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Trivedi 2017 
(India) 
- Patient with 
recognized 
COPD 
according to 
‘GOLD’ criteria - 
Grade A to C 
- Age < 65 years 
- Singing is their 
hobby.  
- Patient with 
other concurrent 
respiratory 
disease or 
associated 
medical 
condition, 
malignant 
disease or did 
not consider 
singing a hobby 
were excluded 
COPD Patients  Hospital 
Outpatient 
Randomised to 
pulmonary 
rehabilitation or 
pulmonary 
rehabilitation 
with Singing  
56 
n=30 
singing 
group 
 
Table 2 – Systematic Review – Study Patient Population Summary 
 
The study papers selected cover the period from 2001 to 2017, and the majority i.e. seventeen 
of the nineteen studies were conducted within the past ten years.  
 
A total of seven studies specifically mention GOLD staging criteria for COPD, (Bonilha et al., 
2009, Canga et al., 2015, Clift et al., 2013, Clift et al., 2017, Lord et al., 2010, Lord et al., 
2012, Pacheco et al., 2014) but use of the terminology COPD diagnosis or ‘stable COPD’ was 
often used more often, without any specific criteria being mentioned. There is little evidence to 
indicate if the criterion was checked individually for each patient within the studies either, which 
is a significant gap in the quality of the data. 
Studies were frequently recruited using patients from pulmonary rehabilitation (PR) groups or 
recruited through pulmonary clinics (Canga et al., 2015, McNaughton et al., 2017) so COPD 
diagnosis may have been assumed. However, pulmonary rehabilitation is often offered in some 
countries to patients that are not necessarily diagnosed with COPD i.e. PR can be offered to 
patients considered functionally disabled by breathlessness (MRC score > 3), patients with 
MRC score > 2 who are symptomatic and disabled by their condition, patients with other chronic 
progressive lung conditions (e.g. bronchiectasis, interstitial lung disease, chronic asthma and 
chest wall disease and also patients pre and post thoracic surgery including lung transplant) as 
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well as patients with a confirmed diagnosis of COPD (NHS UK, 2011). Hence, the expectation 
of meeting GOLD criteria should not just be assumed. It is apparent that even studies which 
mention GOLD criteria as being part of their inclusion may not have tested patients for this 
criterion specifically prior to enrolment. 
 
Study Interventions  
 
The study interventions i.e. the details of the singing intervention for each study were identified 
and are presented in summary in Table 3 below.  
 
Unique 
identifier  
Duration of study and singing intervention 
details 
Control 
interventions 
Bonilha 2009 24 weeks - one hour per week  
Classes for singing practice 
Craft classes 
BLF 2017 12 weeks (3 months) – one hour per week 
Singing for Lung Health sessions led by a local 
singing leader who has taken part in the BLF 
singing programme. Intervention includes 
physical warm-ups, breathing exercises and 
vocal exercises such as rhythm and pitch games. 
Songs were selected as suitable for people with a 
lung condition, as well as being fun. Leaders 
were trained to focus on developing breathing 
techniques to support participants in reducing 
breathlessness and preserve optimal lung 
function, to develop awareness of postural and 
breathing patterns, extend outbreaths through 
sung phrases, to build physical and vocal 
stamina and have fun. Emphasis is on the 
importance of fostering a positive social 
environment for participants and allowing them to 
express themselves creatively; whilst improving 
self-confidence, quality of life and counteracting 
feelings of stress and anxiety 
None 
Canga 2015 6 weeks - 45 minutes per week 
Music therapy session including live music 
visualizations, wind instrument playing with 
clinical improvisation and singing 
None 
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Clift 2013 36 weeks (9 months) - one hour per week 
Exercises and singing with 30 minutes of 
socialising. Singing in classes with no prescribed 
practice at home. Singing session commenced 
with 20 minutes of relaxation, posture, breathing 
and vocal exercises followed by 40 minutes 
singing - familiar and new songs taught by ear. 
Two combined group workshops and two 
performance events 
None 
Clift 2017 38-40 weeks (10 months) - one hour per week  
Exercises and singing with 30 minutes of 
socialising/administration. Singing in classes with 
no prescribed practice at home. Singing sessions 
included relaxation, posture, breathing and vocal 
exercises followed by the singing of songs 
None 
Engen 2005  6 weeks - 45 minutes twice per week 
Twelve instructional sessions with nine weeks 
study time intervention sessions. Two weeks no-
contact period prior to a final follow-up visit 
None 
Goodridge 2013 8 weeks - one hour per week 
Pulmonary rehabilitation program involving eight 
weeks of classroom instruction as well as 
structured exercise classes prior to singing 
Normal care 
Grasch 2013 12 weeks - 10 minutes per day (70 min per week) 
Singing pamphlet guide subjects through a series 
of breathing and vocal warm-ups. Upon 
completion, they follow with singing a song of 
their choice. Subjects were instructed to practice 
singing five minutes each morning and evening 
None 
Herer 2013 3 weeks - one hour per week 
Respiratory education through singing by two 
professional musicians (instrumentalists and 
choirmaster). Twenty minutes included breathing 
exercises consisting in particular of short 
inspirations deep and prolonged expirations. A 
dozen minutes included a vocal warm-up 
especially by vocalizations. Final part of the 
session was singing popular songs with musical 
accompaniment 
None 
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Jamaly 2017 4 weeks - 8 course units of 1.5 hours 
Therapeutic Singing (TS) - a therapy with 
breathing exercises and techniques 
Physiotherapeutic 
lung exercise 
Liu 2016 24 weeks – once per week 
Singing therapy 
Health Education + 
Mental Nursing 
Lichtenschopf 
2014 
2 weeks - one hour twice per week 
Total of four sessions for about one hour with 
singing group meeting four times (1.5 hours each 
time). Include COPD assessed by GOLD II and 
III and who completed inpatient rehabilitation for 
three to four weeks, plus oral interview 
None 
Lord 2010 6 weeks – one hour twice per week 
All subjects received a thirty-minute standard 
session on breathing control and techniques to 
manage breathlessness, delivered by one of two 
senior respiratory physiotherapists involved in the 
study. ‘Pursed-lip’ breathing and nose breathing 
were also discussed in relation to managing 
episodes of shortness of breath. Subjects 
received a booklet and advised to practice the 
techniques at home 
Normal standard of 
care 
Lord 2012 8 weeks - one hour twice per week 
All subjects received a thirty-minute standard 
session on breathing control and techniques to 
manage breathlessness, delivered by one of 
three senior respiratory physiotherapists involved 
in the study. ‘Pursed-lip’ breathing and nose 
breathing were also discussed in relation to 
managing episodes of shortness of breath. 
Subjects received a booklet and advised to 
practice the techniques at home 
Film discussion 
group – once per 
week 
McNaughton 
2017 
6–9 months – one hour per week 
Singing group started with a 5 minute warm-up 
session, the group led by a musician, chose the 
singing option from a mix of genres with attention 
to the group’s voice range and capacity for 
phrase lengths. Musician also discussed 
breathing for singing techniques as the year 
progressed and as the group gained confidence. 
No music reading ability required. CD of songs 
provided to allow practice at home 
None 
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Miyahara 2001 8 weeks – 5 times per week 
(duration of sessions unavailable)  
Japanese 'Shingin' singing programme (requiring 
slow deep breaths in between singing). 
Individualized intensity of training based on 
patient achieving a dyspnoea-score of 3-5 (on 
Borg scale 0-10) 
Normal standard of 
care 
Pacheco 2014 10 weeks - one hour per week 
Classes were coordinated by a singing teacher 
and a physiotherapist including relaxation 
exercises of neck and upper and lower limb 
muscles, conducted by a physiotherapist (15 
min), vocalization exercises, led by a singing 
teacher, as a preparation for singing (10 min) and 
singing training for popular Portuguese songs, 
conducted by a singing teacher (35 min) 
None 
Thomas 2015 88 weeks - one hour per week 
Singing group led by a music therapist and open 
to all patients with respiratory disease.  Duration 
of singing group attendance 15.3 ± 6.5 months 
None 
Trivedi 2017 4 weeks - one hour twice per week 
One class of singing included pre-singing session 
and singing practice. Pre-singing session 
included local relaxation of respiratory muscles (5 
minutes), singing related exercises (slow and fast 
inspiration and expiration practice, vocalization 
exercises by loud and rhythmic pronunciation of 
vowels for 5-10 minutes) and demonstration of 
song and explanation of singing technique (5 
minutes). Singing practice was done for 45 
minutes with one intermittent rest of 5 minutes. 
Singing teacher was instructed to choose Indian 
classical Songs which have positive and 
inspirational lyrics. (Singing in addition to 45 
minutes of PR four days a week for four weeks) 
Pulmonary 
Rehabilitation 
provided to both 
groups (i.e. 
experimental and 
control) with dose 
tailored by patient 
according to 
AACVPR guidelines 
 
Table 3 – Systematic Review - Study Intervention Summary 
 
Duration, Frequency and Design 
 
There were two key approaches taken in regard to study method which were either controlled 
studies or single group observational studies. There were eight randomised or quasi studies 
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with a control group (Bonilha et al., 2009, Goodridge et al., 2013, Jamaly et al., 2017, Liu et 
al., 2016, Lord et al., 2010, Lord et al., 2012, Miyahara et al., 2001, Trivedi, 2017) and eleven 
feasibility, pilot or observational studies (BLF, 2017, Canga et al., 2015, Clift et al., 2013, Clift 
et al., 2017, Engen, 2005, Grasch, 2013, Herer, 2013, Lichtenschopf et al., 2014, 
McNaughton et al., 2017, Pacheco et al., 2014, Thomas et al., 2015). 
 
The frequency of the singing interventions, for studies where this information was explicitly 
presented, was most commonly delivered in one hourly sessions within a group setting either 
once per week (Bonilha et al., 2009, BLF, 2017, Clift et al., 2013, Clift et al., 2017, 
Goodridge et al., 2013, Herer, 2013, Liu et al., 2016, McNaughton et al., 2017, Pacheco et 
al., 2014, Thomas et al., 2015) or twice per week (Lichtenschopf et al., 2014, Lord et al., 
2010, Lord et al., 2012, Trivedi, 2017). Ten of the studies included patients having one session 
per week and four studies presented data for patients attending two sessions per week.  
 
Five other studies appeared to have a more novel or unique approach. In the first of these 
(Grasch, 2013), patients completed a five-minute series of breathing and vocal warm-ups 
followed with singing a song morning and evening. Another (Miyahara et al., 2001) required 
patients to attend hourly group singing sessions five times per week and one (Jamaly et al., 
2017) was set up as eight course units of therapeutic singing (breathing exercises and 
techniques) each one and half hours long and delivered over four weeks. 
 
One study paper (Canga et al., 2015) described weekly music therapy sessions lasting forty-
five minutes but these included live music visualizations, wind instrument playing and clinical 
improvisation, in addition to the target intervention of singing. This was conducted over a six-
week duration hence there are serious confounders limiting inclusion of results within this 
review more fully. It was decided that this study could be included for completeness in regard 
providing valuable information regarding the design and measures used. There is relatively little 
statistical data reported from the study, so it is considered that the impact of including this would 
be of negligible impact to the key messages or conclusions. 
 
The singing sessions for one of the studies (Engen, 2005) were documented to be twice per 
week but were conducted for forty-five minutes instead of one hour and results of the ANOVAs 
for breath management (extent of counting) and breath support (intensity of speech) for this 
study were significant (p < 0.038 & p < 0.000 respectively). Descriptive analyses of this study 
also showed a clear shift in breathing mode from clavicular to diaphragmatic breathing that was 
maintained two weeks after the treatment period. The overall length of study period i.e. period 
for which the singing or control interventions were conducted for participants, ranged from two 
weeks to thirty-six weeks.  
 
There were eight randomised or quasi studies with a control group (Bonilha et al., 2009, 
Goodridge et al., 2013, Jamaly et al., 2017, Liu et al., 2016, Lord et al., 2010, Lord et al., 
2012, Miyahara et al., 2001, Trivedi, 2017), but the type of control activity was quite varied 
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between the studies identified, ranging from normal standard of care or treatment as usual 
(Goodridge et al., 2013, Lord et al., 2010, Miyahara et al., 2001), physiotherapy lung 
exercises (Jamaly et al., 2017), Health Education/Mental Nursing (Liu et al., 2016) film 
discussion groups (Lord et al., 2012) to craft classes (Bonilha et al., 2009). One study 
(Trivedi, 2017) included PR as a control but the singing intervention also included PR in 
addition to the singing intervention. 
 
Several studies also enrolled patients directly from a pulmonary rehabilitation (PR) group (e.g. 
Goodridge et al., 2013, Canga et al., 2015, McNaughton et al., 2017, Pacheco et al., 2014 
etc.) and this does potentially manage some confounding factors and allows patients to start 
from a relatively similar educational perspective or baseline in regard to their respiratory 
understanding, though it may also lead to its own confounders depending on whether the PR 
continues throughout the study or ceases prior to the start. This was certainly the case for two 
studies (Canga et al., 2015, Trivedi, 2017) where the PR continues. This is not specifically 
mentioned for other studies, so it could not be confirmed either way.  
  
The intervention for one of these studies (Canga et al., 2015) did not purely involve singing and 
PR either, it included additional aspects i.e. exercises with musical instruments in parallel with 
singing intervention and PR, which are significant confounding factors regarding outcome data 
in respect to expressing the outcomes within this systematic review.  
 
One other limitation that should be noted is that none of the studies appeared to have recorded 
previous, recent or parallel singing activities of participants either alone or in groups, which 
could potentially be another confounding factor in the results of the studies included. 
 
There are a number of studies which have confounding factors, limitations or concerns in regard 
unclear information. However, for this broader expanded systematic review, the study design, 
conduct and methodology for all these studies are still valuable. All related studies are included 
and discussed so that an understanding of the overall demographic of the work conducted to 
date and the various study designs, measures and implementations can be examined. The 
actual outcome data and conclusions would have significant limitations though and so these 
components are not explored further for this reason. The results of the more robustly designed 
studies are examined collectively and published in the Cochrane review ‘Singing for Adults with 
COPD’ (McNamara et al., 2017) to which the present author contributed. 
 
Power calculation and sample size rationale  
 
The information regarding power calculations and rationale for the size of the samples were 
limited. One study (Bonilha et al., 2009) had no prospective power calculation but reference 
was made to a previous study which showed that muscle training with 32 patients with COPD 
led to significant changes in respiratory pressures. This was used as justification on final 
number of 15 patients to be included in each arm of the trial.  
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One study (Clift et al., 2013) provided an explanation that if a minimum of fifty estimated 
participants were followed up at the end of the study it would provide appropriate information on 
feasibility and potential effects. A conservative approach was estimated for retention of 50% of 
subjects such that the aim would be to recruit one hundred participants to the study to 
accommodate this retention rate. The follow-up study (Clift et al., 2017) aimed to recruit this 
number of patients and further referenced power calculations in its recommendations, 
suggesting that a sufficiently powered trial may well have required finding over two hundred 
people with COPD at the outset to take into account estimated attrition. The authors indicated 
that future multi-centre randomised studies sufficiently powered and capable of assessing the 
effects of the intervention might require recruitment of five hundred to a thousand participants to 
achieve such enrolment numbers for seasonal variations and background pollution levels to be 
taken into account. 
 
A further study (Grasch, 2013) referenced the significant change from pre-study to post-study 
on the quality of life assessment (SGRQ) from a previous study (Bonilha et al., 2009), with 
effect size of 1.02, as being the key factor in calculating the sample size. It was calculated that 
n=30 would give a statistical power in excess of 0.90 for this proposed pilot study to find a 
statistically significant difference, with alpha=0.05, on the SGRQ. The sample size dropped to 
25 patients and this was still felt to be adequate power to detect an effect size of >0.59. 
 
However, the paper presenting the study referenced (Bonilha et al., 2009) expresses concerns 
regarding limitations of this study, including small statistical power for some of the comparisons, 
mainly due to excessive variation in the results. The authors comment that enrolment of a 
greater number of subjects is needed to assess whether significant changes occur in key 
parameters. 
 
One other study (Canga et al., 2015) noted in their discussion that they would recommend 
future studies consider effectiveness of a lengthened duration of intervention period and 
suggested that a larger sample would increase statistical power. However initially there was no 
detail provided as to how the original sample size was calculated. 
 
It was not clear from any of the other studies if there had been a clear discussion or decision on 
how study samples had been calculated. This rationale has not been provided for the majority of 
studies nor has an indication of whether this was considered. 
 
Study Measures 
 
The studies selected in this review included measurements of over seventy different 
parameters, ranging from demography and physical outcomes to depression and anxiety. Many 
also included qualitative data from participant feedback and interviews. While this does illustrate 
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well the wide diversity of options and data that can be collected when researching this area, 
unfortunately the data captured were largely inconsistent throughout the designs and research 
groups, so comparisons of results between studies or robust meta-analysis could not be 
executed particularly effectively. However, there is still interesting content for examination and 
collective discussion. 
 
The measures used by each study are extracted and analysed in a tabular format as presented 
in Table 4 below and then further examined.  
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Measures General 
theme 
Total 
Bonilha 2009 
BLF 2017 
Canga 2015 
Clift 2013 
Clift 2017 
En gen 2005 
Goodrid ge 2013 
Grasch 2013 
Herer 2013 
Jamal y 2017 
Lichtenschopf 2014 
Liu 2016 
Lord 2010 
Lord 2012 
McNau ghton 2017 
Mi yahara 2001 
Pacheco 2014 
Thomas 2015 
Trivedi 2017 
Demographics: 
Gender 
Demography 13 x  x x x x X x x  x      x   x x x
Demographics: Age Demography 15 x  x x x x X x x x    x x x   x x x
Demographics: Height Demography 3      x          x           x   
Demographics: Weight Demography 6      x          x x  x x    x   
Demographics: Body 
Mass Index (BMI) 
derived 
Demography 1     x               
Demographics: Clinical 
history 
Demography 2        x                    x   
Demographics: 
Ethnicity 
Demography 1               x     
Demographics: 
Smoking history 
Demography 5   x          x    x      x     x  
Demographics: 
Alcohol 
Demography 1                  x             
Demographics: 
Adherence to singing 
Demography 1             x                  
Demographics: 
Medication changes 
during the study. 
Demography 1             x                  
Demographics: Social 
Measures (Income, 
Housing, Education) 
Demography 1     x               
Demographics: Marital 
Status 
Demography 1       X             
FVC  Spirometry 5 x    x x     x             x   
FEV1  Spirometry 10 x    x x x X x x x        x   x   
FEV1/FVC  Spirometry 4 x      x     x              x   
FVC%. Spirometry 4 x    x x                    x   
IC Spirometry 1 x                              
ERV  Spirometry 1 x                              
PImax (cmH2O) (%) Spirometry 1 x                              
PEmax (cmH2O) (%) Spirometry 1 x                              
                                                                          
 
  49  
 
Maximal respiratory 
(inspiratory and 
expiratory) pressure 
measurements mouth 
level (PImax, PEmax) 
Spirometry 4 x      x       x            x   
FEV1% Spirometry 7      x x   X x       x x x       
FEV% Spirometry 2 x    x                         
TLC Spirometry 3             x   x           x   
RV Spirometry 3             x   x           x   
VO2max Spirometry 1               x                
Breath management 
(extent of counting or 
single breath counting)  
Breathing 3         x           x x        
Breath hold time  Breathing 2                     x x        
Breath support 
(intensity of speech) 
Breathing 1         x                      
Breathing mode from 
clavicular to 
diaphragmatic 
breathing 
Breathing 1         x                      
O2 Saturation% 
(SpO2%) 
Physical 1     x               
O2 Saturation 
recovery (s) 
Physical 3           X         x x        
Heart Rate recovery (s) Physical 2                     x x        
Subjective recovery (s) Physical 2                     x x        
Blood Pressure 
(Systolic /Diastolic) 
Physical 1     x               
Arterial blood gases  
breathing room air; 
Physical 1 x                              
Heart rate post walk Physical 5        x   X         x x    x   
Distance walked Activity 1         x                      
Six-Minute Walk Test 
(6MWT) min   
Activity 5        x   X   x         x   x   
Incremental Shuttle 
Walk Test (ISWT) min 
Activity 2                     x x        
Incremental shuttle 
Walk Test (ISWT) with 
recovery rates for 
heart rate 
Activity 1                       x        
Shuttle walk distance Activity 3         x           x x        
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Steps per day Activity 1                       x        
Sedentary time 
(minutes per day) 
Activity 1                       x        
Physical activity 
duration (PAD)  
(minutes per day) 
Activity 1                       x        
Activity entry 
expenditure (AEE)  
(Kj per day) 
Activity 1                       x        
Routine exercise Activity 1             x                  
Physical activity was 
measured using 
SenseWear armbands 
pre/post intervention. 
Subjects were given a 
SenseWear Pro 
(SenseWear, Body 
Media, Pittsburgh, 
USA) activity monitor 
for a week prior to 
commencing sessions 
Activity   1                       x        
Exercise recorded  
(all activity) 
Activity   7      x X x x    x x    x   
MRC breathlessness/ 
Dyspnoea scale  
Dyspnoea   7   x   x x   X   x            x  x
BDI evaluations of 
dyspnoea (Basal 
Dyspnoea Index)  
Dyspnoea   2 x  x                           
Borg dyspnoea score Dyspnoea   6 x      x x           x x    x   
University of Cincinnati 
Dyspnoea 
Questionnaire (UCDQ) 
Dyspnoea 1               x                
Chronic Respiratory 
Disease Questionnaire 
(CRQ)  
Respiratory 3    x                  x  x     
COPD Assessment 
Test Score (CAT) 
Respiratory 4   x              x      x    x   
St George’s 
Respiratory 
Questionnaire QoL 
(SGRQ) 
Respiratory 8 x    x x   X x   x    x      x   
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Brief Symptom 
Inventory-x8 Global 
Severity Index 
Respiratory 1             x                  
London Chest Activity 
of Daily Living Scale 
(LCADL)  
Respiratory 1                            x   
Visual Simplified 
Respiratory 
Questionnaire (VSRQ) 
Respiratory 1               x                
Clinical COPD 
Questionnaire (CCQ) 
Respiratory 1               x     
Respiratory illness 
occurred during study. 
Respiratory 1             x                  
EQ-5D EuroQoL Test; Health  4   x   x x                    x   
Short Form Health 
Survey (SF-36) or 
York SF-12  
Health  3     x              x x        
HAD Anxiety Score Health  6                    x x x x   x  x
HAD Depression 
Score 
Health  5                    x x x x      x
Beck Depression 
Inventory 
Health 1    x                           
DUKE physical health 
subscale 
Health  1         x                      
General Anxiety 
Disorder-7 (GAD-7) 
Health  1  x                  
Measures of functional 
outcomes  
Health  1         x                      
Self-reported global 
health rating (10-point 
scale) 
Health  1           x                    
Brief Illness 
Perceptions 
Questionnaire (BIPQ) 
Health  1           x                    
Brief Symptom 
Inventory-18 Global 
Severity Index 
Health  1             x                  
A post intervention 
written evaluation 
survey (acceptability 
and enjoyment) 
Survey 1           x                    
                                                                          
 
  52  
 
Questionnaire - 
CareFusion, Kent, UK 
Survey 1                     x          
Specially prepared 
questionnaire  
Survey 2           x      x             
Service Use 
(Healthcare Utilisation) 
Survey 2     x             x  
Hospital admission 
days for acute 
exacerbation of 
COPD (AECOPD) 
Survey 1               x     
Patient Activation 
Measure (PAM) 
Survey 1  x                  
Principal themes 
expressed from 
participant feedback 
Written text 3      x x                      x  
Interviews, Journals 
and Participant 
Feedback  
Written text 10   x   x x x
  
x         x x x   x x  
Evaluation of adverse 
event occurrence while 
attending the singing 
programme  
Written text 1           x                    
 
Table 4 – Systematic Review – Study Measures Summary  
 
A full explanation or description of the types of measures used, along with general findings from 
the various different measures and tools employed within the studies are grouped into 
categories for summarisation as follows: 
 
Physiological Measures 
 
Lung Function Measures 
 
Lung function or pulmonary health measures are most commonly performed in these studies 
using validated spirometer readings. This measures the amount and speed with which air can 
move in and out of the lungs. The following different spirometry (or pulmonary) measurements 
were captured in more than one of the studies identified: 
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Forced Vital Capacity (FVC) 
 
This is the amount of air exhaled with force relative to population normal values, after inhaling 
as deeply as possible. Five studies (Bonilha et al., 2009, Clift et al., 2013, Clift et al., 2017, 
Grasch, 2013, Pacheco et al., 2014) collected readings of this measure and a small, though 
statistically significant reduction in FVC were shown only in one study (Clift et al., 2013). No 
significant effects were seen in any of the other studies. 
 
Percentage Forced Vital Capacity (FVC%)  
 
This calculation is the % air exhaled with force after inhaling as deeply as possible. Four studies 
(Bonilha et al., 2009, Clift et al., 2013 Clift et al., 2017, Pacheco et al., 2014) collected and 
presented data for this endpoint, though improvements in FVC% were only shown by the same 
study (Clift et al., 2013) that showed improvement in FVC. 
 
Forced Expiratory Volume (FEV) 
 
This is the amount of air exhaled with force in one out-breath. The amount of air exhaled in one 
out-breath may be measured at one second (FEV1), two second (FEV2), or three second 
(FEV3) intervals. (FEV1 divided by FVC can also be determined). Ten studies (Bonilha et al., 
2009, Clift et al., 2013, Clift et al., 2017, Engen, 2005, Goodridge et al., 2013, Grasch, 2013, 
Herer, 2013, Jamaly et al., 2017, McNaughton et al., 2017, Pacheco et al., 2014) described 
this measure. In some cases, this value was only noted as being captured at baseline to 
support inclusion criteria or the analysis of other measures and no further data was reported 
post intervention (e.g. McNaughton et al., 2017). Only one study (Clift et al., 2013) appeared 
to show some improvements in this measure post intervention and another (Pacheco et al., 
2014) observed that the FEV1 improved from 1.15 L (45%) to 1.21 L (47%) for one of four 
patients though this was not significant. 
 
Percentage Forced Expiratory Volume (FEV%, FEV1%)  
 
This is a calculated value of the % air exhaled with force relative to population normal values at 
intervals as above. Eight studies (Clift et al., 2013, Clift et al., 2017, Goodridge et al., 2013, 
Grasch, 2013, Jamaly et al., 2017, Lord et al., 2010, Lord et al., 2012, and McNaughton et 
al., 2017) presented FEV1%, and two studies (Bonilha et al., 2009, Clift et al., 2013) 
presented FEV% results. Interestingly there appears to be only one study (Clift et al., 2013) 
which showed improvement for FEV1% but there were no other significant findings from any of 
the other studies.  
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Calculated Ratio FEV1/FVC 
 
This ratio (also called Tiffeneau-Pinelli index) represents the proportion of FVC that a patient is 
able to expire in the first second of forced expiration. Four studies calculated and referred to this 
ratio (Bonilha et al., 2009, Clift et al., 2017, Grasch, 2013, Pacheco et al., 2014) but there 
were no findings referenced except by one study (Clift et al., 2017) where FEV1 /FVC shows a 
significant improvement, but the research team note that this likely reflects the decrease in FVC 
within this sample. 
 
Maximal Inspiratory Pressure (MIP or PImax)  
 
Maximal Inspiratory Pressure (MIP or PImax) reflects the strength of the diaphragm and other 
inspiratory muscles (Polkey et al., 1995) (An alternative test of inspiratory muscle strength is 
maximal sniff nasal inspiratory pressure (SNIP) but this was not seen in any of the studies 
selected). Maximal inspiratory pressures at the mouth level (MIP or MIP%) were measured for 
four studies (Bonilha et al., 2009, Clift et al., 2017, Herer, 2013, Pacheco et al., 2014). In one 
very small study (Herer, 2013) there was seen to be a principal significant variation observed 
for PImax between baseline and the end of the intervention (11W variation, +14.7%, p = 0.001), 
though this study included singing as part of a pulmonary rehabilitation programme confounding 
the overall finding. No significant changes were noted for any of the other studies where this 
measure was presented. 
 
Maximal Expiratory Pressure (MEP or PEmax)  
 
This reflects the strength of abdominal and other expiratory muscles. Maximal expiratory 
pressures at the mouth level (MEP or MEP%) were measured for four studies (Bonilha et al., 
2009, Herer, 2013, Pacheco et al., 2014). This measure provided the most important functional 
finding for one study (Pacheco et al., 2014) where the positive influence of singing exhibited an 
increase of 3 cm H2O in mean PEmax at the end of the intervention, while the control group 
showed a decrease of 11.3 cm H2O. One other study (Bonilha et al., 2009) noted that while the 
control group showed a clear decline in maximal expiratory pressure, the singing group showed 
a small improvement, and the difference was statistically significant. It also noted that the 
improvement of PEmax associated with singing could also contribute to better coughing. 
 
General Spirometry Measures 
 
A further ten to fifteen additional lung function or inspiratory measures were mentioned, 
recorded or calculated throughout all the selected studies. It is anticipated that some were 
similar or the same despite differing terminology e.g. The generic term spirometry was noted in 
place of explicit detailed spirometry measure readings being captured or presented i.e. FEV etc. 
which would usually be expected as part of a spirometry test.   
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There were two studies (Bonilha et al., 2009, Pacheco et al., 2014) in particular which 
included almost the full range of spirometry readings plus several other different function tests 
or calculations in addition, including: Expiratory Reserve Volume (ERV), which is the maximal 
volume of air that can be exhaled from the end-expiratory position; Tidal Volume (TV), the 
volume of air moved into or out of the lungs during quiet breathing; Inspiratory capacity (IC) 
which is the sum of ERV and TC (Bonilha et al., 2009); Total lung capacity (TLC) the volume in 
the lungs at maximal inflation, Residual volume (RV), the volume of air remaining in the lungs 
after a maximal exhalation and finally Total lung capacity (TLC) which is the volume in the lungs 
at maximal inflation and the sum of VC and RV) (Pacheco et al., 2014). One additional study 
(Jamaly et al., 2017) recorded these two values and showed that there was a significant (p = 
0.002) hyperinflation decrease in a therapeutic singing experimental group i.e. RV%/TLC 58 ± 
12.3% to 51 ± 14.5%. However, the quality of this study is low due to the lack of published data 
currently available. 
 
There seems to be no significant findings for the majority of these other lung function tests 
although it was noted in one randomised controlled trial that a session of singing was 
associated with distinct effects on ERV and IC, detected 2 minutes after its interruption. The 
control group showed an increase of ERV and a decrease of IC but the singing group had 
opposite outcomes (Bonilha et al., 2009). The measurements that were utilised most 
commonly i.e. > 2 studies, were FVC (4 studies), FEV1 (7 studies) and FEV1/FVC (3 studies). 
There was only one study (Clift et al., 2013) which specifically showed significant improvement 
from singing alone in FEV1%, FVC and FVC% results.  
 
Physical Measures (Non-Lung function) 
 
There were more than twenty different types of physical and activity measures recorded, across 
all included studies. These were related to heart rate, exercise, activity etc. The measures that 
were utilised most commonly were the Six-Minute Walk Test (6MWT), incremental shuttle walk 
test (ISWT) and these are outlined in more detail below. 
 
Six-Minute Walk Test (6MWT) 
 
The 6MWT is used as a measure of functional status in patients with a wide variety of diseases, 
but it has been particularly helpful for determining prognosis and response to treatment in 
patients with pulmonary hypertension, congestive heart failure, and COPD. It also correlates 
with maximum oxygen uptake in patients with pulmonary hypertension, congestive heart failure, 
and COPD (Wise and Brown, 2005). 
 
This measure was utilised by five studies (Clift et al., 2017, Goodridge et al., 2013, Herer, 
2013, Pacheco et al., 2014, McNaughton et al., 2017) without any valuable findings from two 
of these (Goodridge et al., 2013, Pacheco et al., 2014) but significant variations observed in 
one very small study (Herer, 2013) where there was a positive variation of +13.8% which was of 
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significance p = 0.006 and another (McNaughton et al., 2017) showed strong evidence for an 
increase in 6MWT after 4 months, with a mean increase of 28 (95%CI 5 to 52) m, p = 0.019, 
increasing further to 65 (95% CI 35 to 99) m, p < 0.001 at 1 year. However, this outcome was 
confounded by the fact that the intervention included participant engagement in physical 
exercise. 
 
One further study (Clift et al., 2017) showed a reduction from 312.7 to 296.6 metres in the 
distance covered in the Six-Minute Walk Test (6MWT) by participants with COPD, but the 
change was not statistically significant, and the evaluations were plagued with unusually high 
temperatures on the days of post-test assessments, impacting exercise evaluation. 
 
Incremental Shuttle Walking Test (ISWT) 
 
The Incremental shuttle walk test (ISWT) is derived from field tests of maximum exercise 
capacity. The shuttle walk test (SWT) has been less extensively studied in COPD than the 
6MWT but has been demonstrated to correlate with Maximal Oxygen Uptake (VO2Max) and in 
particular patients with COPD have a strong correlation of SWT with VO2Max (Wise and 
Brown, 2005). 
 
This test was employed by just two studies (Lord et al., 2010, Lord et al., 2012) with time to 
recovery of oxygen saturation, Borg Dyspnoea score and heart rate following the walk but there 
appeared to be no discernible change over time in walking. One of these studies (Lord et al., 
2010) recorded no differences between the groups for single breath counting, incremental 
shuttle walking test (ISWT) score or recovery time following ISWT.  
 
General Exercise Measurements 
 
A total of seven of the studies (Engen, 2005, Goodridge et al., 2013, Grasch, 2013, Herer, 
2013, Lord et al., 2010, Lord et al., 2012, Pacheco et al., 2014) included at least one exercise 
measure of some kind (including either one of the afore mentioned walk tests, accumulative 
steps per day, distance walked, routine exercise etc.). One study in particular (Lord et al., 
2012) noted many different and detailed physical measures in addition due to the use of ‘Activity 
Monitors’ discussed further in the next section. There seems to be no clear message however 
from any of the studies individually or collectively in regard to exercise in response to the 
intervention. 
 
Activity Monitors 
 
Physical activity was measured using ‘SenseWear©’ armbands by just one study (Lord et al., 
2012) which is a novel approach in this area of research.  This study had a strong focus on 
patient activity, and in addition to other more standard exercise measures there was a detailed 
analysis of a variety of different monitored readings i.e. Steps per day, Sedentary time (min per 
                                                                          
 
  57  
 
day), Physical Activity Duration (PAD) min per day and Activity Energy Expenditure (AEE) Kj per 
day with measures taken prior to and post intervention. 
 
Subjects were given a SenseWear© Pro (Sense-Wear, Body Media, Pittsburgh, USA) activity 
monitor to wear for one week prior to commencing their sessions and given written instructions 
on its usage and cleaning (Lord et al., 2012). It would be interesting to explore further the 
experiences of using such tools in this population as there is no indication of patient feedback 
on using this tool, the reliability or quality of the data or any measures of compliance.    
 
This study (Lord et al., 2012) also utilised two measures to assess control of breathing, which 
were in routine use in the physiotherapy department for the assessment of hyperventilation. All 
members of the singing group reported being more aware of their breathing and how to control 
it more effectively but the difference in perceived improvements between the two groups was 
not accompanied by differences in measures of breathing control, functional exercise capacity 
or daily physical activity. 
 
Oxygen uptake (VO2), Maximal Oxygen Uptake (VO2Max), Oxygen Saturation (SaO2) 
Saturation of Peripheral Oxygen (SpO2) and Saturation recovery (s)  
 
Pulse oximetry is a technology used for patients with COPD and other conditions to measure 
the oxygen level in the blood and the heart rate and can rapidly detect changes in blood oxygen 
level. Six of the studies (Bonilha et al., 2009, Clift et al., 2017, Herer, 2013, Goodridge et al., 
2013, Lord et al., 2010, Lord et al., 2012) utilised various different oxygen readings and these 
are grouped together for simplicity. 
 
Maximal oxygen uptake (VO2Max) is the measurement of the maximum amount of oxygen that 
an individual can utilize during maximal exercise, measured such that it accounts for their 
weight i.e. ml/kg/min and oxygen saturation (SaO2) measures the percentage of hemoglobin 
binding sites in the bloodstream occupied by oxygen. Saturation of Peripheral Oxygen (SpO2) is 
an estimation of the oxygen saturation level and it is an indirect measurement of the oxygen 
content of blood using oximetry. SaO2 is a direct measurement of the oxygen content of the 
blood by arterial blood gas sampling. In patients with COPD, the maximal oxygen uptake (VO2) 
measured at peak exercise and the six-minute walk distance (6MWD) has also been associated 
with survival rates, 6MWD is as good predictor of mortality as the peak VO2 in patients with 
COPD (Cote et al., 2007). 
 
Three of the studies (Goodridge et al., 2013, Lord et al., 2010, Lord et al., 2012) recorded 
time to recovery of oxygen saturation following ISWT but recovery time for oxygen saturation did 
not improve significantly for any of these. Another study (Clift et al., 2017) undertook oxygen 
saturation assessments only as a precautionary measure to ensure that values were in the 
normal range and did not use these as an outcome measure. 
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Similar to the results noted for 6MWT, the same small study (Herer, 2013) observed principal 
significant variations with VO2Max to with a variance of +8.3% (p = 0.01) and one study 
(Bonilha et al., 2009) captured arterial blood gases while breathing room air and showed a 
significantly higher arterial oxygen saturation (SaO2) during the act of singing. 
 
Heart Rate (HR) and HR Variability (HRV) 
 
Two studies (Lord et al., 2010, Lord et al., 2012) recorded Heart Rate (HR) and HR recovery, 
which is defined as the difference in heart rate between peak exercise and 1 minute later in 
seconds as well as subjective recovery post exercise, however neither of these appeared to 
improve. There were also three studies (Clift et al., 2017, Goodridge et al., 2013, Pacheco et 
al., 2014) which recorded Heart Rate following walk, but there were no significant findings. 
None of the studies selected captured HRV. 
 
Patient Reported Outcome Measures 
 
Dyspnoea Measures 
 
The main goal of rehabilitation in chronic respiratory disease is to improve dyspnoea. Hence, 
quantifying dyspnoea is very important and a large number of scales are available to classify 
and characterise this symptom specifically. There are clinical scales (e.g. MRC or BDI/TDI) in 
which information is obtained directly from the patients via questioning and there are also 
psychophysical scales (e.g. Borg scale, VAS). These assess symptom intensity in response to a 
specific stimulus e.g. exercise (Crisafulli and Clini, 2010). 
 
Twelve of the studies included at least one form of dyspnoea questionnaire. Seven studies 
(BLF, 2017, Clift et al., 2013, Clift et al., 2017, Pacheco et al., 2014, Goodridge et al., 2013, 
Herer, 2013, Trivedi, 2017) utilised the ‘MRC breathlessness/ Dyspnoea scale’ or a modified 
version of the MRC. Six studies (Bonilha et al., 2009, Clift et al., 2017, Engen, 2005, Pacheco 
et al., 2014 Lord et al., 2010, Lord et al., 2012) utilised the ‘Borg dyspnoea score’ or a 
modified version of this scale. Two further studies (Bonilha et al., 2009, Canga et al., 2015) 
utilised ‘Evaluations of dyspnoea (basal dyspnoea index (BDI))’ and one study utilised the 
University of Cincinnati Dyspnoea Questionnaire (UCDQ) (Herer, 2013). The details of these 
findings are further outlined below. 
 
MRC Breathlessness/Dyspnoea Scale  
 
The MRC breathlessness scale comprises five statements that describe almost the entire range 
of respiratory disability. The MRC breathlessness scale does not quantify breathlessness itself 
as with the Borg scale or visual analogue scales, but it quantifies the exercise limitation 
associated with breathlessness (Stenton, 2008). 
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In has been indicated that the MRC score correlates well with the results of other 
breathlessness scales and lung function measurements (Mahler and Wells, 1988). It also 
aligns closely with direct measures of disability such as walking distance (Meek et al., 1999). 
The main disadvantage of the MRC measure over other more complex scales is its relative 
insensitivity to change (Stenton, 2008). It has been in use for more than 50 years and has the 
important benefit of not being subject to copyright, making it easily accessible for clinical 
research work and thus more widely used. 
 
Seven of the studies utilised this scale. Two observed significant variations from the initial value. 
One (Herer, 2013) observed 2.3 +/- 0.6 with % variation -21.7% (significance p < 0.01 and the 
other (Trivedi, 2017) observed a more significant change (p = 0.001) in the control group than 
in the experimental group (p = 0.47) suggesting an improvement in dyspnoea due to the singing 
intervention, but there were no significant changes found on the MRC scale by the other five 
feasibility studies (BLF, 2017, Pacheco et al., 2014, Goodridge et al., 2013, Clift et al., 2013, 
Clift et al., 2017).  
 
Borg Dyspnoea Scale 
 
It was demonstrated that the Modified Borg Dyspnoea scale correlated well with other clinical 
parameters often used in the emergency department (Kendrick et al., 2000) and was found to 
be effective in assessing and monitoring treatments in non-acute and the acute environments. It 
has been a practical and effective way to provide documentation and continuity of care 
information and by incorporating the principles of self-rating, the patient is able to contribute 
valuable information to the medical and nursing treatment plan. 
 
Six studies (Bonilha et al., 2009, Clift et al., 2017, Engen, 2005, Pacheco et al., 2014, Lord 
et al., 2010, Lord et al., 2012) utilised this scale. One study (Bonilha et al., 2009) showed a 
significant (p = 0.02) effect using this scale for dyspnoea i.e. transitory elevations on the Borg 
scale. Another study (Grasch, 2013) showed significant change at follow-up from the mean at 
baseline according to the Borg Fatigue rating (7.60 vs 8.88), however this study has a 
confounding factor that pulmonary rehabilitation continued throughout which could impact the 
effect of the intervention of interest i.e. singing. Finally, the distance walked in one study (Clift 
et al., 2017) was shown to have a small but non-significant reduction using the Borg 
breathlessness scale and participants reported no change in breathlessness following the 
6MWT. This is a positive finding though as it showed no deterioration in exercise potential over 
the period of the evaluation. 
 
Baseline/Basal Dyspnoea Index (BDI) 
 
The baseline dyspnoea index (BDI) consists of five specific grades for each of three categories: 
functional impairment, magnitude of task and magnitude of effort. To grade dyspnoea with the 
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BDI, an observer interviews the patient and asks open-ended questions concerning the patient’s 
symptoms which should take around three minutes. They then focus on specific criteria for the 
severity of breathlessness in each category as outlined in the BDI. The degree of impairment is 
based on patient responses and graded related to dyspnoea for all three components. Baseline 
focal score is obtained by adding the three ratings for functional impairment, magnitude of task 
and magnitude of effort (Mahler and Wells, 1988). 
 
This tool was implemented by one study (Bonilha et al., 2009) but noted no significant changes 
in BDI however commented that due to limitations in the study design it cannot be excluded the 
possibility that the enrolment of a greater number of subjects would provide evidence of 
significant changes in these parameters.  
 
University of Cincinnati Dyspnoea Questionnaire (UCDQ) 
 
The University of Cincinnati Dyspnoea Questionnaire (UCDQ) was developed to measure the 
impact of dyspnoea during physical activity, speech activity and simultaneous speech and 
physical activity and provides valid and reliable information about the effect of dyspnoea on 
speech and daily activities (Hodge et al., 2003). This was also only utilised by one study 
(Herer, 2013) and again no significant changes were recorded.  
 
Dyspnoea within other Heath Questionnaires 
 
Several studies utilised tools which contain a component to measure aspects of dyspnoea as 
below: 
 
Chronic Respiratory Disease Questionnaire (CRQ) 
 
Chronic Respiratory Disease Questionnaire (CRQ) is an interviewer-administered questionnaire 
containing a dyspnoea element, utilised by three studies (Canga et al., 2015, Miyahara et al., 
2001, Lord et al., 2011) but with no significant results or findings in regard to singing itself. 
 
One study (Canga et al., 2015) utilised this tool along with a visual analogue scale (VAS), 
consisting of a succession of lung drawings representing the progressive severity of dyspnoea 
with a numerical rating scale. The analysis of the results of two independent tools shows a 
significant improvement of perceived dyspnoea on the control group, observed over session and 
time. The most significant change was observed after the 5th week of treatment. The author 
speculates this might relate to the effect of musical agency on perceived dyspnoea during 
exercise. However, the design of the study utilises several confounding elements in addition to 
singing within the intervention, so it is impossible to draw a firm conclusion about singing itself 
from this study. 
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Physiological Respiratory Measures 
 
Researchers have found that physiological, functional and psychosocial consequences of 
COPD are only ‘poorly to moderately’ related to each other. Comprehensive assessment of the 
effects of COPD requires an extensive amount of instruments that not only capture the disease 
specific effects, but also the overall burden of the disease on patients everyday functioning and 
emotional wellbeing (Engström et al., 2001). 
 
There are a number of patient reported outcomes tools available specifically for respiratory 
illness, those measures most commonly providing key findings within these studies are: 
 
St George’s Respiratory Questionnaire (SGRQ - QoL) 
 
The SGRQ is a self-completed multiple-choice questionnaire involving the patients' perceived 
wellbeing in regard to comfort with their lung function during daily activities and how the disease 
affects their life. Three component scores are calculated: Symptoms, Activity, and Impacts from 
which a total score is derived (Grasch, 2013). 
 
Three studies provided some positive findings utilising this tool. One study (Clift et al., 2013) 
showed a change of 3.3 points in the direction of health improvement. A second study showed a 
significant improvement of 41 ± 20 to 31 ± 18 points (p = 0.016) in the experimental singing 
intervention group compared with a change of 44 ± 12 to 37 ± 16 points (p = 0.037) in the 
control group where participants were assigned to a course of physiotherapy lung exercises 
(Jamaly et al., 2017). 
 
One study (Clift et al., 2017) showed a 0.2 increase in a negative direction on the total score of 
this scale but the change for the symptom scale showed a positive improvement of 7.8 points. 
However, there are no available guidelines on the interpretation of sub-scales within the SGRQ, 
as an assessment of the ‘minimum clinical important difference’ (MICD) in scores for the SGRQ 
can only be made for the total score. 
 
One study (Bonilha et al., 2009) showed significant improvements of ‘Quality of Life’ scale 
within group comparisons. The mean change in ‘Quality of Life’ score of the control group for 
this study was slightly higher than the improvement of the singing group though, but the 
difference did not reach statistical significance (p = 0.06). 
 
Three further studies (Goodridge et al., 2013, Grasch, 2013, Lord et al., 2010, Pacheco et 
al., 2014), employing the SGRQ, did not find improvements in health-related quality of life, 
exercise capacity, or perceptions of illness for participants in the singing program compared to 
those receiving usual care. 
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COPD Assessment Test (CAT) 
 
The COPD Assessment Test (CAT) is a questionnaire designed to measure the impact of 
COPD on a person's life, and how this changes over time. It was developed in response to a 
need for a validated short, simple instrument to quantify chronic obstructive pulmonary disease 
(COPD) impact in routine practice to aid health status assessment and communication between 
patient and physician. It is a short, simple questionnaire for assessing and monitoring COPD. It 
has good measurement properties, is sensitive to differences in state and provides a valid, 
reliable and standardised measure of COPD health status (Jones et al., 2009). The CAT tool 
contains questions which are similar but not as detailed or specific as those contained in the 
SGRQ.  
 
This measure was employed by four studies (BLF, 2017, Lord et al., 2012, Jamaly et al., 
2017, Pacheco et al., 2014). Two studies showed impact of COPD on a patients’ life as 
measured by the CAT improved significantly during the singing intervention. One study (Jamaly 
et al., 2017) recorded significant improvement (p = 0.029) in the singing intervention group (17 
± 9 to 12 ± 8 points) though a significant change (p = 0.161) was not seen in the control group 
(physiotherapy lung exercises). Another study (BLF, 2017) recorded significant mean 
improvement of 1.1 (p = 0.02) post singing intervention. No significant findings were recorded 
with the CAT by the other two studies (Lord et al., 2012, Pacheco et al., 2014). 
 
Visual Simplified Respiratory Questionnaire (VSRQ) 
 
The Visual Simplified Respiratory Questionnaire (VSRQ) is designed to assess health-related 
quality of life (HRQoL) in patients with COPD. It contains eight items: dyspnoea, anxiety, 
depressed mood, sleep, energy, daily activities, social activities and sexual life. Psychometric 
properties of this tool were assessed during a clinical trial of COPD patients, including the 
determination of structure, internal consistency reliability and concurrent validity with the St 
George’s Respiratory Questionnaire (SGRQ), test-retest reliability, clinical validity and 
responsiveness to change over two weeks (Perez et al., 2009). 
 
This was utilised by two studies (Bonilha et al., 2009, Herer, 2013) but only one study (Herer, 
2013) showed principal significant variations (+50.0% p < 0.01 i.e. 87.5%). 
 
Breath Management and Control  
 
Patients control of breathing was assessed by two studies (Lord et al., 2010, Lord et al., 2012) 
using two measures.  These were the breath hold test, where subjects held their breath from 
maximum inspiration and also single breath counting, where subjects were instructed to breathe 
in and then count out loud in time with a metronome running at 60 beats per minute (bpm). 
Three attempts at each manoeuvre were made and the mean values recorded. However, there 
was no improvement shown in either study. 
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One study (Engen, 2005) also captured data for breath management including single breath 
counting as above but with the metronome set at 92 beats/ minute (bpm) falling behind by more 
than one beat stopped the count and the measure taken was the mean of 3 trials. Breath 
support was also captured and defined as the power behind the breath, measured as intensity 
of speech.  
 
Persons with emphysema are known to have a breathy vocal quality and so a measure of vocal 
support (intensity of speech) in decibels, was measured in this study too (Engen, 2005). A 
RadioShack® digital sound level meter was used to record the maximum decibel level during 
speaking (as if to an audience). A simple visual check was also taken at each measurement 
period to determine whether or not the patient could learn to breathe diaphragmatically. 
 
Physiological and Health Measures 
 
Short Form Health Survey SF-36 (SF-36) and York SF-12 (SF-12)  
 
The SF-36 is a generic health status measure which has gained popularity as a measure of 
outcome in a wide variety of patient groups and social surveys. The SF-12 is an even shorter 
measure, which reduces respondent burden and in studies has been seen to accurately 
reproduce the two summary component scores which can be derived from both surveys. 
Physical Component Summary Score (PCS) and Mental Health Component Summary Score 
(MCS) calculated from the SF-36 or a sub-set of 12 items (the 'SF-12') were virtually identical 
and indicated the same magnitude of ill-health and degree of change overtime (Jenkinson et 
al., 1997). 
 
One study utilised the shorter version (SF-12) (Clift et al., 2013) and two studies (Lord et al., 
2010, Lord et al., 2012) utilised the full version (SF-36). No changes were seen on SF-12 
components (Clift et al., 2013), but two studies showed a significant difference in response for 
the physical component summary (PCS) score of the SF-36, favouring the singing group i.e. 
one study (Lord et al., 2010) showed improvement of +7.5(14.6) vs. -3.8(8.4) (p = 0.02) and 
another study (Lord et al., 2012) showed improvement of +12.9 (19.0) vs -0.25(11.9) (p = 0.02). 
 
One study (Clift et al., 2013) referred to the fact that a previous study (Coulton et al., 2015) 
showed SF12 mental health improvements for older people participating in singing over twelve 
weeks, as rationale for using this score, as well as noting the previous changes on SF36 
reported by two earlier studies (Lord et al., 2010, Lord et al., 2012). Evidence shows that the 
SF12 and SF36 scores are strongly correlated (Jenkinson et al., 1997). 
 
There is no further information available to explain which aspects of the PCS score specifically 
were potentially impacted by the singing intervention in the studies that showed improvement 
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(Lord et al., 2010, Lord et al., 2012). It may be interesting to research these characteristics 
further in this population following these results.  
 
EuroQoL Test (EQ-5D)  
 
The EuroQOL five dimensions questionnaire (EQ-5D) is one of the most commonly used 
generic questionnaires to measure health related quality of life (HRQoL). The conceptual basis 
of the EQ-5D includes the medical definition, as well as the fundamental importance of 
independent physical, emotional and social functioning. The concept of health in EQ-5D also 
encompasses both positive aspects (well-being) and negative aspects (illness). The EQ-5D is 
deemed to be short, easy to use and flexible and has been used successfully in several 
different settings (scientific trials, health policies, pharmacoeconomics, clinics, etc.). It consists 
of a questionnaire and a visual analogue scale (EQ-VAS). The EQ-VAS is a self-rated health 
status using a VAS to record patient perceptions of their own current overall health and to 
monitor changes with time. The self-assessment questionnaire is self-reported description of the 
subject’s current health in 5 dimensions i.e., mobility, self-care, usual activities, pain/discomfort 
and anxiety/depression (Gusi et al., 2010).  
 
Four studies (BLF, 2017, Pacheco et al., 2014, Clift et al., 2013, Clift et al., 2017) utilised this 
health questionnaire though no significant changes were found in any of these studies. 
 
Hospital Anxiety and Depression Scale (HADS)  
 
The Hospital Anxiety and Depression Scale, or HADS, was designed to provide a simple yet 
reliable tool for use in medical practice. The term 'hospital' in its title suggests that it is only valid 
in such a setting, but many studies conducted throughout the world have confirmed that it is 
valid when used in community settings and primary care medical practice (Snaith, 2003). 
 
Five studies (Lord et al., 2010, Lord et al., 2012, Liu et al., 2016, McNaughton et al., 2017, 
Trivedi, 2017) utilised both the HAD anxiety and HAD depression scales. One study (Liu et al., 
2016) recorded a significant improvement (p < 0.001) in the experimental group following a 
twenty-four-week singing intervention which was significantly different (p < 0.01) between 
experimental group and control group (control group were provided with health education and 
mental nursing though no further details could be identified). Another study (Trivedi, 2017) 
showed a significant change in total HAD score in both experimental and control groups (both 
also employing PR) but the change in HAD score following intervention for the experimental 
group was more significant (p = 0.001) than that seen in the control group (p = 0.023) 
suggesting an improvement in anxiety and depression due to the singing intervention. 
 
One further study (McNaughton et al., 2017) showed a difference in the mean total HAD score 
between baseline and 12 months but this was not clinically significant (p = 0.37) but a significant 
(p = 0.038) mean reduction in HADS anxiety score of 0.9 units was observed at 1 year though 
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this did not exceed the minimal clinically important difference (MCID) of 1.32. This replicated a 
significant (p = 0.03) improvement in HAD anxiety score -1.1(2.7) vs. +0.8(1.7) noted by one of 
the other earlier studies (Lord et al., 2010). 
 
The other remaining study (Lord et al., 2012) that utilised both the HAD anxiety and HAD 
depression scales and one further study (Pacheco et al., 2014) that utilised the HAD anxiety 
scale alone, showed no further significant results recorded using these tools. 
 
General Anxiety Disorder-7 (GAD-7)  
 
The General Anxiety Disorder-7 GAD-7 is a self-reported anxiety questionnaire that is often 
used in mental health assessment. It is a valid and efficient tool for screening for general 
anxiety disorder and assessing its severity in clinical practice and research (Spitzer et al., 
2006). 
 
This measure was employed for just one study (BLF, 2017) but a significant improvement 
(where p = 0.04) in levels of anxiety in participants was shown after three months.  
 
General Outcome Measures 
 
There were a number of other validated measures which were only utilised within one study, 
most of which did not produce significant study findings. These might however provide useful 
information to support selection of tools for future study design. 
 
Duke Health Profile 
 
The Duke Health Profile is a physical health subscale which addresses quality of life and 
general well-being by asking about self-perception, relationships, breathlessness, overall health, 
and socialisation. Scores are scaled in two broad categories of "function" and "dysfunction." 
One study (Engen, 2005) employed this scale and four of the six functional scales were scored: 
physical health score, mental health score, social health score, and self-esteem score. 
Additionally, three or the five dysfunctional scales were considered: anxiety score, depression 
score, and anxiety depression (DUKE-AD) score. Two of the seven subscales analysed, mental 
health and social health, showed an upward shift in quartile scores though this was not noted as 
significant. 
 
Brief Illness Perceptions Questionnaire (BIPQ) 
 
The Brief Illness Perceptions Questionnaire (BIPQ) is a nine-item scale designed to rapidly 
assess the cognitive and emotional representations of illness (Broadbent et al., 2006). It was 
utilised by one study (Goodridge et al., 2008) but there were no significant differences for this 
scale within or between the groups at baseline or following the programme. 
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London Chest Activity of Daily Living (LCADL) 
 
The London Chest Activity of Daily Living (LCADL) scale is a tool aimed at assessing the level 
of dyspnoea during ADL. The tool is divided into self-care; household activities; physical activity; 
and leisure activities and is considered an inexpensive and user-friendly instrument. It can be a 
feasible clinical tool for assessment and monitoring of dyspnoea-related functional impairment 
in chronic lung disease patients (Muller et al., 2013), as well as for pre- and post-intervention 
assessment as utilised by one other study (Pacheco et al. 2014). This provided no significant 
outcome, but the study had a very small sample size which means the study was under-
powered to detect change. 
 
Brief Symptom Inventory−18 (BSI-18)  
 
The Brief Symptom Inventory−18 (BSI-18) is an 18-item self-report screening tool designed to 
assess current (past seven days) psychological distress in “a broad spectrum of adult medical 
patients 18 or older and adult individuals in the community who are not currently assigned 
patient status” (Meachen, 2008). It measures depression, anxiety, and somatic symptoms, with 
a subscale score in each of these three categories. The General Severity Index is a composite 
score derived from this tool, which assesses the overall distress of the patient (Grasch, 2013). 
It is the second abbreviated version of the 90-item Symptom Checklist based on the Hopkins 
Symptom Checklist (Meachen, 2008). It was successfully utilised by one study (Grasch, 2013) 
but without any significant changes. 
 
Patient Activation Measure (PAM)  
 
The Patient Activation Measure (PAM) measures patient engagement with their self-
management by examining their knowledge, skills and confidence that are essential in their own 
self-care. It is a valid, highly reliable, unidimensional scale that reflects a developmental model 
of activation. Activation is regarded as having four stages: (1) believing the patient role is 
important, (2) having the confidence and knowledge necessary to take action, (3) actually taking 
action to maintain and improve one's health, and (4) staying the course even under stress. The 
measure has good psychometric properties indicating that it can be used at the individual 
patient level to tailor intervention and assess changes (Hibbard et al., 2004). This was 
employed in only one study (BLF, 2017) but with no significant results. 
 
There were some remaining unique tools used e.g. Questionnaires CareFusion, Kent, UK (Lord 
et al., 2010) but no further significant results were produced from these. 
 
Qualitative data - Interviews, Journals and Participant Feedback Surveys 
 
There were a number of interview, journal or participant feedback methods utilised to capture 
comments, experience and other outcomes as provided by participants in verbatim text. 
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Interesting qualitative information is captured extensively within some of these studies (e.g. Clift 
et al., 2013, Clift et al., 2017, McNaughton et al., 2016) and common themes could be 
extracted even though the efforts and methods employed are variable throughout the group of 
studies identified. 
 
A total of nine mixed model studies (BLF, 2017, Clift et al., 2013, Clift et al., 2017, Engen 
2005, Goodridge et al., 2013, Lord et al., 2010, Lord et al., 2012, Pacheco et al., 2014, 
McNaughton et al., 2017) utilised interview, journal or written feedback survey techniques in 
addition to other standardised outcome measures. Only one wholly qualitative study (Thomas 
et al., 2015) was located and included. The written comments provided from individuals during 
interview for three of these studies (Clift et al., 2013, Clift et al., 2017, McNaughton et al. 
2017) were captured and presented with some rigor and the common themes from these were 
further examined using content and thematic analysis (Skingley et al., 2014, Skingley et al., 
2018, McNaughton et al. 2016) to provide in-depth summaries and important considerations.  
 
The findings from one study (Skingley et al., 2014) suggest that singing was perceived as both 
acceptable and beneficial to the participants, not only for breathing but also in relation to 
general physical, psychological and social well-being for example “I love coming to COPD 
Singing Research Project and I always feel much better physically and emotionally afterwards”, 
“It certainly appears to have helped with my general breathing”, and “I believe that the project is 
teaching me how to understand my breathing and how to control it. This is very useful; it stops 
me hyperventilating when my breathing is under pressure i.e. climbing a steep hill”. A further 
similarly designed study (Skingley et al., 2018) provided rich and practical information 
regarding how singing provided meaningful impact to participants, supplementing the 
quantitative data in this area and strengthening the potential for generalisability. The majority of 
participants in this later study agreed that the singing programme led to improvements in 
respiratory symptoms and in mental wellbeing and led to social benefits, often acting as support 
and avenues to seek advice. These qualitative data results were significantly more positive than 
those results expressed by the quantitative data for the same studies.  
 
One mixed model feasibility study conducted in New Zealand (McNaughton et al., 2016) 
analysed transcripts from individual interviews and a focus group meeting, regarding their 
experience after six to nine months of group singing. Individual interviews each lasted thirty to 
forty minutes and focussed on three topics of interest: participants’ experiences of participation 
in the singing group, any perceived effects or consequence as a result of being in the group and 
finally whether the singing group was similar to or different from other community support 
groups or singing groups they had been involved in. Overall, the results indicated that the 
singing group was a highly positive experience and participants reported perceived health 
benefits from participation in the group, and no adverse events. These health benefits included 
improvements in breathing, sputum clearance and exercise tolerance, as well as a general 
sense of improved wellbeing. The key themes from the interviews and focus groups provided an 
explanation for the possible social mechanisms which contributed to the high attendance rates 
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and self-reported health improvements. Four key themes were identified including ‘being in the 
‘right space’, ‘developing a sense of connection with others’, ‘experiencing shared purpose and 
growth’ and ‘participation in meaningful physical activity’. The findings for the qualitative 
componant of the study again further supported the positive outcome of the quantitative results.  
 
A large singing for lung health programme (BLF, 2017) reported positive results from qualitative 
scoping work completed at three months post start, as part of a larger mixed-model study. The 
themes of the feedback provided by patients in the community singing groups were all very 
positive. These themes included ‘Increased understanding of breathing techniques to reduce 
breathlessness and maintain optimal lung function’, ‘Increased awareness of the benefits of 
singing for lung health and self-management’, ‘Increased capacity for creative self-expression 
leading to increased self-confidence and quality of life whilst counteracting feelings of stress 
and anxiety’, Increased accessibility to services which are open and approachable’, ‘Reduced 
social isolation - initial research has demonstrated how groups are removing such barriers, 
helping to bring people back into their local communities’. This positive qualitative data further 
supported the outcomes from the quantitative data from this project. 
 
A further two studies utilised structured interviews lasting for thirty minutes, both with the same 
template (Lord et al., 2010, Lord et al., 2012). Subjects were asked to discuss their perception 
of any physical and emotional benefits or harm they had experienced from attending the 
sessions. A selection of comments indicated a much more positive conclusion than the 
measurement data for example “It has made my life easier; I would have liked this when I was 
first diagnosed”, “I increased my out-breath from 4 to 14 counts”, “I started breathing much 
better, from the stomach”, “The exercises, thinking about breathing and relaxing when I have 
(breathing) problems, this has been very useful”, “I always felt better afterwards physically”. 
There were other positive physical effects described which indicated positive impact on lifestyle 
and functional ability i.e. “I have better posture now”, “Walking better, I go out more when it’s not 
cold”, “Now things are less of a chore, housework is no longer a struggle” (Lord et al., 2010). 
The overall message from the qualitative componant of these studies was again more 
encouraging than the positive quantitative outcome measures assessed. 
 
The only solely qualitative study included in the systematic review (Thomas et al., 2015) 
identified four themes from the qualitative analysis of the semi-structured interviews employed 
at the end of an almost two-year study. The themes identified were ‘Control of Symptoms’, 
‘Community and Friendship’, ‘Psychological Benefits’, and ‘Mastery of Illness’. The singing 
group was reported to improve breathlessness symptoms, enable access to further sources of 
support and formed new friendships. The study concluded that dominant effects were improving 
mood, providing a sense of mastery over breathing to better cope with breathlessness and 
tackling social isolation. The results of this study were positive, but partially confounded in 
regard to the systematic review criteria, because only eleven of the sixteen participants included 
in the study were diagnosed with a COPD related illness.  
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One study (Engen, 2005) reports that throughout the duration of the treatment, subjects were 
asked to keep a journal. Information on practice times, musical preference, frustrations, health 
comments and so forth. These were not analysed as independent measures but were used to 
monitor participants’ reactions. Journal sheets were provided to all participants, but not equally 
used i.e. Study results show male participants only made entries when reminded during 
sessions, while the frequency and quality of entries by women varied widely.  
 
One small feasibility study (Goodridge et al., 2013) included free response journal entries and 
added a satisfaction survey which was mailed to participants post participation.  This post-
intervention programme survey was used to evaluate acceptability and enjoyment of the singing 
programme and additionally served to identify factors that affected sustainability of the 
intervention. This data was provided from written feedback and although neutral findings were 
established from the quantitative measures recorded in the study, the qualitative data from the 
written feedback from participants was uniformly positive about the experience of participating in 
the singing intervention. Twelve participants indicated that they felt singing helped their 
breathing during the session itself and would continue singing after the programme and ten also 
believed that the programme helped their breathing overall. 
 
The final study (Pacheco et al., 2014) held only limited qualitative information. It analysed the 
answers to a specifically designed questionnaire which indicated that all patients reported 
improvement in lung function control, reduced anxiety and more self-esteem after the singing 
lessons. In addition, all patients reported a feeling of well-being and recorded the experience as 
very pleasant. This data was very limited as the sample size included four participants, however 
it did improve the overall outcome of the study which was initially negative based on the 
quantitative data alone. 
 
Several studies that indicated that feedback had been solicited or that interviews had been 
completed did not provide all the details about the questions asked or how the questions or 
interviews were implemented (Engen, 2005, Lord et al., 2010, Lord et al., 2012, Thomas et 
al., 2015), while other studies noted full details of the scripts or indicated that templates or 
qualitative questionnaires were used or specified that researchers were trained to ensure 
consistency of interview technique (BLF, 2017, Clift et al., 2013, Clift et al., 2017, 
McNaughton et al., 2016, Pacheco et al., 2014).  
 
Adverse Outcomes 
 
Adverse events were not formally captured in any of the selected studies. The proportion of 
patients experiencing adverse events due to the intervention appear to be very low though, as 
are the total number of hospitalised days, symptomatic days and proportions of participants who 
had respiratory exacerbations and/or hospitalisations. These are not presented in detail in any 
of the studies reviewed.  
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There is some anecdotal information provided about problems experienced from observations 
by the authors and interviews for example, one study (Bonilha et al., 2009) mentions that vocal 
exercises and singing popular songs were well tolerated by the patients and they did not 
complain of severe dyspnoea, chest pain, regurgitation or dizziness in the course of the activity. 
However, a high prevalence of coughing and sputum expectoration was observed during the 
resting intervals. Another study (McNaughton et al., 2017) asked patients about adverse 
events and noted that a participant had a lung transplant during the year of the study but 
continued to sing with the group indicating it was well tolerated.  
 
Treatment Adherence 
 
Adherence to the classes was not presented for the majority of studies. There were several 
studies that built adherence into the design by ensuring that a patient could only be considered 
for collection of post treatment results if they had attended a number of singing sessions or 
classes e.g. Subjects were required to have attended at least three sequential classes before 
the final assessment (Bonilha et al., 2009) or patients were excluded from the analysis if they 
did not complete the required number of sessions (Canga et al., 2015). 
 
Patient Retention 
 
The retention of patients over all the studies is generally very good and feedback from patients 
was positive. Any detailed explanations provided by each of the authors is summarised in Table 
5 as below (where the information was provided). 
 
Unique 
identifier 
(Author/Year) Study Recruitment and Retention Details 
Bonilha 2009 Seventy-eight patients were evaluated. Thirty-five were excluded due to not 
meeting inclusion criteria or refusal to participate. Out of forty-three patients 
who agreed to participate in the investigation, twenty-three were allocated 
to the Singing Group and twenty to the Control Group. A total of thirteen 
patients discontinued the study, but at a proportion not significantly different 
between groups (Singing group: n=8; Control group: n=5). Reasons for 
abandoning the study in the singing group included non-medical causes (3) 
and non-pulmonary medical conditions (4). Only one patient left the singing 
group due to repeated episodes of acute COPD exacerbation and 
difficulties in regularly attending classes. Reasons for dropping out of the 
Control Group were non-medical causes (4) and a non-pulmonary medical 
condition (1). Fifteen patients concluded the entire protocol in both arms of 
the interventions. The final gender composition was similar in both groups, 
with a predominance of males. There was 30% attrition over 24 weeks. 
                                                                          
 
  71  
 
BLF 2017 At baseline 167 questionnaires were collected and at three months this 
reduced to 80 with a maximum of 70 paired samples. The drop-in follow-up 
was due to some participants not completing the course as well as a 
smaller number of groups folding before completion though the reasons are 
not specified. The majority of singers were women (116/167) and most were 
ex-smokers. Approximately 50% of patients had participated in an exercise 
class or attended PR. The British Lung Foundation (BLF) maintained 
regular phone and email contact with the leaders in order to monitor 
participant attendance and support ongoing recruitment and sustainability of 
their groups. The BLF and local leaders have also been promoting SLH 
through targeted press and social media posts. E.g. featuring in two 
reputable medical journals, The Lancet Respiratory Journal and the 
Practice Nursing Journal. Locally each singing leader was provided with a 
press release to send out, which helped to generate interest locally. One of 
the participants wrote a blog sharing personal stories of involvement and 
benefits. The BLF also created a video to highlight the positive benefits and 
during World COPD Day many groups helped to highlight the day by 
recording a video and sharing it on YouTube.  
Canga 2015 Ninety-eight patients were randomly allocated to the treatment and control 
group. Thirty patients out of the ninety-eight enrolled were excluded from 
analysis due to non-completion of required number of sessions either due to 
anticipated time commitment or personal/medical concerns. Therefore, a 
total of sixty-eight patients were included in the final analysis 
Clift 2013 Thirty-four participants left the study overall and did not complete the final 
questionnaire (32.1% attrition). A further six participants were unable to 
attend for the final spirometry assessments due to other commitments and 
illness (37.7% attrition). The rate of loss to the study is less than the 
conservative estimate of 50% per design. Comparisons were made 
between those dropping out and those remaining in the study and no 
significant differences emerged on any measure taken at baseline, so 
attrition did not introduce bias into the study. In addition, only a small 
number of withdrawals (2.8%) were due specifically to COPD related health 
issues, and only a small proportion of missed attendances during the 
programme were due to COPD related health issues (1.5%).  
Clift 2017 Participants referred themselves into the study on the basis of information 
received through their surgeries or various other routes. Everyone, 
describing themselves as affected by breathing problems, was accepted. 
Groups ran on a weekly basis with good regular attendance. Study did not 
recruit to the level originally hoped. In retrospect, the degree of time and 
effort needed to communicate effectively with health professionals and 
those affected by COPD and to encourage participation was 
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underestimated. At the outset a well thought out strategy was adopted. 
Contact was made with the only BLF Breathe Easy group locally, enlisting 
their support. Suitable venues were found and taster sessions run.  
Times/dates decided so that they could be advertised early. Attractive 
recruitment posters and flyers were used and website created. A high-
profile launch event at the Royal Festival Hall conducted and high quality 
promotional created. Lead GP’s + Practice Managers at 10-12 health 
centres within 30 minutes walking distance of the advertised venues were 
contacted. Posters/flyers sent to surgeries and a request made to surgeries 
to send out information to patients on their COPD registers. The request 
was made a second time as there was low up-take + eventually only six 
practices undertook to write to patients. Recruitment still fell short so further 
efforts were made to enhance publicity through advertising in local 
newspapers, street level leafleting, particularly with the recruitment efforts. 
Baseline assessments took place in September 2015, and three groups 
commenced. At the end of the recruitment process, sixty patients were 
enrolled out of the one hundred targeted.  
Engen 2005  Twelve patients participated but only seven completed the requirements for 
inclusion. One patient withdrew due to a family emergency, two had initial 
breath measures too low for inclusion and two had measurements too high 
for inclusion. The four participants with measures outside inclusion limits 
had signed informed consent and completed the programme as they wished 
to participate. 
Goodridge 
2013 
Twenty-one participants from the original twenty-two identified actually met 
the eligibility criteria. The first fourteen participants were assigned to the 
singing intervention. The remaining seven were assigned to the control 
group receiving usual care. Two of those assigned to the control group 
declined to participate as they were interested in the singing intervention, 
leaving five in the control group and a total of nineteen patients overall. 
Grasch 2013 Thirty-one subjects diagnosed with emphysema consented to participate. 
Twenty-five patients completed the study, nine males and sixteen females 
Herer 2013 All the patients were invited to these sessions a near-maximum attendance; 
However, an asthmatic patient, having a string dysfunction antecedent 
voice, had to prematurely terminate these sessions. 
Lichtenschopf 
2014 
Ninety-two COPD patients and twenty-seven patients were included with 
other underlying disease and all completed the study though no further 
details were included. 
Liu 2016 Total of fifty-six COPD patients were enrolled and divided into intervention 
group and control group. 
Lord 2010 Thirty-six patients were selected with twenty allocated to the singing group 
and sixteen to the control group. Two subjects withdrew from the singing 
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group once the workshop had begun and three did not attend the final 
assessment once completing the workshops. In the control group, one 
withdrew and two did not attend the final assessment. Data are therefore 
presented for the fifteen singers and thirteen controls that completed the 
study. Six of these attended twelve sessions, four attended eleven, two 
came to ten and three came to nine. Attrition rate was 22% over six weeks. 
Lord 2012 One hundred and eighty-three patients were approached to participate. One 
hundred and fifty declined to take part. Eighteen patients were allocated to 
the singing group and fifteen to the film group. Five subjects from the 
singing group withdrew once the sessions had begun. In the film group, one 
subject died after randomization but before attending any sessions and 
three subjects withdrew from the study once the sessions had begun. Data 
were presented for thirteen subjects in the singing group and eleven in the 
film group that completed the study.  Median number of sessions attended 
was 14.5 for the singing group and 7 in the film group. Attrition rate was 
19% over eight weeks. 
McNaughton 
2017 
Twenty-eight patients were enrolled in the singing group: Five patients 
withdrew within one month of enrolment (disinterest or joining another 
therapeutic trial). After six to nine months of singing, twelve participants 
contributed to interviews about their experiences and after analysing data 
from the individual interviews nine of the remaining eleven group member 
participated in a focus group. Two could not attend due to other 
commitments.  
Miyahara 2001 Twenty patients were enrolled in the study and ten patients were randomly 
assigned to an experimental group. No further details were available 
regarding drop out or attrition rates 
Pacheco 2014 Eight patients were selected to participate but two were subsequently 
excluded. Two patients were dropped from the study analysis because they 
did not attend at least seven sessions. 
Thomas 2015 Sixteen patients (four male and twelve female) with mean age 72.6 (50–92) 
years, were interviewed. Diagnoses included COPD (11/16), asthma (2/16), 
bronchiectasis (2/16) and fibrosis (1/16). All were non-smokers (ex-smokers 
12/16); 12/16 (75%) had previously attended pulmonary rehabilitation. 
10/16 lived alone and 8/16 had a history of mental health comorbidity 
requiring treatment. No further details were available regarding drop out or 
attrition rates. 
Trivedi 2017 Ninety patients were screened patients and based on inclusion and 
exclusion criteria fifty-six patients were recruited in the study. All fifty-six 
patients were divided into two groups (n=28) and two patients dropped from 
the experimental group of the study due to non-medical reasons. 
 
Table 5 – Systematic Review - Study Retention and Withdrawal Summary 
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One of the studies (Skingley et al., 2014) reports that reference to the social aspects of the 
singing groups were universally positive in nature. This exceeded the number of comments 
related to breathing with the comments broadly pertaining to friendship and company generally 
or support gained from meeting those similarly experiencing COPD. This might indicate that 
there would be a positive impact on retention rate for singing groups and also a further up-take 
of this intervention in comparison to other traditional alternative activities such as exercise 
classes and pulmonary rehabilitation. This view is supported by the low attrition rate of 32.1% 
noted in this same study (Clift et al., 2013). 
 
Health Care Utilisation  
 
Health care utilisation data acquisition was non-existent in all but four studies (Clift et al., 2013, 
Clift et al., 2017, Liu et al., 2016, Thomas et al., 2015). There was one study (Clift et al., 
2017) that attempted to carefully address this issue by monitoring health and social care service 
usage over the study duration to assess whether any changes took place which could provide 
evidence on potential cost savings associated with participation in group singing.  A section 
entitled ‘Treatments and services to help you with your breathing’ was included which raised 
questions on oxygen and inhaler use, admission to hospital and the health and social services 
used (including visits to a hospital accident and emergency department, appointments with a 
GP, appointments with a practice nurse and home visits). There did not appear to be any 
evidence of significant changes between baseline and follow-up and the research concluded 
that there appeared to be no evidence of either a clear increase or decrease over the period of 
the project.  
 
One study (Liu et al., 2017) confirmed that data for self-reported primary care (GP) visits were 
fewer in the year following commencement of singing but this was not a significant change and 
another (Thomas et al., 2015) noted there was no difference in hospital admissions in the year 
after starting singing compared to the year before.  
 
Study Quality 
 
Randomised controlled trials are the most rigorous way of determining whether a cause-effect 
relation exists between treatment and outcome and for assessing the cost effectiveness of a 
treatment (Sibbald and Roland, 1998). This is largely due to more effective elimination of bias 
by ensuring random allocation to intervention groups and ensuring groups are treated identically 
except for the treatment. It also allows the analysis to be focused on estimating the size of the 
difference in predefined outcomes between intervention groups.  
 
There are four randomised controlled studies (RCTs) within the selected group that compare 
singing alone specifically against an active control (Bonilha et al., 2009, Jamaly et al., 2017, 
Lord et al., 2010, Lord et al., 2012). These trials are therefore more impactful within this area 
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of research and the results from the earlier of these trials are more well-known within the 
research community (Bonilha et al., 2009, Lord et al., 2010, Lord et al., 2012) and as such 
have generally been cited more often to date. 
 
Randomised controlled trials are powerful tools, but their use is limited by ethical and practical 
concern (Sibbald and Roland, 1998), this is particularly true when the intervention itself is 
dependent on the patient’s active involvement, understanding and participation.   
 
Studies including singing or similar activities are certainly impacted by practical concerns due to 
the nature of the intervention. Ethical aspects could be a consideration too, even though singing 
is largely considered as an activity complimentary to standard care rather than a replacement. 
One of the key ethical concerns would be if singing were offered where pulmonary rehabilitation 
is not offered as part of standard of care or offered as an alternative.  Pulmonary rehabilitation is 
now widely used as part of the mechanism for COPD management and meta-analysis as part of 
a Cochrane review strongly supports respiratory rehabilitation as part of the spectrum of 
management for patients with COPD (Lacasse et al., 2009).  
 
Observational studies such as cohort studies or case studies have often been more widely 
executed successfully within this research genre. One study (Lord et al., 2010) reported that in 
addition to a randomised study, an open workshop was also completed. However, the selective 
bias of this study is questionable since certain measures were included or mentioned at 
baseline but not presented post treatment. 
 
The quality of each study was measured using the extended Cochrane Collaboration tool for 
assessing risk of bias (Higgins and Green, 2011) Cochrane Handbook for Systematic Reviews 
of Interventions Version 5.1.0 [updated March 2011]. In this case the questions within the risk of 
bias tool were collated in a tabular format showing the questions and responses of the tool and 
documented in a study risk of bias summary table (This is illustrated in Appendix B*). 
 
The risk of bias generally is very high with the rating of all papers considered to be weak or 
moderate at best. This is largely due to the nature of the intervention i.e. finding a suitable 
blinding method is challenging, such that very few studies actually included robust 
randomisation methods and blinding of participants is not possible. There were only four studies 
(Bonilha et al., 2009, Jamaly et al., 2017, Lord et al., 2010, Lord et al., 2012) which 
mentioned randomisation and included some reference to the assessors or investigators being 
blinded to the intervention, although as mentioned, blinding of patients is challenging in this 
area even in the more robustly designed randomised trials. This increases the potential for 
treatment bias and the challenges faced by researchers are great. 
 
 
                                                                          
 
  76  
 
Systematic Review: Discussion 
 
Study Demographics 
 
Demographic information was variable in quality across the studies selected and there was little 
subgroup analysis regarding demographics, for example to understand how efficacy may be 
dependent on gender or age factors. Nine of the selected studies captured gender information 
and these were generally seen to contain higher proportions of females than males. This could 
likely be due to singing groups and choirs in general often seeing more females having an 
interest in taking part. Singing studies in general speak to the challenges choir directors have in 
recruiting male participants. Research shows that this may be because of the perception of 
singing as being feminine gendered (Warzecha, 2013) and other more complex gender related 
issues regarding physiological changes and challenges particularly during male adolescence 
(Freer, 2007, Freer, 2012). 
 
One of the major steps forward in the field of COPD was a global consensus on the definition, 
classification and management of the disease through the “GOLD” guidelines. This was not only 
was a landmark with regard to providing reliable and up-to-date knowledge about this disease, 
but it also enabled worldwide harmonisation of epidemiological, clinical and experimental 
research studies in patients with COPD. The latter is essential for the comparison of results and 
therefore, for further advances in the field (Sterk, 2004).  
 
Eight studies specifically mention that GOLD staging criteria were used as inclusionary 
diagnosis qualification for COPD, but more often other terminology such as COPD diagnosis or 
‘stable COPD’ was used in the studies identified. In studies where it is mentioned, there is little 
evidence presented to indicate if the criterion were fully adhered to or checked individually for 
each patient (e.g. Lord et al., 2012) or whether there was an assumption per specific rationale 
made by the researchers that patients adhered to this definition. The studies selected for this 
review were often recruited using patients from pulmonary rehabilitation groups, for example, or 
recruited through pulmonary clinics, so it is possible that GOLD criteria could have been utilised 
to diagnose the patients within these groups, even when this was not explicitly mentioned as 
part of the study protocol. It would seem an important step to ensure that agreed diagnostic 
criteria for patients are adopted in future studies in this area, so that data across studies within 
this field can be compared more consistently.  
 
It was estimated in 2012 that more than 90% of COPD deaths occurred worldwide in low and 
middle-income countries (WHO, 2017b), with COPD being more prevalent in these countries 
than in higher income countries. However, the studies identified within this review indicate that 
research in this area to date for the most part has been conducted in high income countries, 
with a bias overall to white, educated participants as specifically highlighted by one study (Clift 
et al., 2013). That said, in 2012 it was accepted that this disease now affects men and women 
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almost equally, due in part to increased tobacco use among women in higher-income countries 
(WHO, 2017b). This suggests a gap in the research base and a need for more research 
globally, particularly across a wider scope of income and educational groups and regions.  
 
The burden of chronic diseases, such as COPD, poses a special challenge in low-income 
countries, where health-care resources are traditionally designed to respond episodically to 
acute disease, especially infectious diseases, and are thus not well adapted to treating chronic 
diseases (Lopez-Campos et al., 2016). Respiratory diseases in general receive little attention 
and funding in comparison with other major causes of global morbidity and mortality. In 
particular, COPD has been a major public health problem and researchers consider it will 
remain a challenge for clinicians within the 21st century (Lopez-Campos et al, 2016). 
 
The additional issue here is that even if financial barriers to access were removed, access to 
quality health care could still be compromised by other barriers, including patients' beliefs, 
difficult access to care centres, insufficient transportation, language barriers, and inadequate 
cultural competency of health-care providers (Finn and Cohen, 2015). It would therefore seem 
potentially important that the relatively low cost and ease of access of singing as an intervention 
could be a key driver in expanding research to low or middle-income countries and extending 
promotion, education and exposure globally.  
 
Study Design 
 
Duration, Frequency and Design 
 
The rationale for study duration and frequency, intensity or duration of the intervention is not 
provided in detail for the majority of studies, which is a significant gap. Those that do provide 
this information show that their designs vary quite widely, and the quality and consistency of the 
intervention is rarely assessed for consistency or quality. 
 
There were only a few studies which included a control or randomised patients and only two 
studies compared singing to an alternative therapy or activity such as film discussion groups 
(Lord et al., 2012) and craft classes (Bonilha et al., 2009). It is challenging to find an activity 
that is similar enough to singing that could be effectively utilised as a control. Types of classes 
or activities such as those mentioned would be a control for the social and logistical aspects of 
the singing class. The only activity close to singing for COPD patients is Pulmonary 
Rehabilitation.  
 
Pulmonary Rehabilitation (PR)  
 
It has been established that rehabilitation relieves dyspnoea and fatigue, improves emotional 
function and enhances patients’ sense of control over their condition. The improvements of 
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pulmonary rehabilitation are moderately large and clinically significant, so rehabilitation now 
forms an important component of the management of COPD (Lacasse et al., 2009). 
 
Several studies enrolled patients directly from pulmonary rehabilitation training groups (e.g. 
McNaughton et al., 2017) as part of their design which is good practice in that it helps manage 
some confounding factors, allowing patients to start from a relatively similar educational 
perspective in regard to their respiratory understanding. Several studies included pulmonary 
rehabilitation as part of the design (Canga et al., 2015, Grasch, 2013, Trivedi, 2017) and this 
could have a potentially confounding effect on any quantitative or qualitative outcomes.   
 
There could certainly be ethical issues in utilising pulmonary rehabilitation specifically as a 
control for singing for COPD however, due to the proven benefits of PR. It could potentially be 
used as a control for studies where patients enrolled having previously rejected PR but again 
this could certainly impact outcomes or bring about its own bias. 
 
Pulmonary rehabilitation is now accepted within health systems as an essential strategy in the 
ongoing management of people with COPD and results of a Cochrane review meta-analysis 
strongly support including at least four weeks of exercise training, as part of the spectrum of 
treatment for patients with COPD (McCarthy et al, 2015). However, at present there is often 
poor access to pulmonary rehabilitation internationally or a low uptake in certain regions. 
Measurable benefits of pulmonary rehabilitation also diminish over time and thus increasing 
uptake of PR and sustaining the benefits of this activity are very important (McNaughton et al., 
2017). Interventions to prolong the beneficial effects of pulmonary rehabilitation have been 
studied but most are not practical or financially feasible, and none have unequivocally been 
shown to be effective (Spruit et al., 2013).  
 
Singing as an intervention could clearly support or enhance this type of treatment since it is both 
enjoyable and has a positive impact on health and well-being of COPD patients. It can act both 
as an activity to potentially improve retention to PR groups or prolong adherence to PR activity 
or more importantly, in its own right as an alternative to PR. It would seem important to establish 
further the patient retention capabilities for singing groups both in their own right and compared 
to retention levels seen in PR groups.  
 
Study Measures 
 
It has been proposed that “disease modification” in regard to COPD be defined as any change 
in a metric, related to the disease, that is maintained over time and that any treatment given 
over time changes one or more of these metrics can be considered disease modification 
(Mahler and Criner, 2007). This concept goes beyond the traditional approach of using lung 
function alone (in particular FEV1) for this purpose. COPD measures are therefore now much 
more extensively used to look at a variety of health aspects in relation to the condition. In the 
studies selected lung function tests showed varied and inconclusive results overall, so the 
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inclusion of additional non-lung function measures and outcomes is key to building a picture of 
how the physiological and psychological mechanisms of action of singing might impact these 
patients’ health and wellbeing. 
 
A large number and variety of measures were used throughout the studies reviewed and there 
was relatively little consistency of tools used between studies. There were also a number of 
studies which highlighted significant positive results, but from tools that are not particularly 
common or were only used for those studies in isolation e.g. a significant proportion of patients 
(87.5%) were seen to have an increased score of greater than four points for QoL using the 
VSRQ (Herer, 2013), but this tool was only used by one study.  
 
In addition to this issue and also the fact that the risk of bias was calculated to be high and 
many studies were lacking robust quality, it was deemed not to be feasible to perform a 
collective data analysis of any of the quantitative measures, as had been outlined for 
consideration in the original review protocol i.e. statistically combining the data from these 
studies could not deliver meaningful results. The Cochrane review protocol was designed to 
select the most robust randomised controlled studies and present any meaningful data analysis 
from these (McNamara et al., 2016).  
 
Journal data would have been valuable in this area but unfortunately in the studies where this 
was used it seemed to be inconsistently administered or spuriously tracked or adhered to e.g. 
missing journal records etc. (Engen, 2005). Information collected from journals, especially in 
regard to treatment adherence and other ongoing patient behaviour data could provide useful 
insight within this research. It would be helpful for further emphasis to be placed on these 
aspects for future studies, particularly where home tools or self-management resources are 
utilised to extend or expand the treatment exposure. It would also be interesting to explore the 
specific components of all those tools where singing was shown to have positive results e.g. 
FVC, FVC%, FEV1, PCS - SF-36 etc. and to further understand whether there is any correlation 
with patient feedback from interviews and journals. This could lend quantitative support to the 
overall positive effects, which in turn could provide insight as to the quality or accuracy of the 
journal information.  
 
Interview techniques and open text questionnaires provided the most positive of all results and 
gave wider insight and information regarding the physiological and psychological mechanisms 
of action involved in singing. The respondents reported improvements in mental wellbeing, 
attributing much of this to the singing group and many social benefits were recorded. These 
extended beyond singing sessions, with fellow participants often acting as support and advice 
channels (Clift et al., 2017, Skingley et al., 2018). One study found that major effects were in 
mood improvements, providing a sense of control over breathing to manage dyspnoea more 
effectively and for tackling social isolation (Thomas et al., 2015).  
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These interview techniques provide a wide source of data, though it can be challenging to 
review or analyse this collectively, due to the varying methodology and formats used. Interviews 
and participant feedback has provided important supportive data within this area and qualitative 
research has much to offer with methods that enrich knowledge. Analysing qualitative data is 
not a simple or quick task (Mays and Pope, 2000) and with quantitative data currently 
becoming cheaper and more accessible to capture and analyse, this is often the most cost-
effective option and more often favoured globally to inform data-driven policy making (Etsy et 
al., 2007). However, it would be recommended that further work to extract and analyse all the 
available qualitative data collected for singing for COPD to date would be worthwhile to help 
inform future research. 
 
COPD progression is traditionally assessed using spirometry, but it has been noted (Mahler 
and Criner, 2007) that lung function is poorly related to other clinical outcomes i.e. dyspnoea, 
exercise performance and exacerbations and these patient-centred metrics are in fact, more 
important to the patients themselves than lung function measures or spirometry readings. This 
is clearly a very important factor regarding the methods of action of singing on COPD, since it 
has the potential to impact the patient in several ways, the magnitude of which could be variable 
between patients too. Individuals may place differing importance on the varying symptoms or 
outcomes of their disease.  
 
Several researchers have studied the predictive accuracy of composite indices that include non-
pulmonary factors to determine whether they can predict outcome better than lung function 
measurements such as FEV1. The use of some tools which are common to recent COPD 
research have not been employed by any of the singing for COPD studies available for this 
review. One tool in particular, which may have provided insight into the more holistic effects of 
singing on the patient is the BODE index. This specific index is constructed from four factors 
found to predict the risk of death in COPD patients. It is so called because it is constructed from 
body-mass index (B), the degree of airflow obstruction as measured by FEV1 (O), dyspnoea (D) 
and exercise capacity (E), measured by the six-minute–walk test (Celli et al., 2004). 
 
The BODE index was prospectively evaluated and patients with higher scores were shown to be 
at greater risk. This showed that the index was able to discriminate the probability of survival 
among patients more strongly than the conventional standard of FEV1 assessment alone. In 
recent studies, this index has also been shown to be an accurate predictor of COPD 
hospitalization and mortality as well as a useful index to track the effect of disease modification. 
It is a simple multidimensional grading system, better than the FEV1 at predicting the risk of 
death from respiratory causes among patients with COPD (Celli et al., 2004). This index was 
created in 1997 and validated by 2004 (Celli et al., 2004) although only one of the studies 
included in this review (Herer, 2013), conducted after 2004 mentions this index or considers 
specifically whether it might be relevant. More importantly there in not a great deal of detail 
within the studies generally that explains the specific rationale as to why interviews or in fact 
any particular tools or measures were selected.   
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There appears to be no clear positive outcomes for any of the exercise measures for the 
majority of studies, although there is anecdotal information within comments and interview 
feedback that there is a positive effect on the symptoms patients are experiencing. There is 
such a large variety of different tests and measures being used both across and also within 
these studies though, that it makes it challenging to arrive at general conclusions from the 
quantitative data. This further enhances the importance of looking at the correlation of data from 
several different measures or outcomes within patient profiles or in relation to ongoing regular 
visit data or journal information. 
 
One aspect worthy of further investigation might be to study the varying effect of frequency, 
consistency and duration of singing sessions e.g. exploring whether increased frequency of 
short singing sessions versus less frequent but longer or more intense sessions have greater 
value for adults with COPD. In addition, it would be of value to know whether group sessions 
need to be continued regularly or if bursts of sessions periodically might deliver similar results. 
These issues are not discussed in any of the papers in detail but exploring them could provide 
insight regarding the optimum duration and frequency of singing sessions, the quality of 
instruction and training given and the importance of repetition and continued practice at home.  
 
Technology Advancements 
 
The studies identified were all quite simple in design in regard to delivery of intervention and 
collection of data there is relatively little use of technology. There is an untapped potential to 
utilise technology in various ways, particularly in the area of data capture/collection but also as 
tools to aid in the delivery of the intervention, retain patients in group sessions or to encourage 
or remind continued practice either for self-management or to enhance engagement with a 
regular singing group. However, it is clear that this often requires investment of significant time 
and cost resources which is often not available in this area of research.  
 
The use of ‘Sensewear©’ armbands for example, (Lord et al., 2011, Lord et al., 2012) was a 
very novel approach but there was no strong positive indication shown within the data. This 
outcome would seem to have impacted any further expansion of this technique as there 
appears to be little development of this technology or use of any other more sophisticated tools 
to capture health data in this area of research since these studies were conducted. It would also 
have been interesting if experiences of using such tools in this population had been explored 
further. There appears to be no indication of patient feedback on using this tool, the reliability or 
quality of the data or any measures of compliance etc.     
 
There is some opportunity to investigate relatively low-cost options which would easily capture 
user data on an ongoing basis, allowing for real time analysis and reporting. Technology used 
for collecting diary info, health data etc. is now more widely available and diary data is not 
necessarily limited to collection using paper journals or specialised and expensive data capture 
tools e.g. e-diary solutions etc. used for large scale clinical trials.  
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The usage of smart phones and other similar personal devices that contain sophisticated 
software applications for sharing, storing and collecting healthcare data is still increasing. The 
reliance on patient-generated data has also been demonstrated using mobile devices to tailor 
diagnostic and treatment decisions as well as educational messages to support desired patient 
behaviours (Roski et al., 2014). 
 
There has been a significant acceleration in data collection, particularly over the last fifteen 
years, which has been driven by advances in technology, data science and the usage of ‘big 
data’ and data mining i.e. wider usage and accessibility to the internet, social media, smart 
phone technology etc. which means that more opportunities are becoming available (Wu et al., 
2014). 
 
However, for health organizations to rely on this type of data, the enabling IT infrastructure has 
to be available. Installing such infrastructure and its components is becoming less expensive. 
Nonetheless, the installation still requires a significant investment of time, training and money, 
and it can involve lost productivity during the transition process. Organizations need to develop 
processes and policies that accommodate new protocols, time requirements, risk factors, and 
mandates for managing data too, especially in the area of privacy and security (Roski et al., 
2014), so this does all need to be taken into consideration. 
 
It is recognised that novel technology maybe less widely used within the regions and 
populations where COPD is often seen to be more prevalent i.e. low and middle-income 
regions, people beyond retirement age, however further investigation into this would be 
important both to improve the available data and inform further research within this population.  
 
There was a brief identification of this gap mentioned by one study paper (Bonilha et al., 2009) 
where it notes a specific deficiency of the research was that changes on respiratory pattern 
during the act of singing were not investigated, and the pulmonary volumes were not measured 
by body plethysmography. Thora3Di© is a technology which allows the measurement of 
abdominal and chest wall movement, using structured light plethysmography. Measurements 
are assessed using a grid of light beamed onto a patient's chest. Measurements can be seen 
real-time and instant feedback on an individual's breathing pattern can be given. Apart from 
traditional pulmonary measurements, this method has the ability to show traditional lung 
function data in a 3D format. 
 
There is much value in exploring further options for technology and tools particularly 
investigating whether there might be more effective ways of establishing potential physiological 
mechanisms of the body during singing, particularly in the COPD population. This information 
could enhance the current understanding of the mechanisms of singing and the reasons why 
COPD patients indicate feeling positive effects in qualitative data even if the quantitative data is 
less robust in supporting this outcome. In turn this information has the potential to assist 
                                                                          
 
  83  
 
development of singing training and other resources for use by singing for COPD or other health 
groups, with an aim to improving the overall effectiveness of the treatment. 
  
Heart Rate Variability  
 
Heart Rate Variability (HRV), as referenced in Chapter 1 is becoming a more commonly used 
measure for athletes, sport scientists, and many more of the general public simply interested in 
improving or monitoring their own health via personal technology. It is more widely accepted as 
an indicator of health with many simple personal aids with low cost phone apps and devices 
becoming easily available to measure improvements in HRV. There is much emerging data and 
research on tracking of behaviours related to negative affect and stress, based on sensors and 
using simple smartphone technology to calculate HRV (Muaremi et al., 2013). 
 
Heart rate variability (HRV) is a measure that is reliably used to assess the functioning of the 
Autonomic Nervous System (ANS) of a patient or healthy person. HRV spectral analysis is a 
non-invasive tool for the quantification of spontaneous HRV in normal humans (Volterrani et 
al., 1994). Interest in HRV, as a measurement of autonomic function, lies in its clinical 
importance. A reduced HRV is a powerful and independent predictor of an adverse prognosis in 
patients with heart disease and in the general population (Nunan et al., 2010). 
 
There is increasing evidence indicating that COPD is more complex than originally thought and 
is not related to airflow obstruction alone. It has been recognized that COPD is a systemic 
disease which has been shown to negatively affect both the cardiovascular and the autonomic 
nerve system (Gestel et al., 2011). In addition to being associated with a strength and 
resistance decrease, COPD is also now closely associated with the dysfunction of the ANS 
(Ricci-Vitor et al., 2013). Preliminary study results suggest that in patients with COPD, there is 
an imbalance in ANS activity. This is apparently driven at rest by an increase in vagal activity 
and through the lack of responsiveness to sympathetic stimulation. This altered balance could 
also contribute to the airways obstruction in COPD (Volterrani et al., 1994). 
 
The autonomic nervous system (ANS) regulates multiple physiological processes, so 
dysfunctions of the ANS are recognized by the symptoms that result from failure of both 
sympathetic and parasympathetic components. The complexity of the physiologic basis by 
which autonomic dysfunction occurs in patients with COPD is considerable and the knowledge 
in this field is still in early stages. The insight into ‘sympathovagal’ imbalance as a pathological 
phenomenon in COPD may be important in understanding the pathophysiology of COPD and 
may have potential clinical importance for improving risk stratification and treatment of patients 
with COPD (Gestel et al., 2011). 
 
Singing is known to produce slow, regular and deep respiration which in turn triggers respiratory 
sinus arrhythmia (Vickoff et al., 2013) this is associated with vagal influence of HRV cycles 
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between singers and thus could hold significant implications for patients with a respiratory 
illness. It has been shown that when singing structure is regular, HRV profiles between healthy 
singers tends to conform in terms of frequency and phase (Muller and Lindenberger, 2011 
and Vickoff et al., 2013). There has been no published investigation or data to date to 
understand the impact of singing on this phenomenon within patients with COPD diagnosis or 
that are otherwise respiratorily compromised. It is an important next step to understand whether 
there is any impact on these same measures by a singing intervention, where the respiratory 
state of patients is impacted. This could be particularly important given that group singing has 
already been seen to impact many other aspects of these patient’s health outcomes and may 
give insight into the various potential physiological and psychological mechanisms of action of 
singing on the respiratory system. 
 
Airway Clearance  
 
Mucus hypersecretion and chronic productive cough are the features of chronic bronchitis and 
chronic obstructive pulmonary disease (COPD). The overproduction and hypersecretion by 
goblet cells and decreased elimination of mucus are the primary mechanisms responsible for 
excessive mucus. Mucus accumulation in COPD patients affects several important outcomes 
such as lung function, health-related quality of life, COPD exacerbations, hospitalizations, and 
mortality (Ramos et al., 2014). 
 
Chronic cough and sputum production are common features of COPD and have a significant 
impact on exacerbation frequency and quality of life. Techniques to assist with removal of 
sputum from the airway do not have a well-defined role in COPD management though. Clinical 
trials of Airway Clearance Techniques (ACTs) in COPD have shown mixed results with little 
evidence of long-term benefit. However, many studies have failed to account for the 
heterogeneity of COPD lung disease. Analysis of short-term studies suggests that there may be 
a cohort of patients who would benefit from prescription of a sputum clearance regimen 
(Holland and Button, 2006), though current evidence based on a systematic review in airway 
clearance reports that uncertainty still exists about the clinical effectiveness of airway clearance 
techniques for patients with stable COPD (Wang, 2015). 
 
Anecdotal evidence from interviews and observations of some of the studies within this review 
shows that there is an increased level of airway clearance for some COPD patients during the 
singing sessions and it could be hypothesised that the act of singing may potentially have 
similar properties to techniques used in chest physiotherapy for airway clearance e.g. chest 
percussion, vibration, cough stimulation. As outlined in detail previously in Chapter 1, the 
techniques used in singing itself follow similar scientific pathways that form the basis of 
successful chest physiotherapy, airway clearance, and airway clearance devices (Goldenberg, 
2018). Daily observations of children have also showed that during breathing exercises, playing 
and laughing and during FEV1 manoeuvres, mucus moved better than most of the time during 
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postural drainage etc. (Schöni, 1989). The effect of group singing versus singing alone, would 
likely involve additional activities such as talking, moving and laughing with others in the group, 
which could enhance this mucus clearance and as such COPD symptoms. 
 
In one study (Bonilha et al., 2009) the investigators observed that the patients coughed and 
eliminated a substantial amount of sputum just after ending the practice of vocal exercises or 
songs. This finding was not registered by employing a formal research protocol though. The 
author does highlight that ‘this indicates that singing may also exhibit bronchial hygiene 
properties’ and that the ‘performance of prolonged and robust expirations has the potential to 
facilitate the mobilization of respiratory secretions towards the upper airways, eliciting the cough 
reflex’. The participants reported in another study (McNaughton et al., 2017) also perceived 
health benefits including sputum clearance from participation in the group. It is also suggested 
by the author that the “improvement of PEmax associated with singing could also contribute to 
better coughing”. Singing did exhibit an increase in mean PEmax for one study (Pacheco et al., 
2014) and their control group showed a decrease, so this certainly indicates further analysis 
using this measure would be interesting. 
 
Dyspnoea Management 
 
There was no clear positive improvement in dyspnoea symptoms shown by any of the 
quantitative data in the studies selected with the exception of two studies (Trivedi, 2017, 
Jamaly et al., 2017). The first (Trivedi, 2017) showed significant improvement in MRC 
Breathlessness/Dyspnoea Scale for the experimental group over the control, however the study 
continued pulmonary rehabilitation in both groups for the duration, which might have a 
confounding effect in the construct of this review. The other study (Jamaly et al., 2017) showed 
a significant improvement for the singing intervention compared with control group where 
participants were assigned to a course of physiotherapy lung exercises, however further details 
on the quality and conduct of this study are still pending. It is clear that with such a high 
variation of dyspnoea scales at play and different elements of dyspnoea symptoms being 
captured and assessed, analysing this data collectively is very challenging. 
 
Studies which used multiple tools to capture similar information may contain useful information 
to look at the consistency of responses in this regard and it could prove useful to obtain raw 
data for these studies to look at this specifically or build this in to future design. Comparisons of 
these tools could hold valuable information about the suitability of the outcome measures used 
within this population and potentially aid future study design. It may be helpful to obtain a 
consensus of the most robust tool for future studies, so that dyspnoea could be reviewed 
further. 
 
Dyspnoea is one of the most important symptoms for COPD patients and has the potential to be 
positively impacted by singing intervention, so finding a way to improve data capture and 
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analysis of this data seems to be important but to date does not appear to have received the 
attention it might deserve. 
 
These studies contain key information about the use and suitability of dyspnoea tools employed 
in this therapeutic area. It could therefore be useful to compare the outcomes of these 
questionnaires within this small batch of studies and potentially analyse this in further detail. 
This could aid and advise which tools might be the most appropriate or sensitive to utilise for 
future research of the impact of dyspnoea in singing for respiratory disorders.  
 
Inflammation and Depression 
 
Inflammation and depression are key factors in the pathophysiology of COPD and there are 
ongoing efforts to understand the links between the two and how these could have relevance for 
COPD treatment. There is an emerging recognition that inflammation may cause depression in 
certain subgroups of individuals. Epidemiological studies on large community samples (as well 
as smaller samples of medically ill individuals) have in addition demonstrated that increased 
inflammation serves as a risk factor for the future development of depression (Miller and 
Raison, 2016). 
 
Singing studies in general support the hypothesis that choir singing positively influences 
emotions as well as immune functions in humans (Kreutz et al., 2004) and research so far 
points to the pivotal role of stress pathways in linking music to an immune response (Fancourt 
et al., 2014). There is evidence that greater improvements in mood as a result of singing are 
associated with lower pro-inflammatory response (Fancourt et al., 2016). In light of the 
importance of emerging data and the implications for singing and COPD research, it is 
surprising that there has been relatively little data collected for these factors within the singing 
for COPD studies. 
 
Four studies (BLF, 2017, Pacheco et al., 2014 Clift et al., 2013, Clift et al., 2017) utilised 
EUROQL questionnaire which captured some depression data, although no significant findings 
were presented in regard to the singing intervention.  
 
One of these (Pacheco et al., 2014) also utilised the HAD anxiety scale and five others (Lord 
et al., 2010, Lord et al., 2012, Liu et al., 2016 McNaughton et al., 2017, Trivedi, 2017) 
utilised both the HAD anxiety and HAD depression. A significant improvement was recorded by 
one of these studies (Liu et al., 2016) following a twenty-four-week singing intervention vs. 
control however the quality of this study is uncertain due to lack of further publication. Another 
study (Trivedi, 2017) showed a suggested significant improvement in anxiety and depression 
due to the singing intervention however, PR was employed throughout for both arms of the 
study, so this result may have been compromised. One further study (McNaughton et al., 
2017) showed a mean reduction in HADS anxiety score observed at one year though this did 
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not exceed the minimal clinically important difference. This also replicated a similar result seen 
over a shorter period as noted by one of the other earlier controlled studies (Lord et al., 2010). 
No other significant results were recorded using these tools in any of the other studies. 
 
There is some investigation into depression in the studies selected but this is only via outcome 
questionnaires and there has been no investigation into biomarkers for depression or 
inflammation in any of the singing studies for COPD patients specifically. This would seem to be 
a considerable gap within the research available. 
 
Health Care Utilisation, Service Use and Cost-effectiveness 
Considerations 
 
One important study (Lopez-Campos et al., 2016) notes that the predominant health-care cost 
item for COPD patients is hospitalizations for exacerbations and it suggests high priority should 
be given to interventions aimed at delaying the progression of disease, preventing 
exacerbations and reducing the risk of comorbidities. This is in order to alleviate the clinical and 
economic burden of COPD in Western and Asian countries as studies on health-care use and 
economic cost to date in Asian countries, confirmed that these findings are now universal. 
 
Health care utilisation does not appear to be captured consistently in any studies which would 
indicate that the current tools in use are possibly not ideal or this area is more challenging to 
assess.  Only four studies made mention of this aspect (Clift et al., 2013, Clift et al., 2017, Liu 
et al., 2016, Thomas et al., 2015). One small qualitative study (Thomas et al., 2015) 
mentioned that there was no difference in hospital admissions in the year after starting singing 
compared to the year before. A larger study (Clift et al., 2017) also reported a stable picture of 
service use though which is encouraging and a positive finding in itself. There were no other 
significant findings. It would be important to explore this for a longer period, across a greater 
number of COPD patients with differing severity of disease and particularly in randomised trial 
setting. It may then be possible to examine in more detail whether a singing intervention for this 
degenerative disease, where service use is likely to increase over time, could be seen to 
maintain levels of health care utilisation at a steady state. It is clearly important that this area 
should continue to be pursued in future research. 
 
It would also seem important to explore the cost-effectiveness of providing singing interventions 
to this population, as the provision of opportunities to meet and sing together have been shown 
to provide cost-effective and acceptable options to maintaining and enhancing health in other 
populations (Coulton et al., 2015), and this would provide useful data to support decisions on 
future policy in this area.  
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Systematic Review - Conclusion 
 
Singing is a well-tolerated intervention that has a number of positive outcomes in support of 
patients with COPD. Singing was shown to have positive outcomes for physical activity (PCS - 
SF-36) (Bonilha et al., 2009) and improvements in lung function (Clift et al., 2013, Pacheco et 
al., 2014) which is possibly the most important clinical finding from the studies.  
 
The overwhelming message from the collective outcomes of the systematic review and studies 
included is a positive one. The majority of the studies, i.e. eighteen of the nineteen studies 
included, reported one or more positive finding, with varying degrees of significance and none of 
the studies concluded any negative findings. Several of these studies (Clift et al., 2017, Engen, 
2005, Grasch, 2013, Herer, 2013, Jamaly et al., 2017) presented both positive and neutral (no 
change) findings and one study (Goodridge et al., 2013) reported only neutral findings. 
However, a neutral finding in this population, with a degenerative disease, may also be 
considered positive in the sense of a lack of negative change in the measure i.e. an indicator of 
‘no change’ in an outcome measure might suggest lack of deterioration. The qualitative data 
from this study was positive, providing a slightly positive message overall. 
 
Only two studies (Pacheco et al., 2014, Clift et al., 2017) reported any negative findings. The 
first was due to a very small sample i.e. a single patient on one data point. The other clearly 
stated that some of the results were likely to have been significantly impacted due to 
extenuating temperature changes on the days of the assessments.  
  
Principal significant variations with maximal oxygen uptake (VO2) and higher arterial oxygen 
saturation (SaO2) respectively (Herer, 2013, Bonilha et al., 2009) have also been observed, 
during the act of singing. These results are provided from a very small sample, but this could be 
interesting for further research. Patients with COPD often show slow, progressive deteriorations 
in arterial blood gases during the night, particularly during rapid eye movement (REM) sleep. 
This is mainly due to hypoventilation, while a deterioration of ventilation/perfusion mismatch 
plays a minor role. Current indications on treatment in this area are based on limited knowledge 
(Marrone et al., 2006) hence any investigation which could improve understanding in this area 
could also be useful.  
 
There have been attempts to address the limitations of previous research (Clift et al., 2013) by 
establishing much larger groups, meeting weekly over a longer period of time. In addition to 
teaching good posture, breathing techniques and engaging in singing, having additional social 
time with others in the group and working towards combined performance events may have 
contributed to the more positive outcomes seen. Hence the quality, consistency and persistence 
of the singing intervention and delivery method may well be essential components of any 
effective singing intervention and such issues need to be a significant focus for future research. 
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The lack of standardisation and agreement of key outcome measures is apparent, and it seems 
important that an agreement is reached and shared among the key opinion leaders and 
researchers in this field so that a more consolidated and consistent approach is taken worldwide 
moving forward. Initial headway has been made in this area and a consensus group convened 
in the UK in 2016 to address a variety of issues pertaining to Singing for Lung Health (Lewis et 
al., 2016). The group agreed that the patient-reported outcome measure, the COPD 
assessment test (CAT) score, is a strong candidate measure for Singing for Lung Health, both 
as feedback to patients and to ensure that the group is functioning effectively (Lewis et al., 
2016). However, further consensus needs to extend globally and encompassing other health 
and wellbeing measures.  
 
This would apply to the collection tools in use, methodology for study design (e.g. inclusion and 
exclusions criteria) and the optimum target intervention adherence (i.e. frequency and duration 
of sessions). This would allow more efficient collaboration between researchers in different 
regions and allow more opportunity to pool and share data across multiple studies. There is also 
little information available regarding the health care utilisation and cost-effectiveness of singing 
interventions compared with other treatment options, which would be helpful to understand 
further and consider for future research for this intervention to aid in policy making. 
  
The anecdotal comments and interview output provided by the qualitative data give much more 
positive reflections on singing interventions, not always reflected in quantitative outcome 
measures (Goodridge et al., 2013). It was even commented in the conclusion of one study that 
given the subjective benefits in physical sensation described by patients the lack of change in 
exercise capacity is interesting i.e. comments such as “housework is no longer a struggle” (Lord 
et al., 2010). It is crucial to continue to pursue the relevant physical data to build on these 
findings as anecdotal information, while encouraging, cannot be relied on to support long term 
solutions or policy change. It is recommended that future work might include a comprehensive 
systematic review of all obtainable interview output for ‘singing for adults with COPD’ and 
related patient comments, as this data would be much more extensive than the current 
quantitative data and could provide further support and direction for future work.  
 
It is recommended that research in this area should extend to incorporate other important 
personal and health data i.e. further exploration of biomarkers, particularly those that provide 
information on the immune system, links between inflammation and depression biomarkers and 
the possibility of improved HRV in patients. This is vital in order to build on the previous 
important research in this area (Vickoff et al., 2013, Kreutz et al., 2004, Fancourt et al., 2014) 
and improve knowledge and understanding of both the physiological and psychological 
mechanisms of action involved in singing. The research to date indicates further investigation as 
to whether singing could impact these biomarkers in COPD patients would be an important step 
in understanding how singing positively impacts symptoms in this population specifically.  
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It is clearly established that the primary cause of COPD is tobacco smoke (either through 
tobacco use or second-hand smoke) and in 2012 it was accepted that this disease now affects 
men and women almost equally, due in part to increased tobacco use among women in higher-
income countries (WHO, 2017b). It is relevant to acknowledge that even with generalised, 
confirmed, continuous reductions in COPD standardised mortality rates, plus some recent 
successful anti-smoking reductions in a number of Western countries, the overarching ageing of 
an ever-expanding world population and other factors such as high rates of smoking in Asia 
specifically, this will continue to make COPD an even larger problem for years to come (Lopez-
Campos et al., 2016). Further global studies, particularly in both higher income and less 
affluent regions is therefore becoming even more desirable.  
 
The overwhelming conclusion from the studies within this broad systematic review are in close 
alignment with the recent Cochrane review (McNamara et al., 2017) i.e. That the availability of 
high quality evidence that singing for COPD improves physical health, dyspnoea or respiratory-
specific quality of life is still limited. This is largely due to the low number of studies and the 
small sample size of each study. The existence of research examining the longer-term effect of 
singing for people with COPD is limited and robust information from randomised controlled trials 
over extended periods is non-existent.  
 
It is essential that researchers build on this existing knowledge through larger, longer, multi-
centre global randomised controlled trials. These should certainly extend to provide more 
consistent data across diverse regions and countries with low, middle and high incomes and 
target more diverse COPD populations. This is where the gap in the current research lies. Key 
data to support these areas is fundamental, both to help determine the impact of group singing 
on health-related quality of life and dyspnoea, and as an established evidence base to support 
health improvements and policy making in the future. 
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Chapter 3 – Methodology 
 
Research Study: Introduction 
 
In order to address two of the three key research questions ‘What are the potential health and 
wellbeing benefits of regular participation in group singing for a small cohort of COPD patients?’ 
and ‘What is the potential feasibility and usefulness of developing and implementing novel 
singing resources for a group of COPD patients, in addition to regular group singing?’ a two-part 
empirical study was designed and executed. This study was of a single group quasi-
experimental design.  
 
The intent of this empirical research was to evaluate the impact of weekly group singing 
sessions for people with COPD including newly developed supplementary resources for 
promotion of self-management in this population. To meet this aim and to provide suitable input 
and learnings for future planning of a larger randomised controlled trial, a study was designed 
with two interrelated but distinct components.  
 
The first component of the study (Part I) concerns review of the overall impact of weekly group 
singing sessions on health and wellbeing measures, for people with COPD, who are also using 
a newly developed supplementary resources. It employs a quasi-experimental pre-test post-test 
design which aims to answer the question ‘What has been established so far by research 
regarding the effects of group singing for COPD patients?’. It is also intended that this study will 
be a feasibility study to help to further understanding of the viability of conducting future 
research in this area of Kent and to potentially inform the methodology of this and future larger 
research study designs. 
 
The second component of this research study (Part II) was concerned with piloting the use of 
newly prepared self-management resources for COPD patients and aimed to answer the 
question ‘What is the potential feasibility and usefulness of developing and implementing novel 
singing resources for a group of COPD patients, in addition to regular group singing?’ 
 
The empirical study was designed in parallel with the systematic review and the finalised design 
of the study followed the initial completion stages of the systematic review in late 2016. This 
was to ensure any important and valuable information from the conclusions of the systematic 
review could be used to inform the research study design. The following components were 
specifically informed by the systematic review. 
 
The frequency and duration of individual sessions, as seen in the majority of those studies with 
positive outcomes, to be one hour of singing and exercise once every week. This was also 
deemed to be the simplest format and in line with the regular arrangements for community 
groups, so this was adopted for this study. The pattern and structure of the singing and exercise 
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sessions was also planned to closely follow those laid out in previous studies (Clift et al., 2013, 
Clift et al., 2017). 
 
Participants were aged between 49-91 years old for the fifteen studies where this was 
presented, so since this was a wide range it was decided that no stipulations were made on age 
for inclusion for the design of this study, except that participants should be adults over 18 years 
old and date of birth would be captured as a data point. 
 
The studies included in the systematic review were conducted across four continents i.e. North 
America, Latin America, Europe and Asia Pacific with the majority in Europe in temperate 
climates. It was considered feasible that a study in South East England would allow achievable 
recruitment. It was also considered most advantageous to enrol and conduct the singing groups 
in spring and summer seasons, similar to previously conducted studies (Clift et al., 2013, Clift 
et al., 2017) and the taster sessions and patient recruitment activities had been previously 
organised with this schedule in mind. 
  
It was decided to keep the data collection simple to administer and as unobtrusive as possible 
to participants, both to enhance good compliance and to ensure the key focus in the time 
commitment for participants remained on singing and exercise activities as the priority.  
 
It was deemed important to capture at least one health related questionnaire specific to COPD. 
The COPD Assessment Test (CAT) is a questionnaire designed to measure the impact of 
COPD on a person's life, and how this changes over time and has good measurement 
properties. The CAT had been used previously by two other studies included in the review. One 
study (Jamaly et al., 2017) recorded significant improvement (p = 0.029) in the singing 
intervention group and another study (BLF, 2017) recorded significant mean improvement of 
1.1 (p = 0.02) post singing intervention on this measure. Since it is sensitive to differences in 
state and provides a valid, reliable and standardised measure of COPD health status (Jones et 
al., 2009) this measure was selected.  
 
It was also decided that is could be important in this group of participants to measure the 
adequacy of asthma control in addition to the CAT and as such the ACQ was selected for this 
purpose. However, this was not informed specifically by the systematic review. The selection of 
the other wellbeing outcome measure similarly was not informed by the outcome of the 
systematic review directly. However, the review did reveal the importance of including a simple 
wellbeing outcome and the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) was 
selected as it had been validated for use in the UK with those aged 16 and above and 
commissioned by NHS Health Scotland (Stewart-Brown and Janmohamed, 2008) and could 
be implemented simply without extensive cost. 
 
Since the qualitative outcomes measures from the studies discussed in the systematic review 
provided data that was shown to enhance the quantitative data for those mixed model studies 
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where this was collected, it was also decided to include an open text questionnaire to give 
participants the opportunity to make comments and provide further feedback in an unstructured 
way.  
 
It would have been ideal to implement a more robust study design here, as recommended by 
the outcome of the systematic review however, this was not feasible at this time due to the time 
and resource availability so a quasi-experimental pre-test post-test design was selected. 
 
Research evidence in healthcare can be classified according to levels of quality known as the 
hierarchy of evidence. There are various versions of the evidence pyramid most of which focus 
on showing weaker study designs (basic science and case series) at the bottom or level 5 
followed by case–control and cohort studies in the middle, then randomised controlled trials 
(RCTs) and systematic reviews and meta-analysis at the top (Murad et al., 2016). The details of 
the levels of this hierarchy are shown in a tabular format in table 6 below.  
 
Level Research Design 
Level 1 
Systematic Reviews or 
Collective Randomized Controlled 
Trials (High Quality) 
Level 2 
One Randomized Controlled Trial 
(High Quality) or  
Collective Randomized Controlled 
Trials (High-Low Quality)  
Prospective Controlled Trial 
Cohort 
Level 3 Case Control Study 
Level 4 
Pre-Post Test Study 
Post Test Study 
Case Series 
Level 5 
Observational Study 
Clinical Consensus 
Case Reports 
  
Table 6 - Levels of the Hierarchy of Evidence (created by author) 
 
The research study components here are relatively small but good quality in regard to conduct. 
However, since the core study has a quasi-experimental pre-test post-test study design and the 
secondary study has a post-test design these would align with level 4 in this hierarchy.  
 
One of the strengths of a quasi-experimental pre-test post-test design are such that it allows a 
study to be designed, implemented and conducted simply and conveniently, both for 
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researchers and participants alike, which was a key consideration for the study schedule and 
patient population. It allowed design to be conducted and granted ethics approval in parallel 
with the planning and recruitment for the singing groups, so that both could start concurrently in 
the spring. This allowed the advantage of conducting the study during the more favourable 
seasonal conditions for COPD patient recruitment and maximised the impact of the previously 
conducted taster sessions on enrolment into the study.  
 
The additional strengths of a pre-test post-test design, relevant to the decision to use it in this 
case, were that it is relatively low cost compared to other types of study design, it can work well 
with surveys such as the patient reported outcome questionnaires, as selected for this study, 
and it can still provide a reasonable evaluation or assessment of a post intervention change. 
The main weaknesses are that this design is not rigorous at eliminating bias or other 
explanations, as is the case with a robust randomised controlled and blinded study designs and 
it can usually only show short term changes.  
 
While the study design meets most of the requirements in terms of execution it clearly reduces 
the overall confidence in the reliability of the results that could be achieved particularly with a 
randomised controlled study or a design which allows some possibility of blinding the 
interventions, since there is strong potential for bias.   
   
The outcome of the literature review highlights more generally that the quality, consistency, 
frequency, length and duration of the singing intervention and the delivery method are essential 
components which need to hold a more significant focus for future research and while this study 
could not be designed to meet these important focus points, it does aim to address the aspect 
of a longer term follow up period and to provide important feasibility information to planning for 
future larger randomised trials, which are essential in this research area. 
 
One potential way to improve the aspects of the group singing intervention, while exploring use 
of low-cost, broad-reaching and more innovative approaches, might be to understand the 
feasibility of tools which encourage good quality home-practice or self-management, that can be 
used to encourage, compliment and support regular and prolonged attendance of group singing 
sessions.  
 
Feasibility of Self-Management Resources 
 
Overall, there is a growing body of evidence to show that, when compared to no intervention 
(i.e. standard care) self-management approaches can provide benefits for participants 
particularly in terms of knowledge, performance of self-management behaviours, self-efficacy 
and aspects of health status (Barlow et al., 2002).  
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The findings from one study that looked at utilising a DVD specifically to improve compliance 
with home exercise programs (Kingston et al., 2014) demonstrated the multidimensional 
nature of compliance and showed an improved understanding of exercises when utilising home 
resources such as DVDs. This suggests self-help guides could be utilised as part of a 
programme that facilitates a patient-therapist relationship. It is considered important to trial 
additional resources and hypothesised that varying and/or combining the medium of delivery of 
this intervention may enhance the experience of group singing, provide a more versatile offering 
and encourage retention and continued adherence to singing exercises in the longer term.  
 
A previous study (McAuley et al., 2013) provided cautiously optimistic evidence that the use of 
DVD-delivered programs designed for a target population can be both effective and utilized on a 
broad scale. This study demonstrated the feasibility, acceptability, and efficacy of delivering 
regularly scheduled activities focusing on older adults via the medium of DVD. This study 
highlighted and recognised that this type of novel intervention is also capable of reaching 
participants from outlying geographical areas who typically would not be able to attend centre-
based activity trials conducted at university or medical centres.  
 
The novel ‘Singing for Better Breathing’ (SfBB) resources created for use in this study have 
been developed such that they may also have other potential uses in the future to provide 
support to those COPD patients who might benefit from the activity of singing but are unable to 
attend group sessions regularly, outside their home environment due to extent of their disease 
or other limiting factors. It might also be speculated that it could be helpful to improve 
consistency of good practice between group sessions and encourage longer term continuation 
of singing. 
 
COPD self-management tools 
 
The current comparable research evidence in the area of self-management specifically in the 
COPD patient population is largely in regard to Pulmonary Rehabilitation (PR) and the results of 
several recent studies of PR home use indicate that home training may be a feasible option for 
COPD patients, in addition to hospital-based PR or instead of hospital-based PR where 
resources for this option are limited.  While preliminary studies have limitations, initial reports 
suggest that home-based PR is safe and may improve clinical outcomes (Holland et al., 2017, 
Guell et al., 2008, Puente-Maestu et al., 2000). 
 
An early study (Strijbos et al., 1996) compared hospital outpatient and home supervised PR in 
groups of COPD patients with moderate to severe airflow limitation. Equal improvements were 
detected in exercise capacity and in Borg dyspnoea for both groups, however, whereas after the 
group-led sessions values tended to return to baseline outcome, after home training a further 
ongoing significant improvement in exercise capacity was observed, while Borg dyspnoea 
scores remained significantly improved over 18 months. Improvements in cycle workload and 
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dyspnoea score were significantly better maintained in the home supervised group as compared 
with hospital outpatient group. A significant improvement in wellbeing was maintained over 18 
months in both rehabilitation groups. Therefore, while beneficial effects were achieved in both 
researchers recommended initiation of home supervision as improvements were maintained 
longer and are even further strengthened in this setting. 
  
One study demonstrated that the improvement in exercise tolerance achieved by COPD 
patients with an unsupervised home pulmonary rehabilitation program is similar to the gains of 
patients in an intensive hospital-based program (Guell et al., 2008). A further study showed that 
both hospital and home rehabilitation strategies were associated with statistically and clinically 
significant improvements and that the home intervention was not inferior to the outpatient 
intervention at 3 months and 1 year, using the primary end-point of improvement in dyspnoea 
(Maltais et al., 2008) further supporting the understanding home rehabilitation is a useful, 
equivalent alternative to outpatient rehabilitation in patients with COPD.  
 
A more recent randomised controlled equivalence study in the COPD population explored the 
use of home-based PR and found that a home-based PR model, delivered with minimal 
resources, produced short term clinical outcomes that were equivalent to centre based PR. 
Although neither model was effective in maintaining gains at 12 months, it was concluded that 
home-based PR could be considered for people with COPD who cannot access centre-based 
PR (Holland et al., 2017). 
 
Finally, a meta-analysis of quality of life outcomes in COPD patients revealed that self-
management interventions can significantly improve COPD patients' health outcomes and 
recommended that due to the multifaceted nature of self-management programmes the process 
of self-management become integrated into patients’ usual care, providing patients with ongoing 
feedback, bolstering their support, in addition to improving their overall health and well-being 
(Cannon et al., 2016). 
 
While the activities and details of many of these PR activities are not directly comparable to 
singing self-practice, it could be speculated that singing home-practice tools and self-
management techniques might be a feasible option for COPD patient population, particularly 
those unable to attend group singing sessions at all or unable to continue group sessions, 
adding to the arsenal of tools and options available to support patients with this debilitating 
illness. 
 
The aim of this next aspect of the research is to further explore these themes by evaluating the 
feasibility of specific tools that might support the improvement of quality, consistency, frequency 
and length of a singing intervention. It is speculated that these tools may support by 
encouraging good practice and persistence between group sessions, in addition to good quality 
group training weekly with a singing leader.  
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The research aims to evaluate the use and usability of a supplementary element of self-
management (in the form of DVD and booklet resources designed specifically for the COPD 
population) in addition to weekly group singing sessions, by evaluating data and feedback from 
a group of patients with respiratory illness over specified durations. 
 
Study Objectives and Endpoints 
 
Objectives 
 
The primary objectives of the research were to review and evaluate the impact of weekly group 
singing on COPD patients’ wellbeing and COPD impact using patient reported outcome 
measures (The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS), The COPD 
Assessment Test (CAT) and The Asthma Control Questionnaire (ACQ-5)) and to assess 
feasibility of specifically created resources “Sidney De Haan (SDHR) ‘Singing for Better 
Breathing’ Resource©” (SfBB), used in conjunction within the target population using a novel 
questionnaire designed for this purpose. The hypothesis being, if participants attend singing for 
COPD groups regularly, there will be improvements noted in their health and wellbeing as 
reported within these outcome measures. 
 
The secondary objectives were to assess recruitment uptake, retention and acceptability and 
adherence to the SfBB resources with the objective of assessing feasibility for this type of 
intervention in this population. Compliance data of group singing and use of resources will be 
collected through both group session attendance records and participant feedback 
questionnaires.  
  
Primary Endpoints 
 
• Mean total score difference from baseline of WEMWBS, CAT and ACQ-5 at Follow-Up Visit 
V2, Week 12 +14 days 
 
Secondary Endpoints 
 
• Mean total score difference from baseline of WEMWBS, CAT and ACQ-5 at Mid-Term Visit 
V1 Week 6 +14 days  
• Mean total score difference from baseline of WEMWBS, CAT and ACQ-5 at Final Follow-Up 
Visit V3 Week 30 +21 days 
• Mean total score SFBBQ for usage and usability of SDHR SfBB resources at Follow-Up 
Visit V2, Week 12 +14 days 
• Summary of all written feedback, as captured in patient evaluation forms. 
• Overall compliance and drop-out rate for singing groups 
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Research Study: Method and Design 
 
The study was conducted following a formal protocol (See Appendix C) 
 
Ethics and Ethics Committee Review 
 
To ensure this research complies with the major ethical issues i.e. Informed consent, risk vs 
benefit to the participant, respect for anonymity, confidentiality and privacy, it is the researcher’s 
responsibility to have prospective approval of the study design including any amendments, 
informed consent documents, patient information sheets and other relevant documents, from a 
local ethics committee. In this case the Faculty Research Ethics Committee of Canterbury Christ 
Church University. All correspondence with the ethics committee is retained by the researcher 
and the formal approval letter is noted in Appendix C, sub-appendix V. 
 
The logistics of the ‘Singing for COPD’ group sessions were planned discretely from the 
research component, with full risk assessments carried out. The intent was that these groups 
with self-referred participants would be maintained and progress independently of the research 
itself. Therefore, the ethical considerations of the research component were specifically related 
to the data collection aspects i.e. capture of documented informed consent prior to the use of 
participants’ data and respect for their anonymity, confidentiality and privacy.  
 
One amendment was considered to continue to collect data for an additional period and this 
was approved by the ethics committee prospectively. The only circumstance in which an 
amendment to the study would be considered to be initiated prior to ethics committee approval 
is where a change is necessary to eliminate apparent immediate hazards to the participants. In 
that unlikely event, the research team would have contacted the ethics committee in writing 
immediately after the implementation. However, this was not required during the conduct of this 
study.  
 
Participant Information and Consent 
 
All potential participants were provided with an information sheet explaining the study (see 
Appendix C, sub-appendix II) and asked to sign an informed consent form (Appendix C, sub-
appendix III). Personal details other than those necessary for demographic information were not 
requested and only data to be analysed and reported as part of the researched was collected. 
All data is treated as confidential and no comments from any participant in the study will be 
attributed to them personally in any publication. 
 
When study data is analysed or compiled for transfer or publication the participant names, 
addresses, and other identifiable data is replaced by a numerical code in order to de-identify 
study participants. The researcher maintained a confidential list of participants who participated 
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in the study linking their numerical code to the participant’s actual identity. In case of data 
transfer, the researcher will maintain high standards of confidentiality and protection of 
participant personal data consistent with applicable privacy laws. 
 
The informed consent documents were in compliance with Faculty Research Ethics Committee 
of Canterbury Christ Church University including applicable privacy laws. The informed consent 
documents used during the informed consent process were reviewed by the researcher, 
submitted and approved by the ethics committee before use and available for inspection. The 
research has been carried out to ensure that each study participant is fully informed about the 
nature and objectives of the study and any other information associated with participation.   
 
Ethical approval of the Informed Consent Document (ICD) and Information sheet was sought 
and obtained from the Faculty Research Ethics Committee of Canterbury Christ Church 
University. It was expected that participants were living independently and not affected by 
serious physical or mental frailty. However, in circumstances where participants might 
potentially be considered vulnerable in view of their age or any related health condition, care 
was taken to present information about the project with due attention to all participants needs 
and capabilities. It was considered that this research project did not carry any risks of harm to 
individuals who were invited to participate. All care was taken to ensure informed consent, risk 
vs. benefit to the participant, respect for anonymity, confidentiality and privacy were upheld at all 
times. 
 
The researcher, or a person designated by the researcher (e.g. singing leader), obtained written 
informed consent from each participant, before any study-specific activity was performed. The 
researcher then retained the original of each participant's signed consent document and a copy 
of this was also provided to the participant for their information and records. 
 
All information gathered is stored securely in the offices of the Sidney De Haan Research 
Centre for Arts and Health, Canterbury Christ Church University. Members of the Sidney De 
Haan Research Centre are the only persons having access to the primary research material. All 
data will be anonymised prior to analysis. 
 
Participant Selection and Recruitment 
 
Initial feasibility was established from patients and carers attending pulmonary rehabilitation 
(PR) groups conducted in the Medway area during summer months (April-July) 2016. Taster 
sessions were arranged for these patients at the end of their pulmonary rehabilitation sessions. 
Originally there were approximately eighty people that expressed an interest in participating in 
attending a Singing for Better Breathing (SfBB) group to be arranged in the Medway area of 
Kent, UK. The potential participants also expressed preference of location for attending the 
sessions. 
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They were each contacted again to confirm interest and establish the most effective locations 
that they could attend regularly bearing in mind the limitations of their respiratory condition. The 
information acquired allowed the set-up of two sites for assessments and weekly singing 
sessions. Total recruitment was confirmed in early spring 2017 with fifty-four potential self-
referred participants, including both those that confirmed the had a respiratory diagnosis and 
those that considered themselves undiagnosed attendees, all identified as strong reliable 
candidates to join one of the two groups. Participants were self-referred based on information 
provided to them in confidence by their Health Care Provider (HCP) or pulmonary rehabilitation 
team. A decision was made to collect and analyse findings for the whole group together, for the 
purposes of retention and to obtain the widest possible feedback on the self-management 
resource tools, while focusing on those diagnosed with COPD for the analysis and reporting of 
health and wellbeing outcomes. 
 
The locations and times of the weekly sessions were decided using criteria of availability at four 
centres identified to have appropriate facilities along with the availability of two trained singing 
leaders, associated with the SDHR centre in the local Kent area in South East England (UK). 
The sessions were selected to be conducted on a Wednesday morning at 10-11 AM (local time) 
at Centre A, a community centre in Gillingham, Kent (UK) and on Thursday afternoons at 1-2 
PM (local time) at Centre B, a community centre in Chatham, Kent (UK). 
 
Leaflets were also used as a recruitment resource to outreach other participants local to the 
selected community centres shortlisted for conducting the sessions and other attendees of local 
British Lung Foundation (BLF) ‘Breath Easy’ groups in the Medway area. While there was some 
interest, the recruitment of all eligible was from the original established NHS PR groups. This 
therefore ensured that all of the enrolled participants had been previously diagnosed with a 
respiratory illness and had attended a course of pulmonary rehabilitation (PR) prior to enrolment 
in the study or were attending as carers of the same. 
 
Inclusion and Exclusion Criteria 
 
This study was only able to fulfil its objectives if appropriate participants were enrolled. The 
singing groups included self-referred participants from pulmonary rehabilitation groups in the 
area and so the majority were diagnosed with COPD or another CRD but also included several 
undiagnosed participants and carers due to the needs and dynamics of the groups. The 
following eligibility criteria below were designed to select only self-referred participants for whom 
the protocol intervention is considered appropriate by their health care provider (HCP) or 
pulmonary rehabilitation team.  
 
The initial enrolment time was very short due to the availability of the venues, so all candidates 
attending the initial two sessions were included in the evaluation, including carers that did not 
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have a lung condition diagnosis, but only participants meeting all of the following criteria were 
deemed eligible for the study evaluations: 
 
Inclusion Criteria 
 
• Over 18 years of age. 
 
• Shows evidence of a personally signed and dated informed consent document, 
indicating that the participant has been informed of all pertinent aspects of the study 
and provided with an information sheet. 
 
• Previously diagnosed with a COPD related lung condition by their Physician or Health 
Care Provider (HCP) 
 
• Willing to commit to participating in the project over the course of thirteen weeks (health 
permitting) 
 
• Enrolled into a singing for COPD group conducted by the Sidney De Haan Research 
Centre 
 
• Physically mobile and able to travel to sessions independently or with support 
 
Exclusion Criteria 
 
Participants with any of the following characteristics/conditions were not included in the study 
though no participants meeting these criteria were identified for exclusion: 
 
• Research site staff members directly involved in the conduct of the study and their 
family members, site staff members otherwise supervised by the researcher, or 
participants who are employees of Sidney De Haan Research Centre or Canterbury 
Christ Church University, including their family members, directly involved in the 
conduct of the study 
 
• Participants who are physically unable to attend group singing evaluation sessions 
 
• Participants with severe dementia or other cognitive or communication problems, which 
in the opinion of the researcher would render consent problematic 
 
• Participants with ongoing or planned participation in pulmonary rehabilitation, scheduled 
to take place within project timescale. 
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Study Intervention 
 
The intervention combined a thirteen-week programme of regular weekly group singing 
sessions with guided home singing practice between sessions.  
 
Singing groups were led by two skilled and experienced singing leaders and the scheduled 
exercise and singing largely followed the guidance within the specially created resources 
provided to the participants to ensure a broadly consistent approach.  
 
Singing sessions were weekly during academic term time, from May 2017 to July 2017 with a 
break during the summer starting again from September 2017 to November 2017. Sessions 
were held in two community halls booked specifically for the purpose. They were private and 
afforded acceptable levels of comfort (heating, light, ambient sound, refreshment making 
facilities, etc.). One had close integral car parking and the other had roadside parking with 
access to public transport and both had flat access to the hall on the ground floor. 
 
Sessions were a total of one hour with thirty minutes available either side of the session for 
setting up, socialising, ‘meeting and greeting’ and clearing away after singing. The sixty-minute 
singing session commenced with twenty minutes of relaxation, posture, breathing and vocal 
exercises followed by forty minutes of singing. Participants also steered the musical direction of 
song choices for their group according to their interests, so that the programme was enjoyable, 
stimulating but consistent across both groups. Songs were taught by ear and were sung mainly 
without accompaniment.  
 
The feasibility study was designed with the aim of enrolling and consenting thirty patients across 
the spectrum of COPD severity to attend one of two research ‘singing for COPD’ groups in 
Medway in Kent. This was to primarily explore the impact of group singing and to obtain 
feedback on two specially created resources. The rationale was to collect initial thoughts and 
comments on booklet and DVD resources produced specifically for home use created for 
potential use with future singing for COPD groups and projects. 
 
The intervention aimed to employ skilled singing facilitators and a planned programme of group 
singing and singing-related exercises run weekly over a period of thirteen weeks ensured 
standardisation of delivery throughout the trial.  
 
Participants were also provided with the SfBB resources in addition, at their baseline visit and 
asked to trial these at home between group sessions. Participants were involved in baseline 
data assessment before the start of the singing groups and after the first seven weeks of 
intervention. Follow-up data collection then took place thirteen weeks after the intervention 
period of the trial to provide the key assessment data. Group singing was then halted for several 
weeks over the summer period and initiated again for a further 12 weeks, at which point a final 
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follow-up assessment was completed to allow for additional longer-term follow-up data to be 
analysed. The intent was then that the sessions might continue depending on interest, funding 
and availability of venue, singing leader etc. 
 
The structured singing during group sessions closely followed the guidance provided in the 
resource booklet (A summary of the songs provided for singing practise are noted in Appendix 
C, sub-appendix IV) and hard copies of the booklet containing full instructions and an 
accompanying DVD were provided to all participants. Guidance was given for participants to 
follow the resource instructions at home outside the group sessions and ‘self-administer’ the 
intervention according to the guidance. The intent was to provide limited information verbally 
about the resources, so as to assess the quality of the instruction and content. This evaluation 
was planned to occur at the Follow-Up Visit V2, twelve weeks post-baseline. 
 
Allocation to Intervention 
 
A single, open non-randomised unblinded design was employed so participants were recruited 
from willing volunteers into newly established self-referred community singing groups with 
approximately thirty to forty participants recruited across the groups. Participants were assigned 
a number sequentially by the principal investigator and the participants DOB and postcode was 
used as a primary key for database analysis and quality control the case report forms collected 
at each visit point. 
 
The investigators knowledge of treatment intervention did not influence the decision to enrol a 
particular participant or affect the order in which participants are enrolled as the study is open. 
 
Study Procedures 
 
Study procedures carried out at each visit are outlined below and specific questionnaire 
evaluations are noted in further detail in the following section. 
 
Baseline Study Visit - V0 Week 0 (+7 days) 
  
• Information Sheet and Informed Consent 
• Demography Questionnaire 
• Warwick-Edinburgh Mental Well-Being Scale (WEMBMS) 
• The COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
• Initial General Feedback Questionnaire 
• Distribution and explanation of SDHC SfBB Booklet/DVD resource 
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Mid-Term Study Visit V1 - Week 6 (+14 days) 
 
• Warwick-Edinburgh Mental Well-Being Scale (WEMBMS) 
• The COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
 
Follow-Up Study Visit V2 - Week 12 (+14 days) 
 
• Warwick-Edinburgh Mental Well-Being Scale (WEMBMS) 
• The COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
• SfBB self-help resource feedback questionnaire 
• Final General Feedback Questionnaire 
 
Final Follow-Up Study Visit V3 - Week 30 (+14 days)  
 
• Warwick-Edinburgh Mental Well-Being Scale (WEMBMS) 
• The COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
 
A flow diagram of the study visits is noted in figure 3 below. 
 
 
Figure 3 - Research Study Design: Flow Diagram for Study Evaluations  
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Measures and Data Collection 
 
The selection of research forms and measures was guided by a variety of rationale and a 
description of each is noted in more detail below. The study was conducted within a community 
setting and the aim was to ensure measures and data could be collected in the most simple and 
unobtrusive way. The measures and means used were required to be acceptable to participants 
and conducted within the confines of a community setting and the time available i.e. Lack of 
access to specialist or diagnostic equipment (e.g. weight scales, spirometers) or trained 
personnel etc. 
 
Questionnaires 
 
Demography Questionnaire 
 
The demography questionnaire was a short form created for collection of key demography data 
as supplied by the participant i.e. Gender, Date of Birth, Respiratory diagnosis and Length of 
time affected by lung problems? It also included questions regarding smoking status and 
previous group singing experience.   
 
It also included a request for the participants’ postcode, which was specifically to be used in 
association with their data of birth to provide a unique anonymised identifier (primary key) for 
matched analysis of samples within the dataset. These two critical data points (date of birth and 
postcode) were further collected at each subsequent visit and retained with the participants 
research form.  
 
Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) 
 
The Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) is a validated questionnaire 
assessing positive mental wellbeing and aims to measure mental well-being and not the 
determinants of mental well-being. It comprises a fourteen-item scale that relates to an 
individual’s state of mental well-being (thoughts and feelings) within the previous two weeks. It 
is a scale of mental well-being covering subjective well-being and psychological functioning, in 
which all items are worded positively and address aspects of positive mental health. The scale 
is scored by summing responses to each item answered on a 1 to 5 Likert scale where the 
minimum scale score is 14 and the maximum is 70. WEMWBS has been validated for use in the 
UK with those aged 16 and above (Stewart-Brown and Janmohamed, 2008). The Warwick-
Edinburgh Mental Well-being Scale was funded by the Scottish Government National 
Programme for Improving Mental Health and Well-being, commissioned by NHS Health 
Scotland, developed by the University of Warwick and the University of Edinburgh, and is jointly 
owned by NHS Health Scotland, the University of Warwick and the University of Edinburgh. 
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The COPD Assessment Test (CAT) 
 
The COPD Assessment Test (CAT) provides clinicians and patients with a simple and reliable 
measure of overall COPD-related health status for the assessment and long-term follow-up of 
individual patients. It consists of eight items, each formatted as a numerical response scale from 
zero to six, making the tool easy to administer and easy for patients to complete. The items 
cover a wide range of disease severity, with the intention that the greatest discriminant power 
would be in the mild to moderate range (Jones et al., 2009). 
 
Asthma Control Questionnaire (ACQ-5) 
 
The Asthma Control Questionnaire (ACQ-5) is an asthma control measurement tool consisting 
of five questions on symptom control; each of the questions is scored on a scale of 0–6 where 0 
represents excellent asthma control and 6 represents extremely poor control (O’Byrne et al., 
2010). The ACQ-5 can include responses to seven questions, five relating to symptoms, one 
relating to rescue symptom use and one to capture FEV1. The shortened, five-question 
‘symptom only’ questionnaire is considered just as valid and is adequate for the purposes of this 
study. 
 
The quantitative variables for all feedback from each of the above questionnaires will be 
expressed as mean values with standard deviation (SD). A comparison of the mean scores of 
each particular question within the questionnaires, as well as the mean overall scores for each 
questionnaire will be completed using an appropriate two-way statistical test against the null 
hypothesis. A p-value less than 0.05 will be considered as statistically significant. Statistical 
analysis will be performed using the Statistical Package for the Social Sciences (SPSS) version 
24 for Windows. 
 
SfBB Questionnaire (SfBB-Q) 
 
A simple SfBB questionnaire was developed with the sole purpose of gaining quantitative 
feedback on the SFBB resources from participants in the study. The design is similar to the 
format of the CAT questionnaire but consists of eight items, each formatted as a numerical 
response scale from zero to six, making the tool simple to administer and easy for participants 
to complete. The items covered various questions regarding the usability of the tools, frequency 
of use and whether the participants would use these or similar tools in the future.  
 
The eight items were as follows: 
 
1. I used the booklet and/or DVD regularly 
2. I found the instructions in the booklet easy to follow 
3. I found the instructions on the DVD easy to follow 
4. Using the booklet and DVD made me feel more confident at the group sessions 
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5. It was easy to fit in regular practice at home 
6. I will continue to use the booklet and DVD to practice 
7. I would recommend the booklet and DVD to others  
8. I would be likely to use this or other singing resources online or via an electronic device, mobile 
phone ‘app’ or similar 
 
Data Collection and Statistical Analysis Methods 
 
Sample Size Determination 
 
Sample size is determined based on sample size calculated for two prior outpatient pulmonary 
rehabilitation studies (Bakarat et al 2008, Mendes de Oliveira et al 2010) where total patients 
recruited into the pulmonary rehabilitation home resources cohort was 19-23. The aim for this 
study was to enrol and consent at least n=30 participants over two groups with conservative 
anticipated drop-out rate of 30-50% allowing for 15-21 participants or over, completing the full 
evaluation.   
 
It would have been advantageous to recruit a larger number of patients if possible to increase 
the power which is low but since this is a pilot study and resources are limited i.e. opportunities 
for wide reaching recruitment options, availability of skilled singing leaders and venues, the aim 
of thirty participants is deemed reasonable given that this will still provide important feasibility 
and proof of concept input for planning of a sufficiently powered larger trial in the near future. 
 
Data Capture and Electronic Data Records 
 
The term Case Report Form (CRF) is understood to refer to either a paper form or an electronic 
data record or both. A Case Report Form is required and completed for each included 
participant. The completed original CRFs are the sole property of the Sidney De Haan Research 
Centre and should not be made available in any form to third parties, except for authorised 
representatives of the Sidney De Haan Research Centre or appropriate, without written 
permission from the researcher. 
 
The researcher has ultimate responsibility for the collection and reporting of all data entered on 
the questionnaires and any other data collection forms, ensuring that they are accurate, 
authentic/original, attributable, complete, consistent, legible, timely (contemporaneous), 
enduring and available when required. The participant records must be signed by the 
researcher to attest that the data contained therein is true.  Any corrections to entries made in 
the source documents are dated, initialled and explained (if necessary) and do not obscure the 
original entry.  
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Data Handling Conventions are utilised, documented and applied to missing or inconsistently 
recorded data for the purposes of final statistical analysis. 
 
Data Handling and Record Keeping 
 
Data for this feasibility study was collected as raw source documentation. This consisted of 
paper questionnaires (See protocol Appendix C, sub-appendix I) which were provided and self-
administered by patients and the data then manually entered into a database by the researcher. 
This data was entered in real time and cleaned on an ongoing basis for processing, analysis 
and delivery as a final study results report. The data handling conventions were documented 
prospectively as recorded in this report. 
 
It is advised that use of estimations to fill in missing values for the WEMWBS should only be 
done in situations where at least a certain proportion of items are answered. If less than this 
proportion has been answered the respondent's score should be set to missing (Stewart-
Brown and Janmohamed, 2008). This assumption was followed for all three scale measures 
(WEMBMS, CAT and ACQ-5) and if more than one question within any questionnaire or 
questionnaire domain was missing, the score was set to missing (i.e. 999) within the dataset. If 
only one question or statement response was missing or left unanswered then the missing 
response was imputed with the questionnaire or domain-specific mean based on the remaining 
answered question scores.  
 
Statistical Analysis  
 
It was planned to use the paired t-test to compare means of two related observations i.e. a 
comparison of given values both before and after an intervention and recorded in pairs per 
participant. The paired t-test was used due to the small sample sizes to compare mean 
differences. The difference between the paired values is assumed to be normally distributed 
and the null hypothesis, that the expectation is zero, is tested by paired t test. 
 
The test is used to compare the means for all three health and wellbeing evaluations over each 
possible interval i.e. between V0 and V1, V1 and V2, V2 and V3, V1 and V3, V0 and V2 and V0 and 
V3 for both the total score and individual question scores. Those with values of significance i.e. 
p < 0.05 are reported. 
 
The p-value produced from the paired t-test indicates the likelihood of the observed difference 
under the null hypothesis. The substantive significance i.e. what the findings indicate about 
population effects themselves will be assessed using a comparison of the mean difference 
expressed as meaningful for each of the individual health and wellbeing scores as noted from 
previous validations of each one. 
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Record Retention 
 
To enable evaluations and/or audits from regulatory authorities all records will be kept records, 
including the identity of all participating participants (sufficient information to link records) and all 
original signed informed consent documents, copies of all CRFs, safety reporting forms, source 
documents, and detailed records of treatment disposition, and adequate documentation of 
relevant correspondence (e.g., letters, meeting minutes, telephone calls reports).  The records 
should be retained by the research team according to International Conference on 
Harmonisation (ICH) or according to local regulations, whichever is longer. 
 
All information gathered will be stored securely in the offices of the Sidney De Haan Research 
Centre for Arts and Health, Canterbury Christ Church University. Members of the research team 
are the only people who will have access to the primary research material. All data will be 
anonymous prior to analysis. 
 
If the research team becomes unable for any reason to continue to retain study records for the 
required period (e.g., retirement, relocation) the study records must be transferred to a 
designee, such as another institution, or to an independent third party.  Records must be kept 
for a minimum of 15 years after completion or discontinuation of the study or for longer if 
required by applicable local regulations.  
 
Publication of Study Results 
 
Publication of study results will be at the discretion and agreement of Canterbury Christ Church 
University, the Sidney De Haan Research Centre and the researcher. 
 
Publications relating to the study will comply with Canterbury Christ Church University 
requirements and recognised ethical standards concerning publications and authorship, 
including Section II - “Ethical Considerations in the Conduct and Reporting of Research” of the 
Uniform Requirements for Manuscripts. 
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Chapter 4 – Results and Discussion – Part I: Core Study 
 
Research Study: Results and Data Analysis Part I 
 
Study Enrolment and Demography 
 
Total recruitment was confirmed as fifty-four potential self-referred participants, including those 
that confirmed a Chronic Respiratory Disease (CRD) diagnosis (COPD and non-COPD) and 
those that considered themselves undiagnosed attendees. All were identified as strong, reliable 
candidates, available for the requested time frame and willing to join one of two singing groups.  
 
Thirty-eight of these participants attended an initial singing group session at one of the two 
selected community centres in the Medway area of Kent in the UK i.e. Centre A, a community 
centre in the centre of Gillingham, Kent (UK) and Centre B, a community centre in the 
surrounding area of Chatham, Kent (UK). A total of thirty-seven participants, were assessed for 
inclusion and provided their informed consent for enrolment in the study across the two newly 
formed singing groups.  
 
In total, twenty-eight of the total thirty-seven participants that completed assessments at 
Baseline Visit V0 were followed up and completed Mid-term Visit V1 and Follow-Up Visit V2. 
Twenty of these original participants also continued attending sessions up to thirty weeks post 
Baseline and were followed up at the Final Follow-Up Visit V3. The demographic details of all 
participants are given in table 7 below. 
 
Diagnosis Total Consented Male Female Mean Age V0 V1 V2 V3 
CRD - COPD 26 26 11 15 67.65 +8.7 26 23 21 17
CRD - Non-COPD 7 7 0 7 63.1 +7.1 7 4 4 1 
Undiagnosed 5 4 1 3 62.5 +7.7 4 3 3 2 
Total 38 37 12 25 66.24 +8.4 37 28 28 20
 
Table 7 – Research Study Part I: All Participants – Demography, Enrolment and 
Assessment Visits Summary 
 
Research Study: Sample for Health and Wellbeing Evaluation 
 
Participants were only considered for inclusion in the health and well-being outcome analysis if 
they strictly met all protocol inclusion criteria, including adherence to inclusion criteria #3 having 
‘Previously been diagnosed with a COPD related lung condition by their Physician or Health 
Care Provider (HCP)’.  
 
                                                                          
 
  111  
 
Participants included in the health and wellbeing assessments were also required to complete 
at least Baseline Visit V0 and Follow-Up Visit V2 to be included in the Follow-Up Visit V2 
evaluation group. Similarly, participants were required to complete at least Baseline Visit V0 and 
Mid-term Visit V1 for inclusion in the Mid-term Visit V1 evaluation group and at least Baseline 
Visit V0, Follow-Up Visit V2 and Final Follow-Up Visit V3 for inclusion in the Final Follow-Up Visit 
V3 evaluation group.   
 
Twenty-six participants indicated that they had previously been diagnosed with a COPD related 
lung condition by their HCP and were confirmed as meeting all inclusion criteria for the study 
protocol (Appendix C). These participants were considered as the ‘per protocol’ (PP) sample 
group and only participants from this group were assessed to evaluate the primary endpoint of 
the study and all health and wellbeing endpoints. 
 
A flow diagram to illustrate the number of participants at each assessment up to Follow-Up Visit 
V2 is shown in figure 4 below. 
 
 
Figure 4 - Research Study Results Part I: Demography - Flow Diagram of Participants 
from Baseline Visit V0 to Follow-Up Visit V2  
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Twenty-one of these COPD participants continued with regular weekly participation up to 
Follow-Up Visit V2 and provided evaluations at Baseline Study Visit V0 (Week 0 +7 days), Mid-
Term Study Visit V1 (Week 6 +14 days) and Follow-up Study Visit V2 (Week 12 +14 days) 
assessment points, having attended at least 75% (n=13) of all group sessions (i.e. ten or more 
of the total of thirteen possible group sessions) within this time frame. This group comprised 
thirteen females and eight males with a mean age of 66.62 +9.3 years. Five of these 
participants (four females and one male) were enrolled at the Centre A and sixteen of these 
participants (nine females and seven males) were enrolled at Centre B. A summary of the 
enrolment numbers and visits completed is shown in table 8 below. 
 
Diagnosis 
Group Total Consented Evaluable Male Female 
Mean 
Age V0 V1 V2 V3
COPD 26 26 21 8 13 
66.62 
+9.3 26 23 21 16 
 
Table 8 – Research Study Part I: COPD Participant Enrolment and Completion of Visits  
 
The data collected from these participants were assessed to evaluate the primary endpoint of 
the study i.e. the ‘Mean total score difference from baseline of WEMWBS, CAT and ACQ-5 at 
Follow-Up Visit V2, Week 12 +14 days and an additional secondary endpoint concerned with 
health and wellbeing i.e. ‘Mean total score difference from baseline of WEMWBS, CAT and 
ACQ-5 at Mid-Term Visit V1 Week 6 +14 days. A flow diagram to illustrate the number of 
participants at each assessment is shown in figure 5 below. 
 
All participants were then given the option to return, following a six-week hiatus during the 
summer months, to continue singing in a single group comprising all participants from the 
original two separate groups. These were combined for logistical purposes at a single location, 
Centre B, led by the singing leader from the original Centre B group. The group sessions 
continued to be conducted weekly from September to November 2017. Sixteen of the original 
twenty-one COPD (PP) participants evaluated at Follow-Up Visit V2 and were further evaluated 
at Final Follow-Up Visit V3 after returning to join the combined singing group.  
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Figure 5 - Research Study Results Part I: Flow Diagram up to Follow-Up Visit V3 
 
Health and wellbeing data collected from the sixteen per protocol participants was further 
assessed at Final Follow-Up Visit V3 Week 30 from Baseline Visit V0 to evaluate a further 
secondary endpoint which was also concerned with health and wellbeing i.e. ‘Mean total score 
difference from baseline of WEMWBS, CAT and ACQ-5 at Final Follow-Up Visit V3 Week 30 
+21 days’.  
 
NB One additional participant was evaluated at this visit, but their data was excluded from the 
‘per protocol’ analysis set as they did not fully comply with the criteria. Details are noted in the 
next section. 
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Study Enrolment and Recruitment 
 
Participants were self-referred and contacted via outreach to pulmonary rehabilitation and other 
self-help breathing groups in the Medway area in Kent (UK) during the year prior to the study. 
Initial feasibility was established from respiratory patients and carers attending pulmonary 
rehabilitation (PR) groups conducted in the Medway area during summer months (April-July) 
2016. Taster sessions were arranged for these patients at the end of their PR sessions and 
approximately eighty potential candidates from these sessions expressed an interest in 
participating.  
 
All candidates were further contacted and a total of fifty-four participants agreed to attend on 
one of the two initial dates at the selected two centres and of these, thirty-eight participants 
attended an initial session. There was an overall drop-out rate of 26% for the whole population 
(n=37) by Follow-Up Visit V2 compared to a drop-out rate of just 19% for participants with a 
COPD diagnosis alone (n=26). Similarly, there was an overall drop-out rate of 47% for the 
whole population (n=37) by Final Follow-Up Visit V3 compared to just 38% for participants with a 
COPD diagnosis (n=26).  
 
Patients were asked to estimate the number of years since they were first diagnosed with their 
respiratory illness and out of a total of thirty-three diagnosed participants that provided this 
information, there were fifteen respiratory patients diagnosed >10 years ago of which twelve 
were diagnosed specifically with COPD. Eighteen respiratory patients indicated they had 
received a diagnosis within the last 10 years of which fourteen of these were diagnosed with a 
COPD-related condition.  
 
Only one participant indicated that they were also involved in another singing group, however 
this participant (#2021) dropped out of the initial assessment due to ill health. They returned for 
the Final Follow-up V3 assessment but had not completed >2 of the original group sessions 
between baseline visit V0 and Follow-Up Visit V2, so they were deemed to be ineligible for 
inclusion in the per protocol (PP) sample. The data for this participant were therefore excluded 
from all health and wellbeing analyses. 
 
Attendance rates overall were very high. All twenty-eight participants that completed a Follow-
Up Visit V2 had an attendance rate of >60% up to that visit. A total of 66% of all these 
participants (n=28) had an attendance rate >85% (n=13) which further increased to 81% for 
those twenty-six participants that were diagnosed with a COPD-related respiratory illness. 
 
Health and Wellbeing Outcomes 
 
The primary endpoint of this research study is the evaluation of the impact of the group singing 
intervention on health and wellbeing scores total score for WEMWBS, CAT and ACQ from 
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baseline evaluation (Baseline Visit V0) to the twelve-week follow-up evaluation (Follow-Up Visit 
V2). Secondary endpoints included evaluation of these same scores at additional six-week mid-
term (V1) and thirty-week follow-up (Final Follow-Up Visit V3) time points. 
 
The null hypothesis in each case is that ‘no change occurred over time on these measures’ 
such that a beneficial impact of the singing intervention over time is assumed as the alternative 
hypothesis. If this were the case, then improvements would be recorded. A two-tailed criterion 
was employed to test the null hypothesis to allow for the possibility of a decrease in mean score 
indicating a decline in participants’ health or wellbeing which is likely in degenerative conditions 
such as COPD. 
 
Health and Wellbeing Outcomes – Total Scores 
 
Paired t-tests were conducted on the total scores for the available sample of patients at every 
visit on for each one of the health and wellbeing outcome scales to explore any potentially 
significant differences between the full range of visits including Baseline to Mid-term, Baseline 
to Follow-up, Baseline to Final Follow-up and also Mid-term to Follow-up and Follow-up to Final 
Follow-up i.e. V0 to V1, V0 to V2, V0 to V3, V1 to V2 and V2 to V3. The full results of all analysis 
combinations are listed in the appendices (Appendix D) and the most significant results are 
summarised as follows. 
 
Paired Samples Test - Change from Baseline Visit V0 
  
Paired Differences 
t df 
Sig. 
(2-
tailed)Mean 
Std. 
Deviation
Std. 
Error 
Mean
95% Confidence 
Interval of the 
Difference 
Lower Upper
 WEMV0 - WEMV1 -2.836 7.316 1.525 -6.000 0.327 -1.859 22 0.076
 WEMV0 - WEMV2 -6.095 10.720 2.339 -10.975 -1.216 -2.606 20 0.017
 WEMV0 - WEMV3 -8.380 9.362 2.340 -13.368 -3.392 -3.581 15 0.003
 CATV0 - CATV1 2.156 6.451 1.375 -0.704 5.016 1.567 21 0.132
 CATV0 - CATV2 4.755 7.828 1.708 1.192 8.319 2.784 20 0.011
 CATV0 - CATV3 5.036 7.001 1.750 1.305 8.766 2.877 15 0.012
 ACQV0 - ACQV1 1.600 3.979 0.890 -0.262 3.462 1.798 19 0.088
 ACQV0 - ACQV2 2.000 4.449 0.995 -0.082 4.082 2.011 19 0.059
 ACQV0 - ACQV3 2.000 4.648 1.162 -0.477 4.477 1.721 15 0.106
 
Table 8 – Research Study Part I: Summary of T-Test Analysis Results for All Health and 
Wellbeing Questionnaires – Change in Total Score from Baseline Visit V0 
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There was a wide range of results for total score across all three health and wellbeing 
questionnaires, particularly at V0 where CAT scores ranged from 4 to 38, WEMWBS ranged 
from 27 to 70 and ACQ ranged from 2 to 21. There are considerable variations in the reported 
health outcomes levels for this group of patients, which would be expected due to the different 
stages of disease and length of time of diagnosis which was reported as anything from 2 years 
to 71 years. 
 
The most important findings were those pertaining to the primary endpoint of the study, which 
are reflected in the analysis of the WEMWBS and CAT scores between Baseline Visit V0 and 
Follow-Up Visit V2 at Week 12 occurring between May to July 2017 along with the results of the 
subsequent Final Follow-Up Visit V3 scores at week 30. 
 
There were statistically significant changes recorded in both total mean WEMWBS and total 
mean CAT scores from Baseline Visit V0 to Follow-Up Visit V2 i.e. p < 0.05. There was an 
increase in the mean WEMWBS scores between Baseline Visit V0 (M=49.14, SD=12.397) and 
Follow-Up Visit V2 at Week 12 (M=55.23, SD=10.150); t(20)=2.606, p = 0.017 and decrease in 
the mean CAT score between Baseline Visit V0 (M=25.03, SD=7.774) and Follow-Up Visit V2 at 
Week 12 (M=20.27, SD=10.659); t(20)=2.784, p = 0.011 for the twenty one ‘per protocol’ COPD 
participants across the two singing groups combined.  
 
Participants were also given the option to continue in a single singing group composed of the 
original two separate groups. These were combined at a single location (Centre B) with the 
singing leader from the original Centre B group. These group sessions were conducted weekly 
from September to November 2017 and included a smaller subgroup of sixteen per protocol 
patients (five participants less than the original total) returning to join the combined singing 
group, following a six-week hiatus during the summer.  
 
The mean WEMWBS score for those participants that were assessed at the Final Follow-Up 
Visit V3 at Week 30 support a finding that the effect from Follow-Up Visit V2 at Week 12 was 
maintained for this outcome measure up to Final Follow-Up Visit V3 i.e. there was a significant 
difference in the mean WEMWBS score between V0 (M=48.43, SD=12.886) and V3 (M=56.81, 
SD=8.719); t(15)=3.581, p = 0.003. In fact, this suggested a further slight overall increase in 
mean WEMWBS score of ~2.285 between Baseline Visit V0 to Follow-Up Visit V2 and Baseline 
Visit V0 to Final Follow-Up Visit V3. 
 
The mean CAT score for those participants that were assessed at the Final Follow-Up Visit V3 
at Week 30 also showed a similar finding in that the effect from Follow-Up Visit V2 at Week 12 
was maintained for this outcome measure up to Final Follow-Up Visit V3 i.e. CAT score between 
Baseline Visit V0 (M=24.16, SD=7.282) and Final Follow-Up Visit V3 (M=19.13, SD=9.563); 
t(15)=2.877, p = 0.012. Similar to the results for the WEMWBS scores, this also revealed a 
further slight overall improvement in mean CAT score of ~0.281 between Baseline Visit V0 to 
Follow-Up Visit V2 and Baseline Visit V0 to Final Follow-Up Visit V3. 
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There was an improvement in total mean ACQ-5 score between Baseline Visit V0 and Follow-
Up Visit V2 (Week 12) but this did not achieve statistical significance (p = 0.059). The results for 
the change in total mean ACQ-5 score showed no significant results for overall score at any 
stage. A demographic analysis was conducted to understand if there were any changes in 
mean total score difference between Baseline Visit V0 and the Follow-Up Visit V2 with regard to 
either age or gender.  
 
A Pearson correlation coefficient analysis of the correlation between age and the three scale 
scores was undertaken, but no significant strong correlations were seen for any of the three 
Health and Wellbeing scales. There was a weak non significant negative correlation detected 
between participant age and change in WEMWBS score (r = -0.499 p = 0.21) and weak positive 
correlation detected between age and change in the CAT score (r = 0.250 p = 0.274) and the 
ACQ score (r = 0.063 p = 0.274) but with such a small number of participants this was 
negligible.  
 
Independent t-tests were conducted to compare for the total change in scores for the available 
sample of patients on each of the health and wellbeing outcome scales against participants’ 
gender, to explore any potentially significant differences (see Appendix D). There was no 
significant difference in the change in WEMWBS scores for males (M=2.88, SD=7.72) and 
females (M=8.08, SD=12.07); t (19) = -1.085, p = 0.292, in the change in CAT scores for males 
(M=-5.66, SD=11.86) and females (M=-4.20, SD=4.38); t (8) = -0.335, p = 0.746 or in the 
change in ACQ scores for males (M=-3.14, SD=6.176) and females (M=-1.38, SD=3.33); t (18)= 
-0.836, p = 0.414 between the Baseline Visit V0 and the Follow-Up Visit V2. 
  
The results suggest there is no real effect of age or gender on the difference of any of the health 
and wellbeing scales between Baseline Visit V0 and the Follow-Up Visit V2. 
 
Weekly Progress – Singing Leader Feedback 
 
General ad hoc feedback and observations from the two trained singing group leaders and the 
researcher indicated that participants were already starting to interact quite quickly and mix with 
each other, exchanging numbers and socialising very early on in the first sessions. They 
generally indicated they were having fun and felt relaxed, and that as time went on friendships 
formed and additional social bonds expanded e.g. participants started arriving earlier than the 
session start just to meet for a coffee and social catch-up prior to singing, bringing additional 
refreshment items, sharing home grown produce, exchanging contact details to connect outside 
the group sessions.   
 
The ongoing ad hoc feedback from participants indicated they were becoming more confident in 
the groups, were finding singing easier and were noticing the difference to their breathing as 
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early as the fourth weekly session. An increasingly common theme of discussion within both 
groups from the second or third sessions onwards was regarding how the groups could be 
continued and sustained beyond the research project. This became more important with time as 
the groups became more cohesive. 
 
General anecdotal comments and feedback regarding how the group was progressing, 
socialising and interacting were also collected weekly in a diary format by one of the singing 
leaders to share with the researcher, including a selection of general unsolicited participant 
comments. These details provide support to the observations above and they help provide 
further understanding of progress, participant acceptability to attending the groups and other 
tacit information not collected as part of the study research e.g. challenges faced by participants 
regarding venue logistics regarding participants with respiratory conditions. They also provide 
supportive information to the observations noted anecdotally above and to the quantitative 
results. 
 
(A high-level summary of these comments made to the singing leader at the Centre A group, 
recorded verbatim and ad hoc, are noted in Appendix E). 
 
General Participant Feedback: Group Session  
 
Baseline Visit V0 – Enrolment Feedback Comments  
 
Participants were asked to provide open text feedback comments at Baseline Visit V0 (Appendix 
C, sub-appendix I). The questions were related to how the participant had heard about the 
sessions, specifically whether it was from their GP and they were asked to advise what they 
hoped to gain from these sessions i.e. Questions asked were ‘How did you hear about this 
project?’, ‘Did your GP or other health care professional recommend you attend?’, ‘What do you 
hope to gain from joining the group?’.  
The responses were all very similar in nature as the group of participants that were included 
were recruited from the same Pulmonary Rehabilitation groups and ‘British Lung Foundation’ - 
Breath-easy meeting groups where the initial taster sessions were conducted. 
 
Nineteen of the twenty-four COPD patients that provided responses, had been advised about 
the course from either their General Practitioner or through a pulmonary rehabilitation or COPD 
exercise group (i.e. nurse, HCP) and the remainder had heard from leaders or friends at their 
local BLF ‘Breatheasy’ group. Only two refrained from responding. 
 
In response to the question ‘What do you hope to gain from joining the group?’ responses were 
broadly similar and as expected i.e. participants hoped to gain some improvement to their 
breathing, wellbeing, mood and confidence. To learn how to manage their condition, control 
their breathing and generally feel better. 
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Follow-Up Visit V2 – Participant Feedback Comments  
 
Participants were asked to provide open text feedback comments at Follow-Up Visit V2 
(Questions detailed in Appendix C, sub-appendix I). 
 
A total of eighteen participants of the possible twenty-eight that completed Follow-Up Visit V2 
(as summarised in figure 6 below), completed the final page of the questionnaire and provided 
free text feedback comments. 
 
 
 
Figure 6 - Research Study Results Part I: Flow of Participants up to Follow-Up Visit V2 
 
These comments were not extensive and since the number was very small a detailed analysis 
was not possible however, there were some key themes noted and the comments were 
reviewed manually. Details regarding either physical health or mental health outcomes were 
identified and collated as below.  
 
A total of eleven patients made a comment that specifically related to physical activities e.g. 
breathing apparatus, lungs, exercise or respiratory condition: 
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“[The leader] has really helped us a lot in exercises and singing, I can 
now let breathe out twice as long as I was able to before we started” 
 
“My lung condition is progressive but singing has helped in the short 
term” 
 
“I find singing does help a lot with my breathing” 
 
“My diaphragm feels looser after singing” 
 
“We soon got refreshed on how to sing well, this in turn helped 
improve my breathing when I got in a panic situation i.e. moving fast 
to the toilet in public and fearing I would not make it.”  
 
“It has helped my breathing and taught me a level of control previously 
lacking” 
 
“The singing has aided my lung condition I would say there is a slight 
improvement however on days I don't sing so much there is a decline 
in my lung condition” 
 
“It has been a great experience and a noticeable improvement in 
breathing” 
 
“It has helped me to learn to breathe from my diaphragm”  
 
“I felt some improvement in my breathing which I think would improve 
if the group exercise continued” 
 
“The singing group was very useful for my lung condition” 
 
“Helped to improve my breathing by correct lung exercises” 
 
“A noticeable improvement in breathing” 
 
The greatest number of comments were made and recorded in relation to participant mental 
health and wellbeing, i.e. the enjoyment of the activities and exercises, improvements in 
confidence, social connectivity, having fun with others etc. Over 77% of participants (n=18) that 
provided free text feedback mentioned one or more comments of this nature.  
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NB. The written comments noted below reflect many more similar verbal comments made to the 
singing leaders and researcher at the start and end of each of the sessions.  
 
 “It gave me an interest” 
 
“It is very much a spiritual help as well as physical” 
 
“It has been absolutely wonderful - physically and mentally” 
 
“I feel happy when we are singing” 
 
“There are times when I have only got out of bed/house because of 
singing”  
 
“The sound of all our voices is spiritually uplifting” 
 
“I have more confidence now” 
 
“I have widened out my singing to the wider community so I will be 
doing charity singing” 
 
“Singing is now part of my day to day life again after a long absence” 
 
“I feel better since starting singing class” 
 
“Really enjoyable and a brilliant way to meet new friends” 
 
“Overall feeling much better” 
 
“I enjoyed coming” 
 
“I have really enjoyed the group”  
 
“Helped with mixing in a group” 
 
“It has been a great experience” 
 
There were in addition to physical and mental wellbeing comments eight other comments of 
note which specifically referred to a responders’ sadness at the cessation of the groups or 
desirability for continuation of the groups. The general comments made to the researchers and 
singing leaders, during socialising following the singing sessions, continued with this same 
theme. 
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 “Will miss our weekly get together a lot” 
 
“I felt some improvement in my breathing which I think would improve 
if the group exercise continued” 
 
“Would like to request a repeat course” 
 
“Am sad that it is ending” 
 
“I hope it can continue in some form” 
 
“The group is very good but needs to continue for it to have a lasting 
benefit and I would be willing to pay a modest sum to enable this” 
 
“It would be brilliant to continue the singing with the group” 
 
“I will sadly miss the group and hope there will be some way of 
continuing” 
 
It should also be mentioned that the discussion regarding continuation of the groups and 
feasibility of raising funds to continue was continually on the agenda of the participants. The 
comments above reflect the strong desirability of long-term continuation of the groups and 
maintenance of support to achieve this end. 
 
Two participants also indicated in their comments some reservations about the sound of their 
singing voice which they had ‘overcome’ due to the regular group singing. 
 
“I have never sung at school I always mimed when singing, in church I 
mimed. Now I sing all the time because of this project” 
 
“I cannot sing, I have joined in and no-one complained” 
 
Finally, one participant provided a comment which was non-positive in regard to the group 
sessions. This patient was in fact a protocol violator and was diagnosed with a CRD other than 
COPD (i.e. Bronchiectasis) so would not have been eligible to be included in the health and 
wellbeing feedback assessments, however their general feedback seemed important to report. 
  
“Although I enjoyed the singing sessions it was difficult to commit to 
weekly sessions. There was also a feeling that some of the group 
wished to perform and make the sessions more public. I would be 
extremely uncomfortable with this and consequently have decided not 
to continue. 
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In general, the participant feedback was limited, though the information collected still provides 
valuable insight.  
 
Participant Attendance  
 
One of the five secondary endpoints of the study was to assess the overall compliance and 
drop-out rate for singing groups. The compliance was collected in the form of registers, 
maintained weekly by the singing leaders of each of the groups. These were submitted regularly 
for data entry by the researcher. The primary aim of this was for compliance purposes i.e. to 
ensure that participants included in the study analysis had attended at least 75% of the 
available group sessions (n=13) during the study period i.e. to be considered regular attendees. 
It was also useful information in understanding if there were any pattern to the retention and 
whether this could be utilised for future study planning. 
 
There was a very low drop-out rate of <20% observed for singing group participants with a 
COPD diagnosis prior to the Mid-Term Visit V1 Week 7 (n=26) with retention remaining steady 
and no further drop out for these participants through to the Follow-Up Visit V2 Week 14.  A 
further 19% of participants (n=26) were seen to drop out between Follow-Up Visit V2 and Final 
Follow-Up Visit V3 which also included the hiatus period during the summer when the groups 
ceased.  
 
The overall attendance at the weekly sessions was well maintained by all included participants 
over time. There was an initial high drop-out around the first two weeks but after this the 
attendance remained steady. The main drop-out reasons, where a reason was provided 
verbally to singing leaders, indicated that participants found the timing or location (e.g. parking 
facilities) of the sessions inconvenient and there was no indication that this was related to 
participants being dissatisfied however, the majority of the participants that dropped out were 
‘lost to follow-up’.  
 
Research Study: Discussion Part I  
 
Health and Wellbeing  
 
In order to assess the endpoints of health and wellbeing quantitatively, the difference in mean 
total score from baseline, for each of the three validated health and wellbeing scales was the 
most important focus of this research.  A two-tailed criterion was employed to test the null 
hypothesis i.e. ‘no change occurred over time on these measures’ such that a beneficial impact 
of the singing intervention over time is assumed as the alternate hypothesis.  
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Questionnaire Data – Total Score 
 
The key outcome of this research indicated that group singing positively affected the health and 
wellbeing of this group of participants diagnosed with COPD. The mean total score for mental 
wellbeing as measured by the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) and the 
mean total score for impact of a patient’s COPD and experience of breathing difficulties and 
how this changes over time, as measured by the COPD Assessment Test (CAT) showed 
significant improvement at Follow-Up Visit V2 (12 weeks +14 days) post Baseline Visit V0 i.e. 
There was an increase in the mean WEMWBS score between Baseline Visit V0 (M=49.14, 
SD=12.397) and Follow-Up Visit V2 at Week 12 (M=55.23, SD=10.150); t(20)=2.606, p = 0.017 
and a decrease noted in the mean CAT score between Baseline Visit V0 (M=25.03, SD=7.774) 
and Follow-Up Visit V2 at Week 12 (M=20.27, SD=10.659); t(20)=2.784, p = 0.011 for the ‘per 
protocol’ COPD participants across the two separate singing groups. 
 
This improvement was maintained and in fact showed further improvement at a level of 
significance at Final Follow-Up Visit V3 (30 weeks +21 days post Baseline Visit V0) i.e. There 
was an increase in the mean WEMWBS score between V0 (M=48.43, SD=12.886) and V3 
(M=56.81, SD=8.719); t(15)=3.581, p = 0.003 and decrease in mean CAT score between 
Baseline Visit V0 (M=24.16, SD=7.282) and Final Follow-Up Visit V3 (M=19.13, SD=9.563); 
t(15)=2.877, p = 0.012 for these two same scales, despite a short cessation in group singing 
sessions post Follow-Up Visit V2. 
 
The mean improvement in WEMWBS and CAT scores between Baseline Visit V0 and Follow-Up 
Visit V2 met required significance i.e. p < 0.05 and this required significance was maintained at 
Final Follow-Up Visit V3. The values for difference in mean total ACQ score at the same 
intervals also showed improvement which was maintained at Final Follow-Up Visit V3, however 
the values for the change in mean total score for this scale fell just short of the required 
significance level (i.e. p = 0.059) for the same periods.  
 
The most reliable estimate of the minimum important difference (MID) for the CAT 
questionnaire, particularly in response to intervention studies, has been assessed to be a 
change of two or more points (Kon et al., 2014). The results obtained from this scale in the 
current study showed a change of five points which was maintained after thirty weeks post 
baseline. This finding is clearly very encouraging in regard to the impact of regular singing on 
COPD symptoms, though caution has to be exercised regarding the small sample size and low 
power and also the low quality of the study due to design constraints.  
 
There is statistical significance in the mean difference, but this only shows the measurement 
precision. The substantive change here is relatively low due to the small sample size, which 
indicates the effect within the population is low. 
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It further supports finding from two previous singing for COPD studies (BLF, 2017, Jamaly et 
al., 2017) where this measure was employed. These are referenced in detail in the earlier 
systematic review. One study (Jamaly et al., 2017) recorded significant improvement of five 
points (17 ± 9 to 12 ± 8 points) in a singing intervention group not seen in the control group 
(physiotherapy lung exercises) after four weeks of more frequent singing sessions (average of 
twice per week), but the full details of this study cannot be assessed clearly for quality. The 
second (BLF, 2017) used this measure to show a significant (p-value = 0.02) mean 
improvement of 1.9 points following twelve weeks of singing intervention in COPD patients, 
which approached but did not exceed the MID value.  
 
Similarly, for the WEMWBS scale it has been suggested (Jaeschke et al., 1989) that an 
improvement of 0.5 on each item in the 5-point Likert scale represents an improvement (one 
which is deemed important to an individual) implying that an improvement of seven points 
across the fourteen items could be deemed important. However, more recent research suggests 
that a meaningful change in WEMWBS score is seen between 1.0 and 2.77 SEM which is 
generally between three and eight points (Maheswaran et al., 2012) so again, the results of this 
study and improvement in six points, is within this range and are encouraging in regard to 
participant wellbeing. 
 
No other similar studies selected for the systematic review used the WEMWBS measure 
specifically, so this study is the first study in this area of research to use this scale. Hence, as a 
result it is not possible to compare the scores obtained with previous findings. However, these 
findings are in alignment with similar studies within this field that found positive results utilising 
similar wellbeing and quality of life scales such as the Short Form Survey (SF-36) (Bonilha et 
al., 2009, Lord et al., 2010). However, this study shows more positive outcomes than similar 
studies using scales such as the EuroQoL (EQ-5D) (BLF, 2017, Clift et al., 2013, Clift et al., 
2017, Pacheco et al., 2014) where no significant outcomes were found. 
 
These outcome values show that the intervention impact on participants’ symptoms due to their 
COPD was slightly more significant than the impact on wellbeing outcomes, which would 
support the general understanding that respiratory changes are one of the most obvious and 
perceptible changes noted by patients (Kang et al., 2017) attributed to their group singing 
intervention.  
  
Participant Feedback 
 
Participant feedback was solicited at Baseline Visit V0 and Follow-Up Visit V2 twelve weeks post 
baseline. The majority of participants chose to write comments to supplement quantitative 
information though due to time availability of venues and resources along with other priorities, 
the written feedback provided was not extensive and is utilised simply for illustration purposes 
i.e. to provide context to the quantitative feedback by the groups. The obvious key themes were 
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manually extracted and support the feasibility, acceptability and effectiveness of group singing 
in this population.  
 
This aspect of the research was not a primary endpoint for the study and as such it was 
appropriate that the focus was placed on ensuring adequate time for the collection of 
quantitative responses. It was also deemed important that the aspect of social engagement 
within the groups (at the start and end of sessions) should be encouraged and this took 
precedence during data collection over requests to participants to provide extensive written 
comments. In future studies, it would be recommended to provide more structured interview 
questions similarly to other recent qualitative studies (Skingley et al., 2018) and to grant more 
time for this during study design and logistic arrangements. 
 
The feedback provided by participants at Baseline Visit V0 was collected to provide an overall 
picture of recruitment regarding the set-up of the singing groups and to provide support to future 
study design and logistic consideration. The comments provided were not extensive, but they 
showed that the majority (~80%) of the participants diagnosed with COPD (n=26) had been 
advised about the course from a healthcare provider and almost all those that responded 
mentioned that the aim was to gain some improvement to their breathing, wellbeing, mood and 
confidence and to learn how to manage their condition, control their breathing and generally feel 
better. 
 
The feedback solicited and captured on the final page of the questionnaire at the Follow-Up 
Visit V2 was aimed at addressing individuals’ state of health and subjective accounts of any 
health benefits or considerations potentially due to the singing intervention. This data was 
analysed to address a secondary endpoint of the study i.e. Summary of all written feedback, as 
captured in patient evaluation forms or by singing leaders. These questionnaires were 
completed by eighteen participants, as recorded in free text feedback comments. Interestingly 
the participants identified various mechanisms whereby benefits were perceived from the 
singing intervention. 
 
Eleven individuals recorded one or more positive comments that specifically related to their 
physical activities and abilities in particular e.g. their breathing apparatus, lungs, exercise or 
respiratory condition. All these participants made comments mentioning that singing was useful, 
aided or helped their health in some way or that they gained a perceived physical health 
improvement from attending the groups. The participant comments noted in relation to mental 
health and wellbeing i.e. the enjoyment of the activities and exercises, improvements in 
confidence, social connectivity, having fun with others etc. was slightly more significant with 
over 77% of participants (n=28) recording comments of this nature which supports recent 
studies that collected similar participant comments (Skingley et al., 2014, Skingley et al., 
2018) that the majority of participants in the research study agreed that the singing programme 
led to improvements in respiratory symptoms between baseline and follow-up.  
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In addition, the responders raised issues of sustainability from early on and while they were 
particularly mentioned at the Follow-Up Visit V2 the discussion around the continuation of the 
groups was a common theme in written feedback and personal comments made to the 
researcher and singing leaders. This even seemed to cause consternation for those members 
for whom the group singing had made a perceived impact on their lives. This discussion 
regarding continuation of the groups and feasibility of raising funds to continue was continually 
on the agenda of the participants and it should be an ethical consideration from the outset to 
ensure that discussions regarding this aspect are brokered with participants during early 
sessions to manage expectations. 
 
Summary of Qualitative Data 
 
All but one of the participant provided comments regarding the intervention, group interactions 
and impact on health and wellbeing, were positive in nature and strongly supported the positive 
findings from the quantitative data. There were comments regarding general enjoyment, feeling 
happy and feeling improvements in their health and wellbeing, including social connectivity and 
self-confidence, all of which provided strongly supportive evidence to the significant increase in 
mean score for individual CAT and WEMWBS statements at Follow-Up Visit V2 in regard 
responses pertaining to feeling optimistic, good about oneself, confident, interested in new 
things, cheerful and having more energy to spare. 
 
Unexpected Results  
 
Two participants also expressed some reservations about the sound of their singing voice, 
which they considered had been ‘overcome’ following regular singing within the group, which 
might illustrate an underlying lack of confidence or even concern. This is also often voiced by 
potential participants during recruitment for singing groups. It is possible that this could be a 
hurdle for encouraging future recruitment as potential participants may be deterred from joining 
similar future groups, particularly in a population which may experience greater issues with self-
confidence. It is important that this worry might be addressed in recruitment material and to 
extend taster sessions more widely to allay this potential fear. 
 
There was one unexpected result in a comment noted from a non-COPD participant (i.e. a 
participant with a respiratory condition which was not COPD and thus was ineligible for inclusion 
in health and wellbeing analysis) who had not returned following the hiatus of the sessions in 
the summer. It raised personal concerns of performing in public and giving rationale that this 
issue along with difficulty in commitment to the sessions held the responder back from 
returning. The participant did not make this concern known during the sessions attended and it 
was obviously unclear to this participant that there would not be pressure to perform or make 
sessions more public.  
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If these concerns had been brought to the attention of the researcher and singing leaders then 
they would certainly have highlighted this clarification more broadly to both groups, as it may 
have been something other participants were also potentially concerned about, then any fears 
or worries could have been addressed.  
 
These findings indicate the importance for organisers or leaders of future groups to continue to 
elicit ongoing feedback from their own participants wherever possible and to ensure they feel 
comfortable with expectations regarding changes to the group structure or public performances. 
In groups where patients are managing health conditions such as COPD which involve 
symptoms such as anxiety and lack of confidence finding avenues to convey and reiterate that 
there is no expectation is key. Participants may feel pressure to enter situations that might 
cause them stress or anxiety which may cause them to refrain from attending further sessions, 
rather than vocalising their concerns. 
 
Similarly, it should be an important consideration for future recruitment and retention of singing 
for health groups that any resources or materials should indicate that public performances are 
optional and that potential attendees should not feel self-conscious about the sound they are 
making. It should be clear that while the aim of the group would be to achieve a quality sound to 
improve the feelings of achievement, cohesiveness and thus wellbeing, the level of the singing 
or performance should not discourage those with lower levels of self-confidence. 
 
It is also important that contact with participants who drop-out of sessions is maintained 
wherever possible or that there is further outreach or contact beyond the group to reduce the 
potential numbers of ‘lost to follow-up’ participants and to gain more feedback of this kind. This 
has not been widely addressed in the previous studies and it is vital for providing learnings for 
communications with future groups and more effectively address potential concerns before they 
‘take root’. It is also essential to provide guidance to research groups and singing leaders to 
ensure these concerns might be addressed more regularly in case there are underlying 
concerns or worries by individuals that may be hidden or not vocalised due to the enthusiasm of 
other group participants. 
 
Enrolment, Compliance and Retention 
 
It is notable that the majority of those recruited into these groups i.e. nineteen of the twenty-four 
COPD patients that provided responses, had been advised about the course from either their 
General Practitioner (GP) or through a pulmonary rehabilitation or COPD exercise group i.e. 
nurse, health care professional (HCP). Since COPD and respiratory disease is predominantly 
seen in older patients it should be recognised that these patients are often seen to respect their 
GP, health care provider or physician's advice and have regular contact with their family doctor, 
so healthcare workers and advisors can also play key and pivotal role in the initiation and 
                                                                          
 
  129  
 
maintenance of these types of exercise behaviours among the population (Schutzer and 
Graves, 2004). 
 
There was a low drop-out rate of <20% of participants (n=37) observed for all COPD singing 
group participants prior to the Mid-Term Visit V1 Week 7 with retention remaining steady with 
only a 0.05% drop out through to the Follow-Up Visit V2 Week 14. This could correlate with the 
high number of positive comments regarding social interaction and cohesion between the 
participants.  
 
There were a further 22% of participants (n=37) seen to drop out between Follow-Up Visit V2 
and Final Follow-Up Visit V3 which also included the hiatus period during the summer when the 
groups ceased. It is possible that this may have impacted the retention rate over this period 
although there is no specific data to support the reason for reduced retention management over 
this timeframe. 
 
Interestingly, during this same period the two separate singing groups that existed initially at 
Centre A and Centre B were amalgamated to one group, located at Centre B. It might be 
anticipated that the group of participants attending sessions at Centre A would be impacted by 
the change in some way, thus impacting retention of this subgroup. However, the five 
participants that dropped-out during this period were all from the original Centre B group and all 
the participants from the separate Centre A group that were given the option to continue at a 
different venue with a new singing leader were all retained up to the Final Follow-Up Visit V3.  
 
Since it has been seen that group cohesion is an effective predictor of both short and long-term 
adherence to exercise in older adults (Estabrooks and Carron, 1999) it might be hypothesised 
that group cohesion could be effective for improving adherence to continued exercise practise in 
this study where a similar effect has been observed. Singing can be seen as a form of exercise 
and the strong cohesive bonds made within these groups may in turn be responsible for the 
positive retention rates seen. This has been highlighted in the participant feedback and it is 
likely due to a variety of other factors brought about by the activity of group singing itself, as 
previous research indicates i.e. that singing increases the release of the hormone oxytocin 
which can induce a socio-biological bonding response (Kreutz, 2014, Pearce et al., 2015).  
 
It is also interesting that the overall drop-out rate for diagnosed COPD patients (n=26) was less 
than that seen for the full group (n=37) which included participants with other lung conditions 
and participants that were not previously diagnosed. This was 7% less between baseline and 
Final Visit V2 and 9% less across the full study i.e. baseline to Final Follow-Up Visit V3 which 
might indicate that the COPD patients may have felt more engagement or benefit from attending 
or alternatively they felt that the activities and exercises were more targeted to the improvement 
of health and wellbeing of their condition of COPD specifically.  
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The reasons for drop-out were not captured systematically and this is something that could be 
improved upon in future study planning. The information provided verbally to singing leaders 
indicated that participants found the timing or location (e.g. parking facilities) of the sessions 
inconvenient and there was no indication that this was related to participants being dissatisfied, 
however since the majority of the participants that dropped out were lost to follow-up and the 
data was not captured or solicited systematically this cannot be analysed. It would be 
recommended that future studies consider follow-up during study plan and capture this critical 
data formally to inform future planning.  
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Chapter 5 – Results and Discussion – Part II: Sub-Study  
 
Research Study: Results and Data Analysis Part II 
 
Study Enrolment and Demography 
 
Research Study: Sample for Self-Management Resources Evaluation 
 
A total of twenty-eight participants were considered eligible to utilise the prepared SfBB 
resources and provide evaluations on these. These same twenty-eight participants were also 
included in the analysis of the overall compliance and drop-out rate for singing groups. 
 
There were initially twenty-six participants diagnosed with COPD and a further eleven other 
participants enrolled at Baseline Visit V0. Five of these participants were undiagnosed with a 
respiratory condition, one of whom declined to give consent for evaluation and was excluded 
from the data collection. (However, they continued in the singing group to support another 
participant diagnosed with a respiratory illness). A further seven other participants, previously 
diagnosed by a Physician or Health Care Provider (HCP) with varying non-COPD Chronic 
Respiratory Diseases (CRDs) i.e. Asthma, Bronchiectasis, Aspergillosis, Bird Lung Disease and 
who were not previously diagnosed with a COPD related lung condition by their Physician or 
Health Care Provider (HCP) were also included.  
 
Three of the undiagnosed participants and four of the participants diagnosed with a CRD (non- 
COPD) continued with the singing group sessions and attended the Follow-Up Visit V2 
evaluations where the SFBB-Q was administered. While these seven participants did not meet 
the full inclusion criteria of the protocol and deviated from inclusion #3 ‘i.e. has ‘previously been 
diagnosed with a COPD related lung condition by their Physician or Health Care Provider 
(HCP)’, they did fully meet all other protocol criteria.  
 
These participants were excluded from health and wellbeing outcome analysis as their 
diagnosis deviated from the strict protocol inclusion criteria regarding COPD. However, since 
these participants were assessed individually as being involved in self-managing respiratory 
conditions in some way, the researcher deemed that their feedback for evaluation of the self-
management resources pilot would be appropriate and valuable. These participants provided 
informed consent and demographics at Baseline Visit V0 and met all other inclusion criteria of 
the study. They were included in all singing sessions which enhanced the overall attendee 
numbers and supported the retention and engagement of the singing groups. A flow diagram to 
illustrate the number of participants at each assessment is shown in figure 7 below. 
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Figure 7 - Research Study Results Part II: Flow of Participants for SfBB Resources 
Evaluation at Follow-Up Visit V2 
 
A total of thirty-seven participants completed baseline evaluations for the study and were 
supplied with SfBB resources (Booklet and DVD) at their Baseline Visit V0, for home use 
throughout the study. Twenty-eight of these thirty-eight participants attended evaluations at both 
baseline (Baseline Visit V0) and post-baseline follow-up (Follow-Up Visit V2) to provide feedback 
on the SFBB resources.  The demographic details of all participants are given in table 11 below.  
 
Demography of those 
Participants Included 
in V2 Evaluation 
Male Female Mean Age V2 
No. of Participants with  
SfBB-Q evaluable for 
total score 
CRD - COPD (PP) 13 8 66.62 +9.3 21 19* 
CRD - Non-COPD) 0 4 63 +9.8 4 4 
Undiagnosed 0 3 59.33 +5.5 3 3 
Total 13 15 65.32 +9.1 28 26 
 
Table 11 – Research Study Results Part II: Summary of Participants with Evaluation at V2 
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NB The reduced number of evaluable questionnaires (*) for the total score, is due to two 
participants with questionnaires having >1 missing response value to an individual question. 
 
Participants were considered for inclusion in the SfBB Resource evaluation group if they met all 
protocol inclusion criteria and had completed at least Baseline Visit V0 and Follow-Up Visit V2 
evaluations. In addition, those participants who had showed a deviation from inclusion criteria 
#2 ‘Patients previously diagnosed with a COPD related lung condition by their Physician or 
Health Care Provider (HCP)’, were also considered to be evaluable. This included three 
undiagnosed participants and four participants, previously diagnosed by an HCP with similar 
Chronic Respiratory Diseases (CRDs) i.e. Asthma, Bronchiectasis, Aspergillosis, Bird Lung 
Disease but not suffering specifically from a COPD related condition. 
 
Research Study: Sample for SfBB Resource Evaluation 
 
One of the key secondary endpoints for this research aimed to assess and review the feasibility 
of specifically designed and created resources for home singing. These were created to support 
and encourage home singing for COPD patients specifically. The tools have been designed to 
assist the consistency and persistence of participant singing outside of the singing sessions. 
These resources consisted of a booklet with songs and instructions, along with a DVD of songs 
with music and lyrics which could be watched and followed for practice between sessions to 
encourage participants to continue their singing exercise beyond just the group sessions 
 
A bespoke questionnaire, created for the purposes of capturing relevant feedback, was utilised 
for this study. The aim of the next section is to present the results for these evaluations. An 
evaluation of the usage and limitations of the questionnaire itself will be presented in 
subsequent sections. 
 
SfBB Resource Evaluation Definition 
 
It was decided that although they deviated from this single protocol inclusion criteria, their 
feedback of the resources would be considered valuable and these participants could be 
included in the SfBB-Q analysis to allow for the maximum evaluation of the SfBB resources.  
 
There were twenty-eight evaluable questionnaires completed overall. Feedback from twenty-
eight participants was available to evaluate SfBB questions #5 to #8, twenty-seven for questions 
#1 to #2 and twenty-six for questions #3 to #4. Two participants left >1 question unanswered but 
provided feedback that they experienced some technical issues and they were unable to utilise 
the SfBB DVD resources and as such were not able to give full feedback on the tools. 
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SfBB Resource Evaluation 
 
There was a total of twenty-eight participants from the group that provided feedback on the 
resources and of these twenty-six that recorded a response to seven or more of the eight 
individual questions i.e. did not leave more than one question blank or marked as not done. 
 
SfBB Questionnaire (SfBB-Q) Total Scores 
 
A secondary endpoint for the study research included the mean total SFBB Questionnaire score 
for usage and usability of SDHR SfBB resources as recorded at V2 (Week 13).  
 
The total score is provided by adding the scores from the eight questions to derive a total score 
(out of a maximum of 48) with 0 being the most positive and 48 being the most negative. A 
score <24 is deemed to indicate an overall positive score and a score >24 deemed negative, 
with 24 being neutral. 
 
Over 88% of the participants that completed the questionnaire (n=28) indicated a positive score 
<24 with only three female participants, (aged 64 -75) recording a negative score >24.  
 
There were two COPD participants whose feedback data were excluded from the overall 
summary score data analysis as they left >1 question unanswered. The overall summary score 
total was available for twenty-six participants out of a total of twenty-eight. This was quite 
misleading and problematic to analyse due to the variety of the questions and challenges faced 
by participants that were not able to access the DVD resources.  
 
Two of these participants showed scoring and feedback which appeared inconsistent, indicating 
that they might have had some confusion in completing the questionnaire or instructions were 
not clear. 
 
Participant #2010 recorded a negative score (>3) for Q1 ‘I used the booklet and/or DVD 
regularly’ and for Q2/Q3 *‘I found the instructions in the booklet/on the DVD easy to follow’ but a 
positive score for Q5 ‘It was easy to fit in regular practice at home’ (2) and Q4 ‘Using the booklet 
and DVD made me feel more confident at the group sessions’ which appeared inconsistent in 
comparison with other scores. The data for these participants appeared spurious for this reason 
but was retained since there was no clear indication that this was completely inaccurate. 
 
Participant #2018 recorded a score of six for all the responses to the questionnaire and in the 
verbatim comment section noted the verbatim text: 
  
‘I didn't get to play the DVD as I haven't got the resource to play it on, so sorry I can't comment’  
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So again, this could be deemed spurious but since this participant provided a negative response 
for all questions, it was included in order to ensure the approach taken with the data was ‘most 
conservative’ possible and did not introduce any positive bias. 
 
The demographic data analysis was conducted to understand if there were any differences in 
total score related to the age of the participants, but no strong correlations were seen. A 
Pearson correlation coefficient analysis was computed to assess the relationship between age 
and the total SfBB score and a very weak positive correlation was detected between these two 
variables r = 0.401 p = 0.035, which was seen to be significant and thus may warrant further 
analysis in future studies. 
 
Independent t-tests were conducted to compare the total SfBB-Q score with gender for the 
available sample of patients, to explore any potentially significant differences (see Appendix D).. 
There was no significant difference in the score for males (M=10.56, SD=4.667) and females 
(M=17.47, SD=9.851); t (26) =-1.989, p = 0.057 between the Baseline Visit V0 and the Follow-
Up Visit V2. 
  
The overall analysis of the total score was indicative of positive reception to the resources but 
was not particularly revealing, due to the variability of the questions and responses. Thus further 
analysis of individual scores was deemed to be more pertinent in examining this feedback. 
  
SfBB Questionnaire (SfBB-Q) Individual Question Scores 
 
The data analysis from each of the questions was deemed more revealing than the total score 
in helping to understand the usage and usability of the tool, so the analysis is further broken 
down into the feedback provided for the individual questions. 
 
The questionnaire has been designed so that a score of <3 shows a positive indication where 
the participant is completely (0), mostly (1) or slightly (2) in agreement with the original positive 
statement on the left and a score of >3 is similarly a negative indication where the participant 
was in agreement completely (6), mostly (5) or slightly (4) with the negative answer on the right. 
A score of 3 indicates neither agreement nor disagreement with either statement. A summary of 
the totals for each of the individual question scores are summarised in Table 13 below. 
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Category 
(Pt = 
Participant) 
V2 SfBB 
Q1 I 
used the 
booklet 
and/or 
DVD 
regularly 
V2 SfBB 
Q2 I 
found the 
instructio
ns in the 
booklet 
easy to 
follow 
V2 SfBB 
Q3 I 
found the 
instructio
ns on the 
DVD 
easy to 
follow 
V2 SfBB 
Q4 Using 
the 
booklet 
and DVD 
made me 
feel more 
confident 
at the 
group 
sessions 
V2 SfBB 
Q5 It was 
easy to fit 
in regular 
practice 
at home 
V2 SfBB 
Q6 I will 
continue 
to use 
the 
booklet 
and DVD 
to 
practice 
V2 SfBB 
Q7 I 
would 
recomme
nd the 
booklet 
and DVD 
to others  
V2 SfBB 
Q8 I 
would be 
likely to 
use this 
or other 
singing 
resource 
online or 
via an 
electronic 
device, 
mobile 
phone 
‘app’ or 
similar 
Total Pts n 
completing 
question  
27 27 26 26 28 28 28 28 
Total No. 
Pts with 
SfBB-Q 
Score <3 
(positive) 
8 19 21 18 14 18 22 19 
Total No. 
Pts with 
SfBB-Q 
Score =3  
(neutral) 
13 5 1 5 4 6 4 4 
Total No. 
Pts with 
SfBB-Q 
Score >3 
(negative) 
6 3 4 3 10 4 2 5 
Total % of 
Pts with 
Positive 
SfBB-Q 
Score  
30 70 81 69 50 64 79 68 
 
Table 13 – Research Study Part II: SFBB-Q - Individual Question Score Summary 
 
Since there was a small sample the scores for the whole group of participants answering that 
question are grouped as positive, neutral or negative for analysis purposes and presented as a 
percentage of the total number of participants answering each individual question. This is to 
help identify any significant patterns within those groups. 
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Q1 I used the booklet and/or DVD regularly 
 
Only 30% of participants (n=27) that completed this question indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘I used the booklet and/or DVD regularly’ and 2 
indicates slight agreement) but a further 48% indicated a neutral response of 3 neither agreeing 
with the statement or agreeing with the negative alternative statement. Only 22% (n=27) 
recorded a value of >3 indicating ‘I did not use the booklet of DVD regularly’. These two 
participants along with one additional participant (who did not answer this question) indicated by 
written comment on the form or by verbal comments to the facilitator, that they were not able to 
use the DVD in their PC or did not have a PC or DVD player facilities. 
 
Examples of comments noted or made to the researcher or singing leaders were:  
 
“The DVD wouldn't work”  
“The DVD didn’t play on my PC”  
“I don’t have a DVD player”  
“I didn't get to play the DVD as I haven't got the resource to play it on” 
 
This indicates that the majority of participants included in the review had used the booklet 
and/or DVD at least once during the first 12 weeks of the study and almost a third of participants 
used the resources more than once. It would also appear that those that did not use it were 
likely impacted by the issues with the DVD access, even though they were encouraged to still 
use the booklet alone. Several of the participants made ad hoc comments to the investigator at 
the mid-way and final visits that they were now singing regularly outside the sessions. However, 
whether it was using the resources as a guide was not always apparent. 
 
Q2 I found the instructions in the booklet easy to follow 
 
Over 70% of participants that completed this question (n=27) indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘I found the instructions in the booklet easy to 
follow’ and 2 indicates slight agreement).  Only one of these participants recorded a value of 5 
which was the highest score selected, indicating I did not find the instructions in the booklet 
easy to follow’.  
 
Q3 I found the instructions on the DVD easy to follow 
 
Over 80% of participants that completed this question (n=26) indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘I found the instructions on the DVD easy to 
follow’ and 2 indicates slight agreement). However, over 69% indicated a score of <2 though 
(i.e. strongly or mostly in agreement with the positive response compared to 65% for the booklet 
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instructions. It is possible that the delivery method of verbal instructions on the DVD, similarly to 
the singing teacher in the sessions, was more readily received. The simplicity of audio/visual 
use impacted the score and may be worth further investigation.  
 
Q4 Using the booklet and DVD made me feel more confident at the group 
sessions 
 
Over 69% of participants that completed this question (n=26) a score of <3 (where 0 indicates 
strong agreement with the statement ‘Using the booklet and DVD made me feel more confident 
at the group sessions’ and two of these twenty-six indicates slight agreement).  Only three of 
these twenty-six participants recorded a value of >3 indicating agreement with the statement 
‘Using the booklet and DVD did not made me feel more confident at the group sessions’. 
 
Q5 It was easy to fit in regular practice at home 
 
Only 50% of participants that completed this question (n=28) indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘‘It was easy to fit in regular practice at home’ 
and 2 indicates slight agreement).  Only ten of these participants recorded a value of >3 
indicating agreement with the statement ‘It was not easy to fit in regular practice at home’. 
 
Q6 I will continue to use the booklet and DVD to practice 
 
Over 64% of participants that completed this question (n=28) indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘I will continue to use the booklet and DVD to 
practice’ and 2 indicates slight agreement). Only four of these participants recorded a value of 
>3 indicating agreement with the statement ‘I will not continue to use the booklet and DVD to 
practice’. 
 
Q7 I would recommend the booklet and DVD to others  
 
Over 78% of participants that completed this question (n=28) indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘I would recommend the booklet and DVD to 
others’ and 2 indicates slight agreement).  Only two of these participants recorded a value of >3 
indicating agreement with the statement ‘I would not recommend the booklet and DVD to others’ 
 
Q8 I would be likely to use this or other singing resources online or via an 
electronic device, mobile phone ‘app’ or similar 
 
Over 67% of participants that completed this question (n=28) indicated a score of <3 (where 0 
indicates strong agreement with the statement ‘I would be likely to use this or other singing 
resources online or via an electronic device, mobile phone ‘app’ or similar’ and 2 indicates slight 
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agreement).  Only two of these participants recorded a value of >3 indicating agreement with 
the statement ‘I would not recommend the booklet and DVD to others’. 
 
SfBB Qualitative Data – Participant Written Feedback 
 
The qualitative information provided by participants regarding the SfBB resources was 
extremely limited. While it was encouraged that participants mention their views and comments 
regarding the resources specifically in the written feedback questionnaire, there were only four 
comments provided. Two of these were related to accessing the DVD i.e. ‘DVD wouldn’t work’ 
and ‘I didn't get to play the DVD as I haven't got the resource to play it on, so sorry I can't 
comment’ which supported the evidence obtained in the quantitative data. 
 
The other two comments both gave a positive message i.e. ‘The DVD and booklet were very 
helpful’ and ‘‘I sang out loud with the DVD and heard my own voice singing for the first time in 
years and felt good about it’ which also supported the quantitative data from the questionnaire.  
 
It was noted that participants did seem eager to provide verbal feedback about the resources 
during the sessions, so on reflection it might be advantageous in future to include discussion 
group methodology to capture verbal feedback from participants regarding their use and views 
of the of the resources or to incorporate questions via interview techniques. The collection of 
more coherently verbal comments could provide rich feedback to improve the development and 
usage of future resources. 
 
Research Study: Discussion Part II  
 
SfBB Questionnaire – SfBB Resources Evaluation 
 
Total SfBB-Q scores were generally very positive with over 88% of the participants that 
completed this questionnaire and had an evaluable total score (n=26), indicating an overall 
positive score <24 with only three female participants, aged between 64 and 75, indicating a 
negative score >24.  
 
The questions or statements that indicated the lowest overall positive scores were two related to 
regularity of use and finding time to practice i.e. question SFBB-Q1 ‘I used the booklet and/or 
DVD regularly’ where only 30% of the participants that completed this question indicated a 
positive score and question SFBB-Q5 ’It was easy to fit in regular practice at home’ where only 
half the participants that completed this question indicated a positive score.  
 
This indicates that one focus for improving the implementation and success of the resources 
might be to find simple ways to encourage regularity of use and improve consistency. This 
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might perhaps be by way of reminders by singing leaders at the group sessions or suggestions 
that the group might practice a song in readiness for the next group session etc. It might be by 
encouraging individuals in the group to find time to regularly complete activities between 
sessions e.g. employing good practices to remember or build activities into their daily or weekly 
routine or to even to take this further by exploring development of new tools to remind and 
enhance the experience e.g. simple reminder tools via a mobile app to increase more frequent 
use, singing exercises delivered via online application, website, mobile app or similar for easy 
practice ‘on the go’. 
 
Materials of this kind should be designed with different kinds of learning styles in mind 
(Franzoni et al., 2008) as people sometimes find it easier to learn and practice in different ways 
and at different speeds, so a variety of teaching resources, tools and methods might be best 
employed for maximum efficacy across different groups of people. Group methods have 
however been rated significantly higher than online tools in relation to content, interaction, 
participation, faculty preparation, and communication (Ryan et al., 1999), so implications call for 
efforts in accessibility and creativity in these tools to ensure long term engagement.   
 
In particular, research based on methods where information is processed through one of two 
usually independent channels where one channel processes verbal information such as text or 
audio and other processes visual information like diagrams, images, animations, etc., has 
concluded that a combination of electronic media used to expose learners, helps to improve 
their learning results (Beacham et al., 2002), so further exploration of methods and tools could 
definitely be advantageous in this area. When singing instructions or tools for practicing these 
activities or exercises for health and wellbeing purposes are developed in future, it is important 
that these factors are considered. There is a need to offer a wider variety of options in addition 
to just verbal instruction, which is commonly used for community singing groups. This research 
supported this concept even though the media itself had somewhat mixed reviews. DVDs did 
not work well as a medium for some participants, but others gave praise to this way of 
presenting guidance. The verbal participant comments to the singing leaders also indicated that 
some participants felt encouraged to seek different types of media themselves e.g. online 
resources. 
 
SfBB-Q statements SFBB-Q2 and SFBB-Q3 refer to the instructions of the booklet and the DVD 
i.e. the ease of use of the resources. The outcome of these questions would initially suggest 
that the participants found the DVD easier to follow than the booklet. The data was further 
explored, and this phenomenon was seen in very few participants i.e. only four participants. 
Three females and one male noted a difference in their individual question score between the 
instructions in the booklet versus the instructions on the DVD, so this would merit further 
exploration before any real conclusions could be made.  
 
If these findings are an accurate reflection of the participants’ views, then it may be possible that 
the delivery method of verbal instructions on the DVD or the simplicity of audio/visual 
                                                                          
 
  141  
 
appearance impacted the score and may be worth further investigation i.e. those that used both 
the DVD and booklet may have found the instructions easier to see or read when visualised on 
a screen in front of them depending on the resolution and size of their monitor screen, system 
or equipment. There are many unknown factors here though, since this was external to the 
control of the research i.e. while the font size in the booklet was known and identical for all 
patients the participant experience of viewing the text or hearing the audio via the DVD was 
variable and unknown to the researcher. The instructions on the DVD were identical to those of 
the booklet, so the slightly less positive score for this statement may have been affected by the 
accessibility challenges some participants faced with use of the technology.  
 
At least three participants were not able to utilise the DVD for technical reasons and provided 
feedback on this. It is possible others may not have been able to use the DVD but may not have 
noted this on the form and simply responded to the items on the scale. One participant 
(Participant ID #2018) recorded a value of six (the most negative response) for almost every 
statement except SfBB-Q2 “I did not find the instructions on the DVD easy to follow which was 
left blank. This impacted the overall average total score for the statements. However, since it 
appeared from the text that they were not able to use the DVD at all (i.e. Participant ID #2018 
comment recorded “I didn't get to play the DVD as I haven't got the resource to play it on”) it is 
difficult to ascertain clearly if these responses of a negative score regarding the instructions on 
the DVD and booklet or all other statements were actually valid or if the participants were simply 
expressing negative scores because they were deterred from using the resources because they 
could not access the DVD at all. 
 
One participant regularly mentioned verbally during the evaluation sessions that he didn’t have 
his glasses/spectacles or told the researcher that he could not read or write though when 
advised that the researcher could support with questionnaire and answers, had replied that he 
was ‘just joking’ and continued to complete the questionnaires. This is just anecdotal 
information from one patient and not recorded in the results, however, this does raise the further 
question of whether lack of confidence may play a factor in asking for help to complete study 
questionnaires or use the resources, particularly within groups where the underlying disease 
has symptoms which could affect self-confidence. It might even be speculated this could be a 
possible reason why instructions on the audio-visual material received differing responses to 
some statements than paper versions for some participants. 
 
The final three questions (i.e. SfBB-Q6 “I will continue to use the booklet and DVD to practice”, 
SfBB-Q7 “I would recommend the booklet and DVD to others” and SfBB-Q8 “I would be likely to 
use this or other singing resources online or via an electronic device, mobile phone ‘app’ or 
similar”) are collectively attempting to elicit specific feedback from the participants to indicate 
and support the value of further exploration and investment of this type of media and technology 
in this population or if there would be little uptake or usage. The overall responses to questions 
SfBB-Q6, SfBB-Q7 and SfBB-Q8 were all positive with >64% of the participants completing 
these questions (n=28) indicating a score of <3, where 0 indicates strong agreement with the 
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most positive response. The results in this small group would suggest that the future 
investigation and development of self-help materials either these or similar resources would be 
valuable and that this engages participants and encourages practice between group singing 
sessions.  
 
The overall outcome of the key evaluations showed improvement in all scores and improvement 
in three of the health and wellbeing questionnaires, two of these meeting the required 
significance levels. This could be for a number of reasons. One possible difference in this study 
to the others as identified in the systematic review of all other previously published studies in 
this area is that novel tools specifically designed to accompany the sessions were utilised. 
Since this is a pilot study with no randomisation or control group, it is only possible to speculate 
rather than draw clear conclusions. It would certainly be a strong suggestion that further 
investigations and trials be conducted to explore whether these tools or similar resources might 
be a factor in the engagement of the participants and the positive outcome.  
 
It was a clear finding that using a variety of media to present the audio or visual recordings 
works well but still needs to be explored further to ensure the most targeted approach for 
specific populations. However, the overall results of the study do support similar previous 
research in this area where specially created novel self-management resources have been 
provided in addition to group singing (Lord et al., 2010) to provide a positive outcome.  
 
SfBB Assessment Questionnaire – SfBB-Q Design Evaluation  
 
The novel SfBB questionnaire was developed specifically for use in this study to collect and 
capture relevant quantitative feedback on the novel SfBB resources created by the Sidney De 
Haan Research Centre (Appendix C, sub-appendix I). The questionnaire design is similar to the 
format of the CAT questionnaire but consists of eight items, each formatted as a numerical 
response scale from zero to six. 
 
The eight items were as follows: 
 
1. I used the booklet and/or DVD regularly 
2. I found the instructions in the booklet easy to follow 
3. I found the instructions on the DVD easy to follow 
4. Using the booklet and DVD made me feel more confident at the group sessions 
5. It was easy to fit in regular practice at home 
6. I will continue to use the booklet and DVD to practice 
7. I would recommend the booklet and DVD to others  
8. I would be likely to use this or other singing resources online or via an electronic device, mobile 
phone ‘app’ or similar 
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The participants were all familiar with the CAT questionnaire and since the SfBB-Q was created 
to be similar in design it was generally well accepted by participants and allowed for some 
useful evaluation of the SfBB tools. The questionnaire was administered easily with little 
instruction. 
 
Several participants posed verbal queries to their neighbouring participants or the researcher 
during the administration of the questionnaire which were all pertaining to a similar theme 
regarding the ‘direction of the scale’ e.g. ‘Is a score of zero the best and six worst?’, “Is a zero 
good?” indicating that this was the key area needing clarification for improved understanding 
and ease of administration.  
 
In two cases participants completed the scale in error and then corrected some responses. In 
just one of these cases (Participant ID #2010) some early responses then appeared completely 
contrary to later statements which lead to a supposition that participants completing the 
questionnaire may have been confused with the direction of the scale. There was only one in 
total, out of a possible twenty-eight that completed the questionnaire, where this showed up in 
the results.  
 
Though the aim of the design was to make the questionnaire similar to the CAT to aid the users 
that were familiar with this questionnaire, it was a clear limitation of the design process that it 
was not noticed that the CAT responses are slightly different from those of the SfBB-Q. i.e. 
while the CAT scoring is from zero to six, where zero is the most positive and six is most 
negative the SfBB questionnaire includes some questions that relate to a frequency variable i.e. 
‘frequency of use’ where participants inherently might feel that a ‘more frequent’ response 
should be recorded as a higher numerical value on the scale. Therefore, it might be 
advantageous to consider reversing the scale for the SfBB-Q to allow the higher value of six to 
indicate the most positive score or value of maximum frequency. One other option, if it is to be 
used again, might be to leave the scale is it stands but to add a further comment in the 
questionnaire instruction to make it more easily understandable when administered. 
 
It was also noted that three participants recorded a value of six for questions regarding the ease 
of use of a specific item e.g. ‘I did not find the instructions on the DVD easy to follow’ indicating 
that they did not find the instructions easy to follow. However, the same participant had also 
indicated by written comment on their evaluation form that they were not able to use the DVD, 
hence this could outline a further limitation of the questionnaire i.e. In future participants should 
be instructed to refrain from answering questions that are not relevant or to include an additional 
‘Not applicable’ option. 
 
To measure the internal consistency or correlation between different items on the SfBB scale, 
the Cronbach’s alpha value was calculated as α = 0.813, where internal consistency (α) ranges 
between 1 and 0. A value 0.8 ≤ α < 0.9 is deemed ‘Good’ and a value 0.7 ≤ α < 0.8 is 
‘Acceptable’ with a value of α < 0.5 being ‘Unacceptable’ (George and Mallery, 2003) indicating 
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there was ‘good’ or adequate internal consistency for this questionnaire within this population 
overall.    
 
It was also noted from this analysis that Question 5 on the scale i.e. ‘It was easy to fit in regular 
practice at home’ was the only question on the scale to show negative correlation in the Inter-
Item Correlation Matrix and as such showed a Corrected Item-Total Correlation score of 0.214.  
Since this value is between 0.2 and 0.7 it would still indicate validity, but is of note as it was the 
only question to have a ‘revised Cronbach’s alpha score if the item were deleted’ higher than 
the overall original Cronbach’s alpha i.e. α = 0.839 for the scale. This might indicate this 
question was not as reliable as the other questions. It might therefore be a consideration to 
remove or revise this question if using the questionnaire in future. 
 
Question 1 on the scale i.e. ‘I used the booklet and/or DVD regularly’ showed a Corrected Item-
Total Correlation score of 0.378 which was slightly lower that the other remaining questions too. 
However it was still well within the range of 0.2 to 0.7 and the revised Cronbach’s alpha score ‘if 
the item were deleted’ was still lower than the overall Cronbach’s alpha i.e. α = 0.810.  All other 
questions recorded high Corrected Item-Total Correlation scores > 0.5 and revised Cronbach’s 
alpha score ‘if the item were deleted’ less than the original Cronbach’s alpha score, indicating 
that the questionnaire was reliable and removal of any question in this case, except question 5, 
would result in a lower Cronbach's alpha and thus lower reliability.  
 
The initial intent of the SfBB-Q was to calculate an overall mean score per patient, summarising 
their feedback, which could then be comparable between participants and across the study. 
However, since the values from each of the questions can be quite variable and inconsistent 
due to the limitation of the SfBB-Q, the analysis of each individual response may hold more 
useful information on the usability of the SfBB guide and future use and uptake of such similar 
self-management resources. 
 
These resources or alternatively, investment in further development of similar materials could 
help improve the quality, consistency and the persistence of the singing intervention and 
delivery method for future research. This has been outlined as an essential component from this 
and previous research (Clift et al., 2013) and this needs to be considered with more focus for 
future research. 
 
The SfBB-Q form provided useful feedback and was readily accepted and completed by 
participants. The qualitative data was very minimal but it did support the findings from the SfBB-
Q. The key learning from this pilot administration is that the SFBB-Q questionnaire would need 
further adaptation and improvement if it is to be used in future analysis. This would ensure it is 
more easily understood by participants, can be self-implemented by participants without 
additional instruction or advice and can provide better quality data. Qualitative feedback in the 
form of verbal group discussions or via participant interview techniques with questions 
dedicated to providing insight into how the resources were utilised would also be strongly 
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recommended for future studies, This could extract valuable tacit information from participants 
to help improve the rollout and uptake of such resources in future. 
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Chapter 6 – Discussion and Conclusions 
 
The overall aims of this research were to answer the following questions: 
 
1) What has been established so far by research regarding the effects of group singing for 
COPD patients? 
 
2) What are the potential health and wellbeing benefits of regular participation in group singing 
for a small cohort of COPD patients? 
 
3) What is the potential feasibility and usefulness of developing and implementing novel singing 
resources in a group of COPD patients, in addition to regular group singing? 
 
The first question ‘What has been established so far by research regarding the effects of group 
singing for COPD patients?’ was addressed by execution of a broad systematic review of all 
available published research on singing for COPD to date, to explore all the evidence and 
supporting information available in this area and to use this knowledge where possible to inform 
future study design.   
 
The key messages from this systematic review and the data for those studies included were 
generally very positive, with the majority of the studies reporting one or more positive finding 
and none of the studies concluding any negative findings. However, the overall conclusion of 
the review is in close alignment with the recent Cochrane review (McNamara et al., 2017), such 
that, the availability of high quality evidence that singing for COPD improves physical health, 
dyspnoea or respiratory-specific quality of life is still limited, largely due to the low number of 
studies and their small sample sizes. This theme also aligns with arts and health studies more 
broadly, as discussed in a report for arts, health and wellbeing which found that evaluation still 
presents challenges and there is a need to address difficulties such as the use of 
randomisation, control and adequate sample sizes in this area of research (RSPH, 2013). 
 
A core study (Part I) was designed using information from the outcome of this systematic review 
to address the question ‘What are the potential health and wellbeing benefits of regular 
participation in group singing for a small cohort of COPD patients?’ and while it was not feasible 
to design a study at this time which met the recommendations outlined for large global 
randomised trials, the durations, population, measures and other aspects were informed by the 
outcome of the systematic review and the study did meet its aim  in addressing this question. It 
also achieved its primary endpoint to assess the mean total difference scores from baseline on 
three health and wellbeing questionnaires (WEMWBS, CAT and ACQ-5) at twelve weeks post 
baseline (i.e. Follow-Up Visit V2, Week 12 +14 days). The mean improvement in WEMWBS and 
CAT scores between Baseline Visit V0 and Follow-Up Visit V2 met required significance i.e. p < 
0.05 and this required significance was maintained at Final Follow-Up Visit V3 for those 
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participants that continued. The results obtained from this scale showed a change of five points 
which was maintained after thirty weeks post baseline. This finding is clearly very encouraging 
in regard to the impact of regular singing on COPD symptoms, though caution must be 
exercised regarding the small sample size and low power and also the low quality of the study 
due to the pre-test post-test design.  
 
It also employed secondary endpoints which included assessment of the mean score 
differences of these questionnaires at six weeks post baseline (i.e. Mid-Term Study Visit V1 
(Week 6 +14 days) and again at thirty weeks post baseline (i.e. Final Follow-Up Visit V3 at Week 
30 +21 days) along with a review of written feedback, compliance and retention data also 
collected at baseline and twelve weeks. This core study aimed to address the question of 
whether participants engaged in group singing for COPD, including the use of new resources, 
express an improvement in any of these measures at the various time points. The clear 
indications from this study show there are some significant improvements.  
 
The research further included a secondary endpoint which aimed to answer the third research 
question: ‘What is the potential feasibility and usefulness of developing and implementing novel 
singing resources in a group of COPD patients, in addition to regular group singing?’ It 
addressed this using a secondary sub-study (Part II) which piloted newly created self-
management resource tools, developed specifically for singing for adults with COPD and 
respiratory illness. The intent of this sub-study was to provide deeper understanding of the 
usability and feasibility of these specific resources and also the potential use more generally of 
these types of tools for this population to provide an insight into any key themes for 
consideration in future use. In addition, this provided opportunities to examine the research 
instruments i.e. potential questionnaires and techniques involved in reviewing such tools for 
group singing in this population.  
 
It was found that the use of novel singing resources in a group of COPD patients, in addition to 
regular group singing is a feasible enterprise, as implementing a variety of media to present 
audio or visual recordings was found to work well in this small population. The majority (78%) of 
participants indicated they would recommend the resources that had been provided and 67% 
agreed that they would use these resources of other types of media to practice in the future. 
These results were encouraging but this was a small population and the study had a high risk of 
bias due to lack of randomised control or blinding, so clearly there is still much to be explored to 
ensure effective design and delivery of these tools to maximise uptake and usability for COPD 
patients to help encourage continued singing practice. 
 
Methodology, Questionnaires and Measures 
 
A European Respiratory Society (ERS) task force report was published with the aim of 
establishing clear diagnostic criteria and standardized methods to examine COPD and it 
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strongly recommended measuring as many different characteristics of COPD patients as 
possible (e.g., respiratory symptoms, exacerbation frequency, comorbidity assessment, body 
mass index (BMI), biological markers, chest radiography, and risk factors assessment) in 
addition to spirometry, to provide a better understanding of the disease (Bakke et al., 2014).  
 
A recent study reviewing the diagnosis of COPD in epidemiological studies concluded that 
single spirometry or clinical respiratory symptoms alone are not enough for accurate COPD 
diagnosis. It further suggests that a comprehensive approach, including clinical assessment and 
follow-up spirometry should be taken into consideration for the diagnosis and management of 
COPD as well as for any screening program or prevalence study conducted in the future 
(Andreeva et al., 2017).  
 
The strategy of recording as many different characteristics of COPD patients as possible is 
advantageous and certainly more easily achievable for large epidemiological studies. However, 
in ‘Singing for COPD’ research, where budgets may be limited, and sample size of the available 
trials is small, it would be more advantageous to utilise consistent outcome measures wherever 
possible across trials so that results could be more widely compared. A key finding from the 
wider systematic review, as documented in Chapter 2 is that there is such a wide variety of 
questionnaires and measures used across the body of work all with varying success and small 
sample sizes, that it makes it very challenging to compare or pool data for analysis to draw 
conclusions. This is supported by a recent Cochrane review (McNamara et al., 2017). There 
are also important new technological advances in lung function that may be more pertinent, 
viable for fast, accurate data collection in future studies e.g. the application of Structured Light 
Plethysmography (SLP), a non-invasive diagnostic method that uses structured light to perform 
pulmonary function testing (de Boer et al., 2010) already holds significant potential in this area. 
 
The research forms and measures were selected for this research within the confines of the 
community setting i.e. without access to specialist or diagnostic equipment (e.g. weighing 
scales, spirometers) or trained personnel etc. Several alternative measures were explored 
during the early planning phase, for feasibility, including measures used by previous studies e.g. 
St. George's Respiratory Questionnaire (SGRQ), Spirometry measures, BODE Index, HRV 
recordings and plethysmography but due to the additional data collection requirements i.e. 
requests for detailed health measures, requirements for specialist equipment etc. and due to the 
additional informed consent and ethical hurdles, this was not considered to be feasible within 
this group. If future larger studies are conducted in a healthcare or hospital setting however, it 
would be recommended that a full review of wider measures is considered.  
 
The overall view on the selected measures was that these were effective, well received and 
permitted a significant amount of quality data to be collected in a simple and unobtrusive way, 
within the time available and logistical constraints. The participants were provided pens, time 
and space to complete their forms and were encouraged to ask for guidance from the 
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researcher regarding completion, but questions were limited, and all participants completed 
feedback wholeheartedly and without any objection. 
 
One other more minor consideration was the cost of the usage of the questionnaire. The 
resources available to conduct such trials in this area of study are limited and the most cost-
effective options were selected to capture pertinent data and support the overall aims of this 
research. It is anticipated that future studies in this field, as in arts and health research more 
generally, would likely be conducted by small self-funding groups with minimal budget such as 
this study. Therefore, low cost solutions were selected with the expectation that other 
researchers would be encouraged to use the same inexpensive and easily accessible 
questionnaires within their studies in future, so more effective consolidation of data from 
multiple trials and improved comparisons of research results might be made.  
 
Research Limitations 
 
The research limitations noted were similar or the same as other singing for COPD trials 
conducted in this area due largely to the impossibility of blinding participants to the nature of the 
intervention and leaving the results exposed to an unmitigated risk of bias i.e. risk of 
‘expectation of benefit’ and risk of potential desire by the participant to please or impact the 
results. The lack of a control group here further exposes the study to the risk of assessor bias. A 
credible randomised control with larger enrolment numbers would have eliminated much of the 
risk of bias, though this was not possible within the confines of the resources available and 
would be recommended in future. It is recommended that future studies employ some form of 
randomised control and that the assessors are blinded to the intervention.  
 
In addition the questionnaires and outcome measures were not completed by the participant in 
isolation e.g. in a quiet space without distraction, so there was a potential for participants to be 
influenced by singing leaders, assessor  and other participants, which may have introduced 
additional bias. It is recommended that participants are assessed in isolation where possible for 
future research, to help mitigate this potential for bias. 
 
The total outcome measures were not extensive and the data collection for these patients was 
deliberately limited to make effective use of the resources i.e. the time availability at the venues, 
the singing leaders’ availability, to ensure all required engagement and administration of the 
measures was respectful of participants’ time and energy reserves. The deliberate selection of 
these simple measures was made to allow data collection to be as non-invasive on participants’ 
time and to be as efficient as possible. Those previous randomised control studies (Bonilha et 
al., 2009, Lord et al., 2010, Lord et al., 2012) and the larger scale community studies (Clift et 
al., 2013, Clift et al., 2017) conducted in this area had the advantage of being completed either 
in a hospital setting or with larger clinical support teams available which allowed for additional 
physical and spirometry readings to be taken etc. However, despite the limitations of this study 
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it was conducted with rigour and the data collected was robust even though the study would be 
considered low quality due to the lack of randomisation, blinding or control. 
 
The attrition rate of the original participants that consented (n=37) was approximately 50% over 
all up to the final assessment reflecting what has been seen previously in larger studies with a 
similar population (Clift et al., 2017) and as noted there, a sufficiently powered future trial would 
need to take this attrition into consideration. It is again a limitation of this study that larger 
population could not be recruited due to resource constraints i.e. suitable locations, availability 
of singing leaders etc. 
 
This research strongly supports previous findings of similar studies in this area (Bonilha et al., 
2009, Lord et al., 2010, Lord et al., 2012, Clift et al., 2013, Clift et al., 2017) that group 
singing does positively impact both health and wellbeing outcomes of these patients in a variety 
of ways. In addition, it further suggests that if sustained, this intervention has the potential to 
support maintenance of these positive effects over longer periods, even if there is a break in the 
group singing intervention.  
 
Final Conclusions 
 
The broad systematic review detailed here provides further evidence in alignment with the 
recent Cochrane review (McNamara et al., 2017) that the availability of high quality evidence to 
support singing for COPD improving physical health, dyspnoea or respiratory-specific quality of 
life is very limited due to the low number of high quality studies. Existence of research 
examining the longer-term effect of singing for people with COPD with large samples sizes is 
limited and randomised controlled data with large samples over extended periods is non-
existent.  
 
It can be concluded that although lung function is poorly related to other clinical outcomes 
(Mahler and Criner, 2007) and it is essential to pursue the use of measures and outcomes 
beyond lung function or spirometry alone, the variety of different measures currently being used 
is too overwhelming and there is a lack of standardisation in this area. This issue applies to 
study methodology and design too, including intervention type, frequency and duration. Global 
or at least regional standards in this area would allow more efficient collaboration and potential 
for shared data and pooled analysis. It is important that health care utilisation, service use and 
cost effectiveness of the intervention is also considered and further explored over the longer 
term to increase the impact of future trials. 
 
The empirical study research here makes a useful contribution to the growing literature on the 
potential value of regular group singing for people with COPD. The study was designed to build 
upon the earlier studies conducted in South East England (Clift et al., 2013, Clift et al., 2017) 
and to assist in understanding further, the feasibility of potentially conducting a larger 
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randomised trial in the Medway area. In this context it successfully met its objective in addition 
to the primary aim which was to show group singing had a significant positive effect on mental 
wellbeing as measured by the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) and a 
significant positive effect on the impact of a patient’s COPD and how this changes over time, as 
measured by the COPD Assessment Test (CAT). It also concluded that despite a short 
cessation in group singing sessions this effect was maintained at thirty weeks post baseline.  
 
This research is low in quality with regard to risk of bias, sample size and low power, largely due 
to the lack of a randomised controlled arm and the pre-test post-test design, which negatively 
impacts the overall confidence in the results. Nevertheless, it does indicate that significant 
improvements could occur within this population in only a very short timeframe. It suggests that 
just a one-hour session continued weekly for approximately twelve weeks could provide 
significant benefits to wellbeing and impact to COPD symptoms. The data further supports 
these effects being maintained up to thirty weeks with continued weekly sessions, even with a 
short cessation in group singing attendance.  
 
This research highlights the importance of continued efforts to encourage this offering in this 
population particularly following initial pulmonary rehabilitation sessions to ensure prolongation 
of the effects. As previously discussed, researchers should continue to strive to use more 
reliable and valid quantitative measures in this area of research and ensure that a framework is 
used to promote use of measures that are validated for the specific population. It would be ideal 
if the leaders within this research community could agree consensus regarding the key 
measures used so that future study data is collected more consistently so that study data 
across multiple studies could potentially be pooled. 
 
Consistent with recent research (Skingley et al., 2018), the qualitative data provided by 
participants was in general agreement that the singing groups contributed to their improved 
state of wellbeing and the majority of participants in this research study agreed that the singing 
programme led to improvements in respiratory symptoms and in their wellbeing, confidence and 
social connections between baseline and follow-up visits. The COPD participants noted 
improvements in mental wellbeing, attributing much of this to the singing group. Social benefits 
were also in evidence, extending to the groups meeting outside of the singing sessions and 
often acting as external support networks. The data collected within this study supplements both 
the current qualitative and quantitative data in this area and adds to the growing body of 
evidence that singing is a safe, enjoyable pastime that helps health and wellbeing for adults with 
a respiratory illness. 
 
This pre-test post-test study was designed to review the impact of group singing on adults with 
COPD within the Medway area and to pilot newly devised tools for the specific purpose of home 
support within the COPD population. This study shows significant positive outcomes and 
contributes to the expanding body of evidence on the potential value of group singing for adults 
with respiratory illnesses more broadly and particularly adults with COPD. This research 
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supports and builds on existing evidence indicating that group singing may offer many potential 
health and well-being benefits for adults with COPD related respiratory conditions (Clift et al., 
2017, Bonilha et al., 2009, Lord et al., 2010).  
 
Recommendations for Future Research  
 
The collective recommendations from the systematic review and the research studies are that, it 
is essential that researchers build on existing knowledge and that, longer, larger, multi-centre 
global randomised controlled trials are conducted with increased standardisation of measures 
between studies. These should certainly extend to provide more consistent data across diverse 
regions and countries with low, middle and high incomes and target more diverse COPD 
populations.  
 
These findings are consistent with arts and health literature more broadly and in particular with 
a review of art, healing, and public health (Stuckey and Nobel, 2010) which collectively 
reviewed four primary therapies (music engagement, visual arts therapy, movement-based 
creative expression and expressive writing) suggesting researchers should make better 
attempts to establish meaningful control groups, to quantify interventions and outcome variables 
at higher levels of standardisation and precision allowing more cross-study comparison. It also 
suggested similar to the outcomes of this research, that future research should expand study 
populations to allow exploration of the effects of interventions in groups, and should plan for 
longer term follow-ups to assess the sustainability of outcomes over time. 
 
It is strongly recommended based on that the group singing intervention for future studies 
includes at least one hour of regular singing and exercise each week and that participants are 
encouraged to practice in between sessions. Careful consideration and planning should be 
undertaken regarding logistical matters. It is recommended that selected venues singing and 
assessments have adequate access (ground floor level facilities where possible) and are central 
for public transport and with good parking facilities.  
 
It is also suggested that at least thirty minutes is allowed at the start and the end of singing 
sessions to allow for setting up the space in readiness for the participants and clearing 
everything away afterwards, so that patients with respiratory needs do not feel ‘rushed’ and 
stressful situations are avoided. It would also be ideal where possible for questionnaires and 
outcome measures to be completed by participants in isolation and further recommended that 
assessors and data collection teams are blinded to the intervention. 
 
The intervention period of the empirical study was conducted from spring to autumn in South 
East England, with the majority of assessments performed specifically in the spring and autumn, 
avoiding excessive temperature and environmental changes potentially experienced in summer 
and winter months. The temperatures were considered mostly temperate during the intervention 
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period, which allowed researcher and singing leaders to accommodate participants with COPD 
symptoms during these periods, since the condition is often impacted by temperature, allergens 
and other pollutants usually associated with more extreme seasonal climates both positively 
and negatively. Research suggests a distinct and independent influence of season on 
exacerbation outcomes and mortality (Rabe et al., 2013) and participants’ conditions i.e. 
dyspnoea combined with disease progression can cause inability to travel, especially in winter 
months (BLF, 2017). The arrangement of sessions around the seasons in this study appeared 
to positively support recruitment and retention of participants and avoided seasonal changes 
that could potentially have impacted assessment variables as seen previously (Clift et al., 
2017). It is recommended that future research planning strongly take this into account.  
 
The recruitment and retention of participants into research trials has become more sophisticated 
in recent years. Researchers are more widely pursuing extensive feedback from the target 
population early on during feasibility planning to ensure input for study design, timings and 
logistics for particular populations is provided. It would be useful if this data could be more 
critically discussed in the planning of the research and delivery of group singing sessions within 
these studies too. This could potentially help to reduce attrition rates. It was not feasible to 
employ more sophisticated measures in the case of this study due to the time available and 
nature of the study but for larger complex randomised studies it is recommended. 
 
It is recommended, that future work might involve a further comprehensive  mapping of 
collective qualitative interview output for ‘singing for adults with COPD’ too, since there could be 
an extensive trove of this information from previous studies which has not yet been fully 
assessed holistically and this might direct future work. It is also recommended that sufficient 
time is made available during study planning to collect additional feedback comments and to 
ensure there is time or space available beyond the singing groups to allow time for socialising. 
This was considered valuable by the participants of this research and is something that could 
also potentially help with retention of participants. 
 
The data collected for this research was limited to outcome measures to assess impact of 
COPD on participants’ life and quality of life, but other symptoms and measures would be very 
desirable for future research i.e. Pulmonary function tests, other more detailed dyspnoea 
scales, changes in breathing pattern during and after singing, physical measures, hormone 
changes and effect on frequency and amount of expectoration of sputum. This might expand 
the knowledge base and also help understand more fully the physiological and psychological 
aspects and mechanisms of action that group singing may have on COPD symptoms. 
  
The predominant health-care cost item for COPD patients is hospitalizations for exacerbations 
and high priority should be given to interventions aimed at delaying the progression of disease, 
preventing exacerbations and reducing the risk of comorbidities (Lopez-Campos et al., 2016).  
It has been shown that the provision of opportunities to meet and sing together provide cost-
effective and acceptable options for maintenance and enhancement of health in other 
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populations (Coulton et al., 2015). However, much more robust data in these areas are clearly 
vital for the COPD population. A particular need is the exploration of service use and cost of 
COPD group singing over a longer period, across greater numbers of COPD patients with 
differing severity of disease and particularly in a randomised trial setting.   
 
In alignment with previous recommendations and ideals (BLF, 2017) it is important that the 
consideration of sustainability of groups beyond the research period remains high on the 
agenda for any forthcoming projects. The singing group intervention in this study was so well 
received that there were feelings of concern and possibly even anxiety raised by participants as 
the study drew to a close, as to how the groups might continue. These issues were raised and 
discussed on many occasions and were a theme within the verbal and written comments 
provided by the majority of participants. It is therefore a recommendation that considerations of 
sustainability are addressed with participants from the outset wherever possible. 
 
The findings of this research, including both the systematic review and the empirical research 
are consistent with the fundamental outcomes outlined in other recent reviews (Lewis et al., 
2016, McNamara et al., 2017) and studies (Bonilha et al., 2009, Lord et al., 2010, Lord et al., 
2012, Clift et al., 2013, Clift et al., 2018) in this area, in that there are critical limitations in the 
current body of evidence and it is vital that larger randomised controlled trials with longer 
durations and robust methodology be conducted to build on the existing evidence.  
 
Ideally these trials should extend across more diverse regions globally and should provide more 
consistent data collected more frequently with a wider outreach to include a broad range of 
societies, incomes and educational levels. There should also be a focus on long-term follow-up 
data, regularity and consistency of group singing and consistency of the types of quantitative 
data collected to support core policy making in the future. 
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Protocol Summary 
 
Abstract (2) 
 
Respiratory disorders manifest themselves with chest symptoms including shortness of breath 
and a decline of lung function and a therapy is needed to provide treatment and support for 
these patients. There is a growing body of evidence to suggest that therapies that include 
breath control exercises, such as singing, may have health benefits for respiratory function and 
psychological well-being. 
 
The objective of this review is to search the current body of evidence and evaluate the evidence 
available for singing as an intervention for health and wellbeing for patients diagnosed with a 
respiratory illness. 
 
Terms: Singing, Respiratory Illness, Respiratory disorder, Chronic Respiratory disease 
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Introduction 
 
Rationale (3) 
 
Respiratory diseases are among the leading cause of death worldwide. Lung infections (mostly 
pneumonia and tuberculosis), lung cancer and chronic obstructive pulmonary disease (COPD) 
together accounted for 9.5 million deaths worldwide during 2008, one-sixth of the global total. 
The World Health Organization (WHO) estimates that the same four diseases accounted for 
one-tenth of the ‘disability adjusted life-years’ (DALYs) lost worldwide in the same year. 
 
Respiratory diseases are likely to remain a major burden on European societies for decades to 
come. The prevention and treatment of lung diseases will need to be improved, if their impact 
on longevity and quality of life (QoL) of individuals and their economic burden on society are to 
be reduced in Europe and worldwide (WHO 2012). 
 
Respiratory Disorders manifest themselves with chest symptoms including shortness of breath 
and a decline of lung function. Singing is an activity that may support lung function and enhance 
quality of life in people with certain respiratory disorders.  
 
Bonilha et al. (2009) concluded, based on a small, randomised study of COPD patients, that 
singing classes are a well-tolerated activity for selected patients and that the regular practice of 
singing may improve QoL, and preserve the maximal expiratory pressure of these patients. The 
feasibility study on the health benefits of a community singing programme for older people with 
COPD by Clift et al. (2013) further supports this, showing that measures of lung function and 
health-related quality of life significantly improved over a 10 months period of the singing 
programme. 
 
This research is in line with existing UK Department of Health (DH) Chronic Obstructive 
Pulmonary Disease (COPD) outcomes strategy discussions, particularly objectives identified in 
the UK Department of Health companion document (DH May 2012), which outlines directions 
for enhancing quality of life for these patients. 
  
The evidence suggests that singing has the potential of improving health outcomes in patients 
with respiratory illness. However, although individual systematic reviews of research literature 
have been completed for singing in patients with certain specific respiratory disorders for 
example ‘Singing for Cystic Fibrosis’ and ‘Singing for Bronchiectasis’ (Irons et al., 2010a, Irons 
et al., 2010b), a systematic review of singing for chronic respiratory disorders collectively and in 
particular COPD, has not yet been carried out. 
 
This systematic review aims to research current knowledge in the area of singing for respiratory 
illness specifically those collectively known as COPD, with the intent to consolidate existing 
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evidence in one place and support future research methodology and practice development. This 
could potentially impact patient welfare positively and reduce health care utilisation for patients 
with impaired respiration. 
 
Condition 
 
Respiratory illness encompasses developmental, pathological conditions affecting the organs 
and tissues that make gas exchange possible in higher organisms, and includes conditions of 
the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and 
the nerves and muscles of breathing (WHO, 1978). 
 
The respiratory tract is the site of an exceptionally large range of disorders for three main 
reasons:  
1) It is exposed to the environment and therefore may be affected by inhaled organisms, dusts 
or gases  
2) It possesses a large network of capillaries through which the entire output of the heart has to 
pass, which means that diseases that affect the small blood vessels are likely to affect the lung  
3) It may be the site of “sensitivity” or allergic phenomena that may profoundly affect function  
(Britannica, 2018) 
 
Respiratory disease in the context of this review refers to one of those disorders included in the 
list of common chronic respiratory diseases as identified by WHO classification 2007 and is 
noted along with the related symptoms in Appendix I of this document. 
 
Intervention 
 
The intervention of singing and the suggested method of action are summarised very 
comprehensively within Cochrane review protocol ‘Singing for Adults with COPD’ (McNamara 
et al., 2016) as detailed verbatim below: 
 
Intervention - description (McNamara et al., 2016) 
 
Singing is the production of musical words or sounds with the voice (Oxford, 2016). Singing 
can be performed individually or in a group (choir) and can be arranged or improvised. 
Singing is a much more complex physical activity than speaking due to the greater length of 
phrases and greater range of pitch required (Irons et al., 2010b). Singing is dependent on 
the use of the lungs for air supply. During normal tidal breathing, the diaphragm contracts for 
inhalation, while exhalation occurs passively. During singing air flow must be regulated and 
larger lung volumes are required, thus exhalation is active and aided by the abdominal, 
internal intercostal and pelvic muscles. Singing requires a high degree of muscle co-
ordination by highly developed muscle reflexes. There are four stages of breathing with 
singing: inhalation; suspension; controlled exhalation (when phonation occurs); and 
recovery. A singer controls these stages consciously until they become conditioned reflexes 
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(Mathis, 2009). Diaphragmatic breathing requires an increase in abdominal wall motion with 
a reduction in upper rib cage motion (Gosselink, 2004), and is the method of breathing 
employed by singers, as the diaphragm can generate the greatest inspiratory muscle force 
to increase lung volumes and change subglottal pressures necessary for singing 
(Sundberg, 1993). The subglottal air pressure requirements are much greater for singing 
tasks than for speaking tasks (Leanderson et al., 1987, Leanderson and Sundberg, 
1988), as higher subglottal pressures are required for loudness and higher pitch (Sundberg, 
1993). Audible speech can be produced with subglottal pressures as low as 2 cmH2O 
(centimetre of water pressure), with ordinary speech ranging from 7 cmH2O to 10 cmH2O; 
however, singing can vary from 5 cmH2O to 40 cmH2O for soft to loud tones (Proctor, 
1980). An increase in subglottal pressure is achieved by decreasing the volume of the rib 
cage using muscular forces, elasticity forces and gravity (Sundberg, 1993). Posture can 
greatly affect the quantity of air, the capacity of the lungs and the ability to move air in and 
out when singing. Good posture facilitates an efficient breathing pattern and can influence 
the voice (Bunch, 1995, Staes et al., 2011). Trained singers have greater breathing 
efficiency and greater use of their lung capacity than non-trained singers (Gould and 
Okamura 1973, Salomoni et al., 2016). Mastery of diaphragmatic breathing is vital for 
singing. Data from Engen, (2005) suggests a minimum of four half-hour group singing 
sessions could be sufficient for people with emphysema to learn the diaphragmatic 
breathing technique correctly. Thus, singing needs to be performed for a sufficient duration, 
and most likely at sufficient intensity in order to ensure an effective stimulus for learning this 
technique and for potentially having an effect on important health outcomes. The precise 
’dosage’ will likely vary for each person and may depend on their age, disease severity, and 
previous experience with singing (Irons et al., 2010a). 
 
Intervention - suggested method of action (McNamara et al., 2016) 
 
Singing is an activity that has the potential to improve health outcomes, such as relieving 
dyspnoea and enhancing quality of life, in people with COPD due to employment of 
diaphragmatic breathing, altered posture, and improved breathing co-ordination. Qualitative 
studies of singing and health report that singing can enhance mood, provide social support 
and friendship, help develop self-esteem and self-confidence, relieve stress, promote good 
posture and distract attention from personal worries (MacDonald et al., 2013). Singing in 
people with COPD has the potential to demonstrate similar effects due to the enjoyable and 
low-risk nature of the activity (Engen, 2005), and may have a positive impact on the 
distressing effects of COPD such as breathlessness, reduced quality of life and fatigue. The 
perceptions of people with COPD following a group singing programme support this (Clift et 
al, 2013, Skingley et al, 2014). Therapies that incorporate breathing manoeuvres, such as 
controlled breathing techniques including diaphragmatic breathing and active expiration (as 
performed during singing), have been shown to improve lung function (Esteve et al., 1996), 
alleviate dyspnoea and improve quality of life (Gosselink, 2003, Gosselink, 2004), and 
improve functional exercise capacity (Holland et al., 2012) in people with COPD. Singing 
requires great control to ensure a smooth and sustained exhalation. This exhalation is 
similar to that of pursed lip breathing and controlled breathing, which have been shown to 
reduce breathlessness in people with COPD (Gosselink, 2003, Bianchi et al., 2004). 
Education on breathing and air support is fundamental in the process of learning to sing, and 
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knowledge of the physical processes that make up the act of singing, and how those 
processes function (Mathis, 2009), may improve breathing awareness and efficiency in 
people with COPD. Poor posture (hyperkyphosis), which is common in people with COPD 
(Gaude et al., 2014), can restrict the expansion of the rib cage and movement of the 
diaphragm. Singing requires the development of skills in controlling posture that may be 
transferable to activities in daily life for people with COPD (Lord et al, 2010). 
 
Objectives (4) 
 
The key objective of the review is to systematically search the existing published body of 
research on singing for respiratory illnesses, and to formally present findings to enable 
comparison, assessment and summarisation of current knowledge. 
 
Primary Endpoint 
 
Assessment of singing for pulmonary function in patients with a respiratory illness. 
 
Secondary Endpoint 
 
Assessment of singing for quality of life and wellbeing in patients with a respiratory illness. 
 
Methods 
 
Protocol (5)   
 
The conduct of this study protocol is strongly guided by the framework outlined in the Cochrane 
Collaboration Handbook, 2011 (Higgins and Green, 2011) and based on the reporting 
principles of PRISMA statement guidelines (Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses) (Prisma, 2015). The heading numbers in parentheses throughout this 
protocol, refer to the PRISMA checklist headings detailed in Appendix V. 
 
This protocol is not currently registered. 
 
Eligibility Criteria (6) 
 
Criteria for considering studies for inclusion in this review are as detailed below: 
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Study types 
 
Randomised controlled trials or quasi experimental designs and recorded in any language and 
meeting relevant eligibility criteria below.   
 
Patient Inclusion Criteria 
 
Studies where the patients included have one or more diagnosed respiratory disorder (defined 
clinically or radiologically) as identified under the subheading of ‘Chronic obstructive lung 
disease’ in the list of chronic respiratory disorders outlined by the World Health Organisation 
(WHO) in Appendix I. 
 
Intervention Inclusion Criteria  
 
Studies where diagnosed patients of any age have participated in programs that include singing 
activities, carried out in a group (choir) or one-to-one setting with a singing teacher or instructor 
for a minimum of two half-hour sessions.  
 
Outcome Measures (13) 
 
Primary Outcomes 
 
1. Mean difference in respiratory function from baseline that reflects respiratory muscle function 
(maximal inspiratory and expiratory flow, cough peak flow)  
2. Mean difference in other lung function indices from baseline (Spirometry or other lung 
volumes) 
3. Mean difference in other subjective scores (Likert scale, Visual analogue scale (VAS), Level 
of interference of Cough, Cough diary, etc.) 
4. Mean difference in quality of life (QoL) from baseline 
 
Secondary Outcomes 
 
1. Proportions experiencing adverse effects of the intervention 
2. Total number of hospitalised days or symptomatic days 
3. Proportions of participants who had respiratory exacerbations and/or hospitalisations 
4. Treatment adherence + retention in the study 
5. Psychological assessments measuring well-being, self-efficacy, depression and anxiety 
6. Physical function assessments 
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Information Sources (7) 
 
Searches will target the key bibliographic databases noted in Appendix II to identify relevant 
studies. 
 
Searches of other resources will also be carried out for completeness i.e. 
1. Searches of other databases and search engines, including grey literature 
2. References cited in relevant publications or included at recent conference proceedings 
3. Communication with the authors of trials included in the review. 
 
Search (8) 
 
Specific search criteria will be applied to the key bibliographic databases detailed in Appendix II. 
This is broken down into three key components to identify all unique research studies where 
singing is an intervention in this specific patient population. The search criteria will be developed 
by combining searches for the following terms: 
 
‘Intervention’ term 
 
The term ‘Singing’ is the intervention of interest and following initial preliminary investigation 
during pilot searches, singing is a 'Medical Subject Heading' (MeSH) term and delivers by far 
the highest specificity of literature in most key bibliographic databases. Those databases, which 
do not recognise MeSH terms, will be searched to retrieve studies where ‘singing’ is recorded 
as a key term.  
 
‘Population’ term 
 
The term Respiratory illness is also a MeSH term and following initial preliminary investigation 
during pilot searches delivered by far the highest specificity of literature too. Databases, which 
do not recognise MeSH terms, will be searched for ‘respiratory illness’, ‘respiratory disease’ or 
‘respiratory disorder’ as a key term (depending on the individual database definitions). Key 
additional respiratory terms selected from those identified by WHO as detailed in Appendix I will 
potentially be used as an alternative in those databases which are require more specificity or 
which do not recognise generic ‘respiratory’ terms. All searches are to be documented for 
reproducibility.  
 
Reverse searches and quality checks have been completed on MeSH terms to ensure relevant 
illness/disorder terms and singing terms are included prior to use. 
 
The results of these two searches are merged to provide a list of unique literature in preparation 
for manual review for those studies that potentially meet the inclusion criteria. 
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Study Selection (9) 
 
The abstracts of those studies retrieved by the search process, along with the title and 
descriptors, are to be reviewed independently by at least two reviewers. The reviewers will 
identify all studies in which singing has been observed as an intervention for patients with a 
diagnosed form of a respiratory illness. Only studies clearly unrelated to the area of interest are 
to be excluded at this stage. A final list will then be agreed, and full details retrieved for all 
available included studies. 
 
Data Collection Process (10) 
 
The full details for all studies selected by the initial screening process and appearing to meet 
eligibility criteria will be independently reviewed comprehensively by at least two reviewers. The 
key data will be extracted and collated for comparison in a specifically developed data collection 
tool using Microsoft XLS™. 
 
Studies identified are to be further screened at this stage to exclude studies where one or more 
of the measures identified in Appendix III have not been assessed at baseline and >1 other 
time-point or visit.  
 
If any disagreement occurs regarding inclusion of a study either at this stage or at the search 
stage, this is to be resolved by third party adjudication. 
 
Data Items (11)  
 
Data points identified in Appendix IV will be considered for each eligible study, extracted and 
captured in the data collection tool. If data are missing, the field will be noted as NA (Not 
applicable) or UNK (unknown) or an explanatory comment will be recorded.  
 
If important key data impacting an endpoint appear to be missing or unclear, an attempt will be 
made to contact the study author(s) to acquire additional information or clarification. 
 
Reviewers will compare and discuss outcomes to deliver a final agreed version of the database. 
 
Risk of bias in individual included studies (12) 
 
Studies are to be evaluated on:  
(i) Methodological quality - extent to which design and conduct are likely to have prevented 
systematic errors 
(ii) Precision - measurement of likelihood of random errors (usually confidence interval width 
around result)  
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(iii) External validity - extent to which results are applicable to patients with a respiratory 
disorder and other populations  
 
The risk of bias will be assessed for all studies, following criteria outlined in the Cochrane 
Handbook for Systematic Reviews of Interventions. (Higgins and Green, 2011). The Cochrane 
Collaboration's tool for assessing risk of bias shown in Appendix VI will be utilised to support 
reviewers in critically assessing bias for various domains within the review.  
 
To assess the study level risk of bias the quality of the studies included will be assessed with 
reference to the following domains and graded with either a ’low’, ’high’ or ’unclear’ risk of bias: 
 
(i)   Selection/Randomisation bias 
(ii)  Performance bias  
(iii) Detection/Blinding bias 
(iv) Attrition/Incomplete data bias 
(v)  Selective reporting bias 
(vi) Other (e.g. design-specific) 
 
Those assessing risk of bias will not be blinded to the names of the study authors, institutions, 
journal or results of a study.  
 
Quality Appraisal 
 
The findings will be critically assessed, identifying common themes with a particular focus on 
the study design, intervention details and measures implemented for existing research. It is 
thought that these components in particular could be potentially important in supporting the 
direction and design of future research in this area.  
 
Synthesis of Results and Data Analysis (14) 
 
Analysis of the impact of the intervention on the quantitative outcome measures will be the 
focus of this review. The nature of the intervention in studies included may have some ‘mixed 
method’ designs or will have elements of qualitative data reported, i.e. within patient interviews 
or comments. This information could potentially enhance the relevance of the review and help 
with interpretation of the quantitative data results. While the qualitative data will not be included 
in the review itself, a parallel synthesis approach will be adopted to ensure pertinent qualitative 
concepts or themes are synthesised for inclusion in the discussion. 
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Quantitative Data 
 
A review will be conducted for all available meta-data extracted for primary and secondary 
endpoints, to assess if this is comparable. If the same efficacy scales of interest have been 
used (e.g. Lung function measures) and meta-data are comparable, then the data will be pooled 
and the mean difference (MDs) and 95% confidence interval (CI) change from baseline will be 
calculated. These results will be compared with established published standards to suggest if 
any clinical significance may be determined. 
 
Qualitative Data 
 
Qualitative evidence will be assessed and coded for any distinct and comparable themes or 
concepts. These will be grouped and discussed separately and if deemed relevant, incorporated 
or commented upon in the overall review discussion. 
 
The differences in study populations, inclusion/exclusion criteria, interventions, design and 
outcome assessment will be compared and discussed for all studies selected. Details of studies 
excluded from analysis will be recorded with explanation.  
 
Risk of bias across included studies (15) 
 
Risk of bias affecting the cumulative evidence acquired i.e. publication bias or selective 
reporting bias will be considered and discussed if sufficient publications are included. If the 
combination of data and meta-analysis (with at least 10 studies) is possible, publication bias will 
also be assessed using methodology according to the recommendation of the Cochrane 
Collaboration Handbook (Higgins and Green, 2011). 
 
Investigation of heterogeneity (16) 
 
If there are a sufficient number of studies meeting the inclusion criteria then the clinical, 
methodological and statistical heterogeneity between included studies will be investigated using 
guidance from the Cochrane Collaboration Handbook (Higgins and Green, 2011). 
 
Heterogeneity between the study results will be examined, described and tested to see if it 
reached statistical significance. The I2 statistic will be used to measure heterogeneity among the 
trials in each analysis if sufficient data are available. Interpretation of statistical heterogeneity 
will be according to the recommendation of the Cochrane Collaboration's tool (Higgins and 
Green, 2011). 
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 (i)  0% > I2 < 40% indicates low heterogeneity 
 (ii) 30% > I2 < 50% indicates moderate heterogeneity 
(iii) 50% > I2 < 90% indicates substantial heterogeneity 
 
Where substantial heterogeneity (I2 > 50%) is identified, it will be explored using a pre-specified 
subgroup analyses where possible. 
  
Potential subgroup analysis (16) 
 
The following subgroup analyses may be considered, where sufficient studies can be included, 
dependant on assessment of results: 
 
1. Children (aged 18 years or less) and adults (>18 years) 
2. Participant type (Respiratory Disorder as primary disease vs Respiratory Disorder as co-
existent disease) 
3. Type and length of singing intervention (e.g. short term: <1 month; medium term: 1-6 months; 
long term >6 months; type of training) 
4. Stable state vs exacerbation phases of Respiratory Disorder  
5. Severity of Respiratory impairment (based on FEV1: >80% classified as mild, 50-79% 
classified as moderate, 30-49% classified as severe, <30% classified as very severe) 
6. Types of singing material used for the intervention 
                                                                          
 
  xvii  
 
References 
 
Bianchi, R., Gigliotti, F., Romagnoli, I., Lanini, B., Castellani, C., Grazzini, M. and Scano, 
G. (2004) Chest wall kinematics and breathlessness during pursed-lip breathing in patients with 
COPD. Chest, 125(2), pp.459-465. 
Bonilha, A. G., Onofre, F., Vieira, L. M., Prado, M. Y. and Martinez, J. A. (2008) Effects of 
singing classes on pulmonary function and quality of life of COPD patients. International Journal 
of COPD, 4(1), pp.1–8. 
Bousquet, J., Dahl, R. and Khaltaev, N. (2007) Global alliance against chronic respiratory 
diseases. Allergy, 62(3), pp.216-223. 
Bunch, M. A. (1995) Posture and breathing in singing. In Dynamics of the Singing Voice (pp. 
23-55). Springer, Vienna. 
Clift, S., Morrison, I., Coulton, S., Treadwell, P., Page, S., Vella-Burrows, T. and Skingley, 
A. (2013) A feasibility study on the health benefits of a participative community singing 
programme for older people with Chronic Obstructive Pulmonary Disease (COPD). Canterbury 
Christ Church University, UK: Sidney De Haan Research Centre for Arts and Health. 
Encyclopædia Britannica, Inc. (2018) https://www.britannica.com/science/respiratory-
disease [Accessed June 2018] 
Engen R. (2005) The singer’s breath: Implications for treatment of persons with emphysema. 
Jurnal of Music Therapy; 42(1), pp.20–48. 
Estève, F., Blanc-Gras, N., Gallego, J. and Benchetrit, G. (1996) The effects of breathing 
pattern training on ventilatory function in patients with COPD. Biofeedback and Self-regulation, 
21(4), pp.311-321. 
 
Gaude, G. S., Savadatti, R. and Hattiholi, J. (2014) Postural correction for kyphosis improves 
the dyspnea index and pulmonary functions in patients with chronic obstructive pulmonary 
disease: A randomized trial over 12 weeks. International Journal of Health & Allied Sciences, 
3(1), p.44. 
 
Gosselink, R. (2003) Controlled breathing and dyspnea in patients with chronic obstructive 
pulmonary disease (COPD). Journal of Rehabilitation research and development, 40(5), p.25. 
 
Gosselink, R. (2004) Breathing techniques in patients with chronic obstructive pulmonary disease 
(COPD). Chronic Respiratory Disease, 1(3), pp.163-172. 
 
                                                                          
 
  xviii  
 
Gould, W. J., and Okamura, H. (1973) Static lung volumes in singers. Annals of Otology, Rhinology 
and Laryngology, 82(1), pp.89-95. 
 
Higgins, J. P. T., and Green S. (editors) (2011) Cochrane Handbook for Systematic Reviews 
of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. 
Available from www.cochrane-handbook.org 
 
Holland, A., Hill, C., Jones, A. and McDonald, C. (2012) Breathing exercises for chronic 
obstructive pulmonary disease. Cochrane Database of Systematic Reviews, Issue 10. Art. No.: 
CD008250. 
 
Irons, J. Y., Kenny, D. T. and Chang, A. B. (2010a) Singing for children and adults with cystic 
fibrosis. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD008036.  
 
Irons, J. Y., Kenny, D. T. and Chang, A. B. (2010b) Singing for children and adults with 
bronchiectasis. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD007729.  
 
Leanderson, R., Sundberg, J. and Von Euler, C. (1987) Breathing muscle activity and subglottal 
pressure dynamics in singing and speech. Journal of Voice, 1(3), pp.258-261. 
 
Leanderson, R. and Sundberg, J. (1988) Breathing for singing. Journal of Voice, 2(1), pp.2–
12. 
 
Lord, V., Cave, P., Hume, V., Flude, E., Evans, A., Kelly, J., Polkey, M. I. and Hopkinson, N. 
(2010) Singing teaching as a therapy for chronic respiratory disease - A randomised controlled 
trial and qualitative evaluation. BMC Pulmonary Medicine, 10. 
 
MacDonald, R., Kreutz, G. and Mitchell, L. (Eds.). (2013) Music, health, and wellbeing. 
Oxford University Press. 
 
Mathis, D. R. (2009) Melodic sculpturing: The art and science of singing. AuthorHouse 
 
McNamara, R. J., Epsley, C, Coren, E and McKeough, Z. J. (2016) Singing for adults with 
chronic obstructive pulmonary disease (COPD) (Protocol). Cochrane Database of Systematic 
Reviews 2016, Issue 7. Art. No.: CD012296. 
 
Proctor, D. F. (2013) Breathing, speech and song. Springer Science & Business Media 
 
Oxford University Press (2018) Oxford dictionary 2018 
www.oxforddictionaries.com/definition/english/sing [Accessed June 2018] 
 
                                                                          
 
  xix  
 
Salomoni, S., van den Hoorn, W. and Hodges, P. (2016) Breathing and singing: objective 
characterization of breathing patterns in classical singers. PloS one, 11(5), p.e0155084. 
 
Skingley, A., Page, S., Clift, S., Morrison, I., Coulton, S., Treadwell, P., Vella-Burrows, T., 
Salisbury, I. and Shipton, M. (2014) ‘Singing for breathing’: participants’ perceptions of a 
group singing programme for people with COPD. Arts & Health 6, 1, p.59-74. 
 
Staes, F. F., Jansen, L., Vilette, A., Coveliers, Y., Daniels, K. and Decoster, W. (2011) 
Physical therapy as a means to optimize posture and voice parameters in student classical 
singers: a case report. Journal of Voice, 25(3), pp.e91-e101. 
 
Sundberg, J. (1993) Breathing behavior during singing. The NATS Journal, 49(3), pp.4-9. 
 
Guidance documents 
 
PRISMA (2015) PRISMA statement guidelines (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses www.prisma-statement.org) [Accessed June 2018] 
 
WHO (1978) World Health Organization (1978) International classification of diseases: [9th] 
ninth revision, basic tabulation list with alphabetic index. 
https://icd.who.int/dev11/f/en#!/http%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F2000006803 
[Accessed June 2018] 
 
 
                                                                          
 
  xx  
 
Appendices 
 
Appendix I - Term selection 
 
(i) Respiratory Disorders  
 
(WHO Table 2 Common chronic respiratory diseases (ICD-10)) (Bousquet et al 2007) 
 
Asthma  
Bronchiectasis  
Chronic obstructive lung disease 
      (Incl. chronic obstructive pulmonary disease (COPD), bronchitis and Emphysema) 
Chronic rhinosinusitis  
Hypersensitivity pneumonitis  
Lung cancer and neoplasms of respiratory and intrathoracic organs  
Lung fibrosis  
Chronic pleural diseases  
Pneumoconiosis  
Pulmonary eosinophilia  
Pulmonary heart disease and diseases of pulmonary circulation  
      (Incl. pulmonary embolism, pulmonary hypertension and corpulmonale) 
Rhinitis  
Sarcoidosis  
Sleep apnoea syndrome  
 
(ii) Respiratory Symptoms  
 
(WHO Table 3 Symptoms and signs involving the respiratory system) 
 
Haemorrhage from respiratory passages 
-Epistaxis  
-Haemoptysis  
Cough  
Abnormalities of breathing  
-Dyspnoea  
-Stridor  
-Wheezing 
-Hyperventilation  
-Sneezing 
Pain in the throat and chest 
Other symptoms and signs involving the circulatory and respiratory systems 
-Asphyxia  
-Pleurisy 
-Respiratory arrest (cardiorespiratory failure) 
-Abnormal sputum 
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Appendix II - Selected Research Databases 
 
Trials will be identified from the following key bibliographic database sources: 
 
BNI (British Nursing Index) 
CINAHL (1982 to present) Cumulative Index to Nursing and Allied Health Literature 
Clinical Trials Register (www.clinicaltrials.gov) 
International Clinical Trials Registry Platform (WHO) 
The Cochrane Airways Group Specialised Trials Register  
The Cochrane Central Register of Controlled Trials (CENTRAL) 
EMBASE (1980 to present) 
MEDLINE (1966 to present) 
OLDMEDLINE (1950 to 1965) 
PsycINFO (1872 to present) 
Web of Science  
ZETOC (Grey literature database) 
Music & Medicine 
Arts & Health 
Singing for Snorers web 
ATS - American Thoracic Society 
IBSS - International Bibliography of the Social Sciences 
PubMED US & EU 
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Appendix III - Outcome Measures 
 
Studies selected should contain >1 of the following measures: 
 
MRC breathlessness scale 
Chest x-ray  
Chest computed tomography (CT) scan 
Arterial blood gas test 
Borg dyspnea scale  
6-minute walk test (6MWD) 
Inspiratory muscle strength 
Exercise capacity 
Lung function recordings:  
Maximum voluntary ventilation 
Residual lung volume (RV) 
Total lung capacity (TLC) 
Forced expiratory volume in one second (FEV1) 
Forced vital capacity (FVC) 
Mean forced expiratory flow during the middle half of FVC 
FEV1 / FVC 
RV/TLC 
Peak expiratory pressure 
Peak inspiratory pressure 
Spirometry 
Biomarkers: 
Salivary Immoglobulin A (SIg A) 
Cortisol,  
Oxytocin 
TNF-alpha  
Prolactin 
Heart rate 
Heart rate variability 
Blood pressure 
Electromyographic tension 
Peripheral skin temperature 
Skin conductance 
Spielberger’s trait anxiety inventory (STAI)  
Shortness of Breath Questionnaire (SOBQ) 
EQ-5 Questionnaire 
St George’s questionnaires (SGRQ) 
York SF-12 
UWIST mood adjective checklist 
Positive and Negative Affect Scale (PANAS) 
Oxford Happiness Inventory (OHI) 
Qualitative patient feedback via patient interviews  
Patient statements/comments verbatim 
General Hospital Questionnaire-28 (GHQ-28) 
Hospital Anxiety and Depression Scale (HADS) 
Geriatric Depression Scale – Short Form 
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Appendix IV - Data Extraction Fields 
 
The key fields below will be captured for each study in a tabular/spreadsheet format for 
analysis. This may be reformatted in one or more tables for reporting purposes and delivery of 
results. 
 
Study setting 
Year of study  
Patient details (e.g. country, health status, age, gender, total population sample and eligibility 
criteria) 
Numbers of patients 
Study methods (e.g. Design, schedule of activities, method of allocation concealment used) 
Duration of intervention 
Interventions (e.g. methods, delivery type (individual/group), session number/duration)  
Outcome measures recorded (Type, administration frequency, Patient reported outcomes 
(PRO)) 
Randomisation method 
Key results and findings (e.g. Mean PRO values, respiratory symptoms, acute exacerbations) 
Study conclusions 
 
The following fields will also be captured if available and pertinent 
 
Source of funding  
Inclusion criteria 
Exclusion criteria  
Other symptoms  
Blinding (masking) procedure(s)  
Care provider/Outcome assessors 
Previous singing training  
Co-interventions 
Numbers of patients not followed up 
Reasons for withdrawals from study protocol   
Details on adverse events of therapy 
Patient comments or interview text 
Other measurement results 
Mean Difference from baseline for any measure 
Intervention details (vocal exercises, song type, pitch and dynamic range, delivery format, 
control methods and prescribed singing practice time) 
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Appendix V - PRISMA checklist  
 
Numbers in blue superscript parentheses refer to the PRISMA 2009 checklist headings 1-16 
below – for illustration purposes only: 
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Appendix VI - Cochrane Collaboration 
Risk of Bias Table 
 
 
 (Higgins and Green, 2011) 
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Appendix B – Systematic Review Risk of Bias (illustration purposes only) 
Systematic Review – Risk of Bias Table for All Included Studies  
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(s/s format)
Bonilh
a 2008
BLF 
2017
Canga 
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2013/ 
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2017
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Lichtensc
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Lord 
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ghton 
Miyah
ara 
Pacheco 
2014
Thomas 
2015
Trivedi 
2017
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4 Can’t tell
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1 80 - 100% agreement 1 1 1 1 1 1
2 60 – 79% agreement 2 2 2
3 less than 60% agreement 3 3 3
4 Not applicable
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A RATE THIS SECTION
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See dictionary
B B) STUDY DESIGN
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study
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If Yes, was the method of randomization described? (See dictionary)
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B RATE THIS SECTION
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2 MODERATE 2 2 2 2 2 2 2 2 2 2 2 2
3 WEAK 3
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Q4
(Q4) Is the analysis performed by intervention allocation status 
(i.e. intention to treat) rather than the actual intervention 
received?
1 Yes
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3 Can’t tell 3 3 3
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GLOBAL RATING FOR THIS PAPER (circle one):
1 1 STRONG (no WEAK ratings)
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Appendix C – Research Study Protocol  
 
 
 
 
 
 
 
Singing for Chronic Obstructive Pulmonary Disease 
(COPD) 
  
An Evaluation of a Community Programme including 
Feasibility of a Self-help Booklet and DVD Guide: 
“Sidney De Haan Research Centre - ‘Singing for Better 
Breathing’ Resource©” 
 
 
 
Version – Final V1 
Version date – 07-Apr-17 
Author: Charlotte Epsley 
 
 
This document contains confidential information belonging to the author. Except as otherwise 
agreed to in writing, by accepting or reviewing this document, you agree to hold this information 
in confidence and not copy or disclose it to others (except where required by applicable law) or 
use it for unauthorized purposes. In the event of any actual or suspected breach of this 
obligation, the author must be promptly notified. 
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Protocol Summary 
 
Abstract  
 
Respiratory disorders manifest themselves with chest symptoms including shortness of breath 
and a decline of lung function and a therapy is needed to provide treatment and support for 
these patients. There is a growing body of evidence to suggest that therapies that include 
breath control exercises, such as singing, may have health benefits for respiratory function and 
psychological well-being. 
 
In addition to group singing, supplementary activities which encourage regular and ongoing 
singing practice, participation in group singing and observing the correct techniques have 
potential to further support the objectives of singing for respiratory health. This protocol outlines 
the planned evaluation of a community-based singing group for adults with COPD and usability 
of carefully prepared home practice guides provided to participants to use between singing 
sessions.  
 
Terms: Singing, COPD, Chronic Respiratory Disease, self-study resources 
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Introduction 
 
Respiratory diseases are among the leading causes of death worldwide and are likely to remain 
a major burden for decades to come. It is estimated that sixty-five million people have moderate 
to severe COPD worldwide and more than three million deaths occurred (5% of all deaths 
globally) in 2015 (WHO, 2016). The prevention and treatment of lung diseases will need to be 
improved, if their impact on longevity and the quality of life (QoL) of individuals and their 
economic burden on society are to be reduced in Europe and worldwide (WHO, 2012). 
 
Respiratory Disorders manifest themselves with chest symptoms including shortness of breath 
and a decline of lung function. Chronic obstructive pulmonary disease (COPD) is one such term 
for a group of these airway conditions which are characterised by progressive, irreversible 
limitation of airflow, and a major goal of its treatment is to ensure that the patient’s health is 
optimised (Jones et al., 2009). 
 
Dyspnoea, or shortness of breath, is perhaps the most common accompaniment of lung 
disease (Burki and Lee, 2010). Patients with chronic respiratory disease, including COPD, are 
often limited in their activities by respiratory discomfort of this kind. Airflow limitation in patients 
with COPD leads to dynamic hyperinflation, particularly during exercise and several important 
consequences of dynamic hyperinflation serve to worsen dyspnoea (Meek et al., 1999). A 
reduction in functional status and quality of life of these patients, along with disability are 
frequent consequences. These diseases may leave patients presenting with this significant 
breathlessness symptom despite maximal therapy and are estimated to debilitate millions of 
people worldwide (Herigstad et al., 2010). Group singing is an activity that may support lung 
function and enhance quality of life in people with certain respiratory disorders and it has the 
potential to play an important role as an adjunct therapy to other established and proven 
offerings. 
 
A small, randomised study of COPD patients (Bonilha et al., 2009) concluded that singing 
classes are a well-tolerated activity for selected patients and that the regular practice of singing 
may improve QoL and preserve maximal expiratory pressure of these patients. A feasibility 
study of the health benefits of a community singing programme for older people with COPD 
(Clift et al., 2013) further supports this, indicating that measures of lung function and health-
related quality of life significantly improved over a ten months period of the singing programme. 
In addition, recent results published by the British Lung Foundation (BLF, 2017) indicate that 
taught exercises, specifically focused on improving lung conditions, compared to singing for 
wellbeing in general, demonstrate improvement in the impact living with a lung condition has on 
a patients’ daily life. 
 
This planned research is in line with these finding and with existing UK Department of Health 
(DH) Chronic Obstructive Pulmonary Disease (COPD) outcomes strategy discussions, 
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particularly objectives identified in the UK DH (2012) companion document, which outlines 
directions for enhancing quality of life for these patients and supporting outcome strategies to 
improve respiratory health and well-being of all communities. 
 
It is still recommended that further research is necessary (Bonilha et al., 2009, Lord et al., 
2012, Clift et al., 2013) to gain more robust results and further understand the outcome of 
group singing for this indication and population. It is also considered that additional singing 
practice outside group sessions may help improve the overall frequency, compliance and 
retention of patients to prolong their engagement, and maximise exposure and therapeutic 
effect.  
 
To that end ‘Singing for Better Breathing’ (SfBB) resources, including a supportive guidance 
booklet and DVD have been developed by the research team at the Sidney De Haan Research 
Centre to support simple practice activities between sessions. It is the objective of this study to 
explore the feasibility of using such tools in this population and gain feedback and experience of 
this media in a real life setting with COPD patients. 
 
There has been some limited research in self-help or home learning for comparable disciplines 
e.g. Pulmonary Retention for COPD patients (Mendes de Oliveira et al., 2010), exercise for 
older adults (McAuley et al., 2013) and for DVD exercise programmes more broadly 
(Rasmussen et al., 2013, Kingston et al., 2014) and some singing for COPD studies have 
even included a home singing practice element (Lord et al., 2010, Lord et al., 2012). However, 
this is not explored in any detail and there is very little evidence of research in home delivery 
methods or programmes for singing guidance targeted specifically at COPD patients.  
 
Mechanism of Action 
 
The key mechanism of action of singing in these patients appears to be the active engagement 
of the muscles of the entire respiratory system and an increase in respiratory muscle strength, 
leading to increased lung volume and effective cough (Kang et al., 2006, Wiens et al., 1999). 
Poor posture (hyperkyphosis) is often common in COPD patients and can restrict the expansion 
of the rib cage and movement of the diaphragm. Since singing requires the development of 
skills in controlling posture this may be transferable to activities in daily life in people with COPD 
(Lord et al., 2010). 
 
The other mechanisms that may have significance include a reduction of fear, anxiety and pain 
perception (Kenny and Faunce, 2004) possibly by increased breath control improving the 
autonomic nervous system through enhanced activation of the parasympathetic system, leading 
to higher vagal tone (Pramanik et al., 2009, Kok and Fredrickson, 2010, Vickoff et al., 2016). 
This in turn and in combination with the improvements in a patients overall improved 
consciousness of their own breathing due to the singing training, may reduce the occurrence or 
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severity of dyspnoea episodes; Improvement of mood (Unwin et al., 2002) positively impacted 
by socialising and meeting people, thus combating isolation; Finally, although there is little 
evidence in this population specifically, Immunoglobulin A (S-IgA) levels have been revealed to 
be particularly responsive to music (Fancourt et al., 2014) and greater improvements in mood, 
as a result of singing have been associated with lower pro-inflammatory response (Fancourt et 
al., 2016) leading to a potential hypothesis that singing could lead to a positive impact on 
depression and inflammation which would be a particularly important effect for COPD patients. 
These mechanisms are all thought likely to be interrelated too, thus enhancing the overall 
benefit by form of a virtuous circle potentially combating the ‘spiral of decline’ (Jones, 2009) 
associated with the condition.  
 
Background and Rationale 
 
Condition 
 
Respiratory illness encompasses developmental, pathological conditions affecting the organs 
and tissues that make gas exchange possible in higher organisms, and includes conditions of 
the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and 
the nerves and muscles of breathing (WHO, 1978). 
 
COPD is characterised by poorly reversible airflow obstruction and an abnormal inflammatory 
response in the lungs, which represents the innate and adaptive immune responses to long 
term exposure to noxious particles and gases (MacNee, 2006). 
 
Intervention 
 
The intervention combines a thirteen-week programme of regular weekly group singing 
sessions with guided home singing practice between sessions. The findings of a study looking 
at utilising a DVD to improve compliance with home exercise programs (Kingston et al., 2014) 
demonstrated the multidimensional nature of compliance and showed improved understanding 
of exercises when utilising home resources such as DVDs. This suggests self-help guides such 
could be utilised as part of a programme that facilitates the patient-therapist relationship. It is 
considered important to trial additional resources both to enhance the experience of group 
singing, vary the medium of delivery of this intervention, provide a more versatile offering and to 
encourage retention and continued adherence to singing exercises longer term.  
A previous study (McAuley et al., 2013) provided cautiously optimistic evidence that the use of 
DVD-delivered programs designed for a target population can be both effective and utilized on a 
broad scale. This study demonstrated the feasibility, acceptability, and efficacy of delivering 
regularly scheduled activities focusing on older adults via the medium of DVD. This study 
highlighted and recognised that this type of novel intervention is also capable of reaching 
participants from outlying geographical areas who typically would not be able to attend centre-
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based activity trials conducted at university or medical centres. The SfBB resources have been 
developed such that they may also have other potential uses in the future to provide support to 
those COPD patients who might benefit from the activity of singing but are unable to attend 
group sessions outside their home environment due to extent of their disease or other 
limitations.  
 
Although centre-based interventions for exercise programs are generally shown to have 
success in improving functional performance in older adults, such approaches can be costly, 
have limited reach, can be challenging to implement and sustain, and are often not 
generalizable (Glasgow et al., 1999). Low-cost, broad-reaching, and innovative approaches to 
delivering physical activity programs are therefore needed.  
 
Study Objectives and Endpoints 
 
Objectives 
 
The primary objectives of the research is to review and evaluate the impact of weekly group 
singing on COPD patients and to assess specifically created resources “Sidney De Haan 
(SDHR) ‘Singing for Better Breathing’ Resource©” (SfBB) used in conjunction within the target 
population, and obtain patient feedback on the usefulness, usability and format of this tool to 
support or enhance the effectiveness of group singing for patients with COPD 
 
The secondary objectives will be to assess recruitment uptake, retention and acceptability and 
adherence to the SfBB resources with the objective of assessing feasibility for this type of 
intervention in this population. Compliance data of group singing and use of resources will be 
collected through group attendance records and participant feedback questionnaires. 
 
Primary Endpoint 
 
• Participant feedback of SDHR SfBB resources via specially designed SFBB Questionnaire 
• Impact of weekly group singing on participants using WEMWBS, CAT and ACQ-5 data 
 
Secondary Endpoints 
 
• SDH SfBB suggestions for improvement per written feedback from patient evaluation form 
• Suggestions for improvements as per feedback from patient questionnaire 
• Compliance with SDH SfBB resource guidance schedule 
• Overall compliance and drop-out rate  
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• Patient reported outcomes from COPD patients that have agreed to use the tools in real 
time, including evaluation solicited from patients written comments regarding the usability of 
the resources. 
 
Study Design 
 
Participant Selection 
 
This study can fulfil its objectives only if appropriate participants are enrolled. The following 
eligibility criteria are designed to select only self-referred participants for whom the protocol 
intervention is considered appropriate by their health care provider (HCP) or pulmonary 
rehabilitation team. 
 
Inclusion Criteria 
 
Participants must meet all of the following inclusion criteria to be eligible for enrolment in the 
study: 
 
Over 18 years of age. 
 
Shows evidence of a personally signed and dated informed consent document, indicating that 
the participant has been informed of all pertinent aspects of the study and provided with an 
information sheet. 
 
Previously diagnosed with COPD or lung condition by their Physician or other Health Care 
Provider (HCP) 
 
Willing to commit to participating in the initial project over the course of 13 weeks (health 
permitting) 
 
Enrolled into a singing for COPD group run by the Sidney De Haan Research Centre 
 
Physically mobile and able to travel to sessions independently or with support 
 
NB. Participant eligibility should be reviewed and documented by an appropriate member of the 
research team before participants are included in the study. 
 
Exclusion Criteria 
 
Participants with any of the following characteristics/conditions will not be included in the study: 
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Research team site staff members directly involved in the conduct of the study and their family 
members, site staff members otherwise supervised by the research team, or participants who 
are employees of Sidney De Haan Research Centre or Canterbury Christ Church University, 
including their family members, directly involved in the conduct of the study 
 
Participants who are physically unable to attend group singing evaluation sessions 
 
Participants with severe dementia or other cognitive or communication problems, which in the 
opinion of the research team would render consent problematic 
 
Participants with ongoing or planned participation in pulmonary rehabilitation, scheduled to take 
place within project timescale. 
 
Study Intervention 
 
Singing groups will run weekly over a period of thirteen weeks. Skilled singing facilitators and a 
planned programme of singing and singing-related exercises will ensure standardisation of 
delivery throughout the trial. Participants will be involved in baseline data assessment before 
the start of the singing groups and after the first seven weeks of intervention. Follow-up data 
collection will take place thirteen weeks after the intervention period of the trial. 
 
The structured singing during group sessions will closely follow the guidance provided in the 
resource booklet (Appendix I) and copies of the booklet instructions and an accompanying DVD 
will be provided to all participants. Guidance will be given for participants to follow the resource 
instructions at home outside the group sessions and ‘self-administer’ the intervention according 
to the guidance. 
  
Allocation to Intervention 
 
A single, non-randomised un-blinded design will be employed. Participants will be recruited from 
willing volunteers in newly established self-referred community groups with approximately thirty 
to forty participants recruited across the groups. Participants will be assigned a number 
sequentially by research team members. 
 
The research team knowledge of treatment should not influence the decision to enrol a 
particular participant or affect the order in which participants are enrolled. 
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Study Procedures 
 
Baseline Visit V1 - Week 1 (+7 days) 
 
• Information Sheet and Informed Consent Document Sign-off 
• Demography Questionnaire 
• Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) 
• COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
• Initial General Feedback Questionnaire 
• Handout SDHC SfBB Booklet/DVD resources 
 
Study Period Visit V2 - Week 7 (+7 days) 
 
• Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) 
• The COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
 
Follow Up Visit V3 - Week 13 (+7 days) 
 
• Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) 
• COPD Assessment Test (CAT) 
• Asthma Control Questionnaire (ACQ-5) 
• SfBB self-help resource feedback questionnaire (SfBBQ) 
• Final General Feedback Questionnaire 
 
Assessments 
 
• Demography Questionnaire 
• Warwick-Edinburgh Mental Well-Being Scale 
• COPD Assessment Test (CAT) 
• Asthma Control Questionnaire 
• General Feedback Questionnaire (pre-intervention) 
• General Feedback Questionnaire (post-intervention) 
 
  
                                                                          
 
  xxxviii  
 
Questionnaires 
 
Warwick-Edinburgh Mental Well-Being Scale 
 
The Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) (Appendix I) is a validated 
questionnaire assessing positive mental wellbeing and aims to measure mental well-being itself 
and not the determinants of mental well-being. It comprises 14 item scale that relate to an 
individual’s state of mental well-being (thoughts and feelings) in the previous two weeks. It is a 
scale of mental well-being covering subjective well-being and psychological functioning, in 
which all items are worded positively and address aspects of positive mental health. The scale 
is scored by summing responses to each item answered on a 1 to 5 Likert scale. The minimum 
scale score is 14 and the maximum is 70. WEMWBS has been validated for use in the UK with 
those aged 16 and above (Stewart-Brown et al., 2008).  
 
The COPD Assessment Test (CAT) 
 
The COPD Assessment Test (CAT) (Appendix I) provides clinicians and patients with a simple 
and reliable measure of overall COPD-related health status for the assessment and long-term 
follow-up of individual patients. It consists of eight items, each formatted as a semantic six-point 
differential scale, making the tool easy to administer and easy for patients to complete. The 
items cover a wide range of disease severity, with the intention that the greatest discriminant 
power would be in the mild to moderate range (Jones et al., 2009). 
 
Asthma Control Questionnaire (ACQ-5) 
 
The Asthma Control Questionnaire ACQ-5 (Appendix I) is an asthma control measurement tool 
consisting of five questions on symptom control; each of the questions is scored on a scale of 
0–6 where 0 represents excellent asthma control and 6 represents extremely poor control 
(O’Byrne et al., 2010). The ACQ can include responses to seven questions, five relating to 
symptoms, one relating to rescue symptom use and one to capture FEV1. The shortened, five-
question ‘symptom only’ questionnaire is considered just as valid and is adequate for the 
purposes of this study. 
 
Participant Withdrawal 
 
‘Withdrawal of Consent’: Participants who request to discontinue will remain in the study and 
must continue to be followed for protocol specified follow-up procedures. The only exception to 
this is when a participant specifically withdraws consent for any further contact with him/her or 
persons previously authorized by participant to provide this information. Participants should 
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notify the research team of the decision to withdraw consent from future follow-up whenever 
possible. All attempts should be documented. 
 
‘Lost to Follow-Up’: All reasonable efforts must be made to locate participants to determine and 
report their current status. Lost to follow-up is defined by the inability to reach the participant 
after a minimum of three documented efforts (phone calls, faxes, letter or emails). All attempts 
should be documented.  
 
The study team will consult publicly available sources, such as public health registries and 
databases, in order to obtain updated contact information. If after all attempts, the participant 
remains lost to follow-up, then the last known contact date as determined by the study team 
should be reported and documented.  
 
Participants may withdraw from the study at any time at their own request, or they may be 
withdrawn at any time at the discretion of the study team.  
 
If a participant does not return for a scheduled visit, every effort should be made to contact the 
participant. All attempts to contact the participant and information received during contact 
attempts will be documented. In any circumstance, every effort should be made to document 
participant outcome, if possible.  The study team should inquire about the reason for withdrawal 
and request the participant to return for a final visit, if applicable. 
 
If the participant withdraws from the study, and also withdraws consent for disclosure of future 
information, no further evaluations should be performed, and no additional data should be 
collected. The researcher may retain and continue to use any data collected before such 
withdrawal of consent. 
 
Data Analysis and Statistical Methods 
 
The paired t-test will be used to compare means of two related observations i.e. a comparison 
of given values both before and after an intervention and recorded in pairs per participant. The 
paired t-test is selected due to the small sample sizes to compare mean differences. The 
difference between the paired values is assumed to be normally distributed and the null 
hypothesis, that the expectation is zero, is tested by paired t test. 
 
The test is used to compare the means for all three health and wellbeing evaluations over each 
possible interval i.e. between V0 and V1, V1 and V2, V2 and V3, V1 and V3, V0 and V2 and V0 and 
V3 for both the total score and individual question scores. Those with values of significance i.e. 
p < 0.05 are reported. 
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The calculation of the statistical significance shows the improbability of findings drawn from 
assumptions about the null hypothesis. The substantive significance i.e. what the findings 
indicate about population effects themselves will be assessed using a comparison of the mean 
difference expressed as meaningful for each of the individual health and wellbeing scores as 
noted from previous validations of each one. 
 
Sample Size Determination 
 
Sample size is determined based on sample size calculated for two prior outpatient pulmonary 
rehabilitation studies (Bakarat et al., 2008, Mendes de Oliveira et al., 2010) where total 
patients recruited into the PR home resources cohort was 19-23. The aim for this study will be 
to enrol at least 30 participants over two groups with conservative anticipated drop-out rate of 
30-50% allowing for 15-21 participants or over, completing the full evaluation.   
 
Data Sources 
 
Data sources will be questionnaires designed to solicit specific feedback directly from the 
participants regarding their health and wellbeing and the tools under study. This will include a 
novel questionnaire designed for participants to answer simple questions about use of the SfBB 
tools. Attendance data for the singing group sessions will also be collected to capture 
participant compliance to regular weekly singing. 
 
Data Handling and Record Keeping 
 
Case Report Forms - Electronic Data Record 
 
The term Case Report Form (CRF) as used in this protocol should be understood to refer to 
either a paper form or an electronic data record or both, depending on the data collection 
method(s) used. A CRF is required and should be completed for each included participant.  The 
completed original CRFs are the sole property of the Sidney De Haan Research Centre and 
should not be made available in any form to third parties, except for authorized representatives 
of the Sidney De Haan Research Centre or appropriate regulatory authorities, without written 
permission from the research team. 
 
The study team has ultimate responsibility for the collection and reporting of all data entered on 
the CRFs and any other data collection forms and ensuring that they are accurate, authentic / 
original, attributable, complete, consistent, legible, timely (contemporaneous), enduring and 
available when required.  The CRFs must be signed by a member of the research team to attest 
that the data contained on the CRFs is true.  Any corrections to entries made in the CRFs or 
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source documents must be dated, initialled and explained (if necessary) and should not obscure 
the original entry. Data Handling Conventions may be utilised, documented and applied to 
missing or inconsistently recorded data for the purposes of final statistical analysis. 
 
Record Retention 
 
To enable evaluations and/or audits from regulatory authorities, the research team agrees to 
keep records, including the identity of all participating participants (sufficient information to link 
records, e.g., CRFs), all original signed informed consent documents, copies of all CRFs, safety 
reporting forms, source documents, and detailed records of treatment disposition, and adequate 
documentation of relevant correspondence (e.g., letters, meeting minutes, telephone calls 
reports).  The records should be retained by the research team according to International 
Conference on Harmonisation (ICH) or according to local regulations, whichever is longer. 
 
All information gathered will be stored securely in the offices of the Sidney De Haan Research 
Centre for Arts and Health, Canterbury Christ Church University. Members of the research team 
are the only people who will have access to the primary research material. All data will be 
anonymous prior to analysis. 
 
If the research team becomes unable for any reason to continue to retain study records for the 
required period (e.g., retirement, relocation) the study records must be transferred to a 
designee, such as another institution, or to an independent third party.  Records must be kept 
for a minimum of 15 years after completion or discontinuation of the study or for longer if 
required by applicable local regulations.  
 
Ethics 
 
Institutional Review Board (IRB)/Ethics Committee (EC) 
 
It is the responsibility of the research team to have prospective approval of the study protocol, 
protocol amendments, informed consent documents, and other relevant documents, if 
applicable, from the local IRB/EC.  All correspondence with the IRB/EC should be retained by 
the study team. 
 
The only circumstance in which an amendment may be initiated prior to IRB/EC approval is 
where the change is necessary to eliminate apparent immediate hazards to the participants.  In 
that event, the research team must notify the IRB/EC in writing immediately after the 
implementation. 
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Ethics Conduct of the Study 
 
The study will be conducted in accordance with legal and regulatory requirements, as well as 
the general principles set forth in the Guidelines for GCP (ICH 1996), and the Declaration of 
Helsinki (World Medical Association 1996 & 2008). In addition, the study will be conducted in 
accordance with the protocol, the ICH guideline on GCP, and applicable local regulatory 
requirements and laws. 
 
Participant Information and Consent 
 
All potential participants will be provided with an information sheet explaining the study and 
asked to sign a consent form. Personal details other than those necessary for demographic 
information will not be requested. All data will be treated as confidential and no comments from 
any participant in the study will be attributed to them personally in any publication. 
 
When study data is compiled for transfer outside the investigating team, participant names, 
addresses, and other identifiable data will be replaced by a numerical code in order to de-
identify study participants. The study team will maintain a confidential list of participants who 
participated in the study linking their numerical code to the participant’s actual identity.  In case 
of data transfer, the research team will maintain high standards of confidentiality and protection 
of participant personal data consistent with applicable privacy laws. 
 
The informed consent documents must be in compliance with ICH GCP, local regulatory 
requirements, and legal requirements, including applicable privacy laws. The informed consent 
documents used during the informed consent process must be reviewed by the research team, 
approved by the IRB/EC before use and available for inspection.  The research team must 
ensure that each study participant is fully informed about the nature and objectives of the study 
and possible risks associated with participation.   
 
Ethical approval will be sought from the Faculty Research Ethics Committee of Canterbury 
Christ Church University. The study will be conducted in accordance with GCP/MRC GRP 
guidelines and the Declaration of Helsinki. It is expected that participants will generally be living 
independently and not affected by serious physical or mental frailty.  However, participants may 
be considered vulnerable in view of their age, therefore care will be taken to present information 
about the project with due attention to their needs and capabilities.  It is not believed that the 
research project outlined carries any risks of harm to individuals who will be invited to 
participate.  
 
All information gathered will be stored securely in the offices of the Sidney De Haan Research 
Centre for Arts and Health, Canterbury Christ Church University. Members of the research team 
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are the only people who will have access to the primary research material. All data will be 
anonymous prior to analysis. 
 
The research team, or a person designated by the research team, will obtain written informed 
consent from each participant, before any study-specific activity is performed, unless a waiver of 
informed consent has been granted by an IRB/EC. The research team will retain the original of 
each participant's signed consent document. 
 
Participant Recruitment 
 
Participants will be recruited from a pool of participants attending newly formed or established 
singing groups. These participants will have been self-referred on the basis of information 
provided by their Health Care Provider (HCP) or pulmonary rehabilitation team. Participants will 
have been invited to attend ‘taster’ sessions in advance of visit 1 to encourage interest and 
recruitment. 
 
Definition of End of Study 
 
End of Study (EOS) is defined as last participant’s last visit. 
 
Premature termination of this study may occur because of a regulatory authority decision, 
change in opinion of the IRB/IEC or at the discretion of the Sidney De Haan Research Centre, 
Canterbury Christ Church University. 
 
If a study is prematurely terminated or discontinued the research team will be notified. All study 
materials will be collected and CRFs completed to the greatest extent possible. 
 
Publication of Study Results 
 
Publication of study results will be at the discretion and agreement of Canterbury Christ Church 
University, Sidney De Haan Research Centre research team and the Primary Investigator. 
 
Publications relating to the study will comply with Canterbury Christ Church University 
requirements and recognized ethical standards concerning publications and authorship, 
including Section II - “Ethical Considerations in the Conduct and Reporting of Research” of the 
Uniform Requirements for Manuscripts Submitted to Biomedical Journals, 
http://www.icmje.org/index.html#authorship established by the International Committee of 
Medical Journal Editors. 
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Appendices 
 
Appendix I – Participant Response Questionnaires  
 
 
 
 
 
‘Singing for Better Breathing’ 
Singing and COPD Project 
Evaluation Questionnaire  
 
Dear Singing Group Participant,  
 
Canterbury Christ Church University is running Singing for Better Breathing 
groups in Kent to gather feedback from participants to assess whether they 
have gained any benefits from participation and to assess whether they have 
found new tools useful.  
 
This is the purpose of this questionnaire, which we will ask you to complete at 
the beginning and end of the course. It is entirely your choice whether to 
complete it.   
 
The questionnaire is confidential and anonymous, but on the first page we 
ask for your date of birth and also your post code.  This is so that your 
questionnaires before and after the course can be matched up. 
 
Please read the statements or questions carefully and tick the answer that is 
best for you.  The questionnaire ends with some further questions about you 
and there is a space to write any comments you would like to make about the 
project. 
 
Thank you for your help. 
 
Charlotte Epsley 
Primary Investigator 
Sidney De Haan Research Centre for Arts and Health  
Canterbury Christ Church University 
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Personal details 
 
Please circle your answers to the following questions or write in the 
details 
 
Sex/Gender:  ____________________________  
 
 
Date of birth: (DD-MMM-YY) ____________________________ 
 
 
Do you have:   Asthma COPD Another lung problem  
 
 
If another please describe _________________________________ 
 
 
How long have you been affected by lung problems?   ______ years 
 
 
Do you smoke?  Yes  Have given up  Never 
 
 
As an adult, have you been part of a singing group?   Yes  No 
 
 
Please give your post code:   ____________________________________ 
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Personal details 
 
Date of birth: (DD-MMM-YY) ____________________________ 
 
Please give your post code:   ____________________________ 
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The Warwick-Edinburgh Mental Well-Being Scale 
 
Below are some statements about your thoughts and feelings. Please tick the 
box that BEST describes your experience of each over the last TWO WEEKS. 
 
 
STATEMENTS 
No
ne
 of
   
the
 tim
e 
Ra
rel
y  
So
me
 of
   
the
 tim
e  
Of
ten
 
All
 of
    
   
the
 tim
e  
I’ve been feeling optimistic about 
the future      
I’ve been feeling useful 
 
     
I’ve been feeling relaxed 
 
     
I’ve been feeling interested in 
other people      
I’ve had energy to spare 
 
     
I’ve been dealing with problems 
well      
I’ve been thinking clearly 
 
     
I’ve been feeling good about 
myself      
I’ve been feeling close to other 
people      
I’ve been feeling confident 
 
     
I’ve been able to make up my 
own mind about things      
I’ve been feeling loved 
 
     
I’ve been interested in new 
things      
I’ve been feeling cheerful 
 
     
“Warwick Edinburgh Mental Well-Being Scale (WEMWBS) © NHS Health Scotland, University 
of Warwick and University of Edinburgh, 2006, all rights reserved.”
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The COPD Assessment Test (CAT) 
 
This questionnaire is designed to measure the impact COPD (Chronic 
Obstructive Pulmonary Disease) has on wellbeing and daily life.  It can also 
identify difficulties experienced due to other lung conditions like asthma.  For 
each item below, circle the number that best describes you CURRENTLY. Be 
sure to only select one response for each question. 
 
I never cough  0   1   2   3   4   5   6  I cough all the time 
I have no phelgm 
(mucus) in my chest at all 
 0   1   2   3   4   5   6  My chest is completely 
full of phelgm (mucus) 
My chest does not feel 
tight at all 
 0   1   2   3   4   5   6  My chest feels very tight 
When I walk up a hill or 
one flight of stairs I am 
not breathless 
 0   1   2   3   4   5   6  When I walk up a hill or 
one flight of stairs I am 
very breathless 
I am not limited doing any 
activities at home 
 0   1   2   3   4   5   6  I am very limited doing 
activities at home 
I am confident leaving my 
home despite my lung 
condition 
 0   1   2   3   4   5   6  I am not at all confident 
leaving my home 
because of my lung 
condition 
I sleep soundly  0   1   2   3   4   5   6  I don’t sleep soundly 
because of my lung 
condition 
I have lots of energy  0   1   2   3   4   5   6  I have no energy at all 
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Asthma Control Questionnaire 
This questionnaire is designed to measure the impact Asthma has on wellbeing 
and daily life.  It can also identify difficulties experienced due to other lung 
conditions like COPD.  For each item below, circle the number of the response 
that best describes how you have been during the PAST WEEK. 
 
1. On average, during the past week, how often were you woken by your asthma (or 
other conditions) during the night? 
 
0  Never  
1  Hardly ever  
2  A few minutes  
3  Several times  
4  Many times  
5  A great many times  
6  Unable to sleep because of asthma  
 
2. On average, during the past week, how bad were your asthma symptoms (or other 
conditions) when you woke up in the morning? 
 
0  No symptoms  
1  Very mild symptoms  
2  Mild symptoms  
3  Moderate symptoms  
4  Quite severe symptoms  
5  Severe symptoms  
6  Very severe symptoms  
 
3. In general, during the past week, how limited were you in your activities because of 
your asthma (or other conditions)? 
 
0  Not limited at all  
1  Very slightly limited  
2  Slightly limited  
3  Moderately limited  
4  Very limited  
5  Extremely limited  
6  Totally limited  
 
                                                                          
 
  liii  
 
4. In general, during the past week, how much shortness of breath did you experience 
because of your asthma (or other conditions)? 
 
0  None  
1  A very little  
2  A little  
3  A moderate amount  
4  Quite a lot  
5  A great deal  
6  A very great deal  
 
5. In general, during the past week, how much of the time did you wheeze? 
 
0 Not at all  
1  Hardly any of the time  
2  A little of the time  
3  A moderate amount of the time  
4  A lot of the time  
5  Most of the time  
6  All the time  
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We are very keen to have feedback from you  
How did you hear about this project? 
Did your GP or other health care professional recommend you attend? 
What do you hope to gain from joining the group? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please continue overleaf if you need more space 
Thank you for completing this questionnaire. 
Please check that you have answered all the items. 
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SfBB Booklet and DVD Resource© - Final Overall Feedback 
 
To be completed only once and after the last session  
 
Circle the number that best describes how you feel about the booklet and DVD 
overall - complete this section at the end of the programme and only select one 
response for each question. 
 
I used the booklet and/or 
DVD regularly  
0   1   2   3   4   5   6  I did not use the booklet 
and/or DVD regularly 
I found the instructions in 
the booklet easy to follow  
 0   1   2   3   4   5   6  I did not find the instructions 
in the booklet easy to follow
I found the instructions on 
the DVD easy to follow 
 0   1   2   3   4   5   6  I did not find the instructions 
on the DVD easy to follow 
Using the booklet and/or 
DVD made me feel more 
confident at the group 
sessions 
 0   1   2   3   4   5   6  Using the booklet and/or 
DVD did not make me feel 
more confident at the group 
sessions 
It was easy to fit in regular 
singing practice at home 
 0   1   2   3   4   5   6  It was difficult to fit in 
regular singing practice at 
home 
I will continue to use the 
booklet and DVD to 
practice 
 0   1   2   3   4   5   6  I will not continue to use the 
booklet and DVD to practice
I would recommend the 
booklet and DVD to others  
 0   1   2   3   4   5   6  I would not recommend the 
booklet and DVD to others 
I would be likely to use this 
or other singing resources 
online or via an electronic 
device, mobile phone ‘app’ 
or similar 
 0   1   2   3   4   5   6  I would not be likely to use 
this or other singing 
resources online or via an 
electronic device, mobile 
phone ‘app’ or similar 
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We are very keen to have any other feedback from you about the impact of 
group singing on you and your lung condition and about the SfBB Booklet and 
DVD resource 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please continue overleaf if you need more space 
Thank you for completing this questionnaire.  
Please check that you have answered all the items. 
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Appendix II – Participant Information Sheet 
 
 
 
Participant Information Sheet 
 
Study title: ‘Singing for Better Breathing’ - Singing and COPD Project 
The above study is being conducted by Charlotte Epsley with the Sidney De Haan Research 
Centre for Arts and Health at Canterbury Christ Church University (CCCU)  
Before you decide to take part in the study it is important for you to understand why the research 
is being done and what it will involve.  Please take time to read the following information carefully 
before making a decision to take part in the study. 
 
Background 
A number of recent research studies have shown that regular group singing can be beneficial for 
people with lung conditions that make breathing difficult, lead to problems of breathlessness and 
limit physical activity. This study aims to set up and evaluate a number of weekly singing groups 
for residents in Kent to further research this idea. The aim is to test whether regular community 
singing is helpful for people with respiratory illness (chronic obstructive pulmonary disease/ 
COPD) and test whether some tools (a booklet and a DVD) are helpful for practising singing 
outside the group meetings. 
What will you be required to do? 
You will have the opportunity to attend a singing group meeting every week in a venue in your 
neighbourhood for thirteen weeks. We would like you to attend every week if this is possible for 
you, but understand that your health and other commitments may mean you have to miss 
occasional sessions. To help us assess the benefits of this activity, you will be asked to complete 
some questionnaires about this and about health and wellbeing. You have the right to leave blank 
any questions you would rather not answer. 
The data collection exercises will take place at the beginning, during and after the research 
project. Towards the end of the project we may also invite you to take part in a recorded 
interview with a member of the research team.   
During the study we may also make a documentary record using photography and filming.  You 
will be asked at every stage for your permission to be involved in any photography or filming 
that happens during the project and the team will make sure that you are not photographed or 
filmed if you choose not to be involved. You can take part in the project but still refuse to be 
photographed or filmed without giving any reason for your decision.  
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To participate in this research, you must 
• Be aged 18 or over 
• Be able to attend a local venue where a singing group is taking place weekly for 13 weeks 
• Be willing to practise at home using a booklet and/or DVD  
• Be willing to complete questionnaires 
• Be able to complete questionnaires in English (help will be provided) 
Confidentiality 
All data and personal information will be stored securely within CCCU premises in accordance 
with the Data Protection Act 1998 and the University’s own data protection requirements. Data 
can only be accessed by members of the research team. After completion of the study, all data 
will be made anonymous (i.e. all personal information associated with the data will be 
removed). 
 
Dissemination of results 
We will be writing up the results of the study in a report. There will also be a summary of the 
results which will be available for people who have taken part. We may also publish the results 
in health journals. A film documentary of the project may also be produced which would be 
available through the internet. You will be asked for your permission to be involved at every 
stage of filming and you will have the opportunity to see the film before it is made public to 
ensure that you are happy to be included. 
 
Deciding whether to participate 
If you have any questions or concerns about the nature, procedures or requirements for 
participation do not hesitate to contact us.  If you decide to participate that doesn’t mean that 
you have to continue with the project. You can decide to stop coming to the singing groups and 
being part of the research project at any time without having to give a reason. 
 
Any questions? 
If you have any questions or concerns about the nature, procedures or requirements for 
participation do not hesitate to contact:  
Charlotte Epsley 
Sidney De Haan Research Centre for Arts and Health,  
Canterbury Christ Church University, 65-69 Tontine Street, Folkestone, Kent CT20 1JR   
 
Email: ce162@canterbury.ac.uk 
Tel: 01303 220870 
 
Thank you very much for taking the time to consider being involved in this study 
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Appendix III – Participant Informed Consent 
 
 
 
CONSENT FORM 
 
Title of Project: ‘Singing for Better Breathing’ – Singing and COPD Project –  
Initial consenting for participation in the evaluation 
 
Name of Researcher:   Charlotte Epsley (Primary Investigator)  
   Supervisor – Prof. Stephen Clift 
Contact details:   
Address:  Sidney De Haan Research Centre for Arts and Health, Canterbury 
Christ Church University, 69 Tontine Street, Folkestone, Kent, 
CT20 1JR 
Tel:  01303 220870 
Email:  ce162.canterbury.ac.uk  
 
          Please initial 
box 
  
1. I confirm that I have read and understand the information sheet for the above 
study and have had the opportunity to ask questions.   
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason.   
3. I understand that any personal information that I provide to the researchers will be 
kept strictly confidential   
4. I agree to take part in the above study.   
 
 
 
________________________ ________________            ____________________ 
Name of Participant Date Signature 
 
 
_________________________ ________________            ____________________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
___________________________ ________________             ____________________ 
Researcher Date Signature 
 
 
 
 
Copies: 1 for participant,  1 for researcher 
 
Participant consent forms Version 1 07Apr17 
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CONSENT FORM 
 
Title of Project: ‘Singing for Better Breathing’ – Singing and COPD Project –  
Further consenting for interview, photographing and filming 
 
Name of Researcher:   Charlotte Epsley (Primary Investigator)  
   Supervisor – Prof. Stephen Clift 
 
Contact details:   
Address:  Sidney De Haan Research Centre for Arts and Health, Canterbury 
Christ Church University, 69 Tontine Street, Folkestone, Kent, 
CT20 1JR 
Tel:  01303 220870 
Email:  ce162.canterbury.ac.uk 
 
          Please initial 
box 
  
1. I confirm that I have previously given my consent to participate in this study and 
understand that my participation is voluntary and that any personal information I 
provide will be kept confidential   
2. I agree to photography and filming during group singing sessions and combined 
performance events    
3. I understand that I will have the opportunity to view any images before they are 
used in reports and presentations on the project and for purposes of 
disseminating findings from the project   
4. I agree to audio recording of a short interview during group singing session   
 
________________________ ________________            ____________________ 
Name of Participant Date Signature 
 
 
_________________________ ________________            ____________________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
___________________________ ________________             ____________________ 
Researcher Date Signature 
 
 
 
Copies: 1 for participant,  1 for researcher 
 
Participant consent forms Version 1 07Apr17 
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Appendix IV – Sidney De Haan ‘Singing for Better Breathing’ 
Resource© Summary of Songs 
 
SfBB Main Film - with introduction and warm-up exercises. 
 
DVD and Booklet containing recorded sing-a-long films and lyrics to the following: 
 
Song 1 - Daisy Bell  
Song 2 - Moon River 
Song 3 - Kookaburra 
Song 4 - I'd Like to Teach the World to Sing 
Song 5 - My Bonnie 
Song 6 - Consider Yourself 
Song 7 - Train Is A-Comin' 
Song 8 - Happy Talk 
Song 9 - Some Enchanted Evening 
Song 10 - Charlie Is My Darling 
Song 11 - The Wild Mountain Thyme 
Song 12 - What A Wonderful World 
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Appendix V – Ethics Committee Approval Letter  
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Appendix D – Research Study - Analysis of Results 
 
Analysis – T-Test Tables using SPSS 
 
CAT – CAT total score 
WEM – WEMBMS total score 
ACQ – ACQ-5 total score 
 
V0 = Baseline Visit V0 
V1 = Mid-Term Visit V1 
V2 = Follow-Up Visit V2 
V3 = Final Follow-up V3 
 
Health and Wellbeing Outcomes – Total Score Analysis 
 
Analysis for per protocol dataset i.e. COPD = 1 and Attendance > 2 sessions 
    
 
Paired Samples Statistics 
  Mean N Std. 
Deviation 
Std. 
Error 
Mean 
WEMV0 48.30 23 12.150 2.533 
WEMV1 51.14 23 11.459 2.389 
WEMV0 49.14 21 12.397 2.705 
WEMV2 55.23 21 10.150 2.215 
WEMV0 48.43 16 12.886 3.222 
WEMV3 56.81 16 8.719 2.180 
CATV0 24.57 22 7.698 1.641 
CATV1 22.42 22 9.532 2.032 
CATV0 25.03 21 7.774 1.696 
CATV2 20.27 21 10.659 2.326 
CATV0 24.16 16 7.282 1.820 
CATV3 19.13 16 9.563 2.391 
ACQV0 11.80 20 5.064 1.132 
ACQV1 10.20 20 6.254 1.398 
ACQV0 12.05 20 4.989 1.116 
ACQV2 10.05 20 6.022 1.346 
ACQV0 11.81 16 4.490 1.123 
ACQV3 9.81 16 5.833 1.458 
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Paired Samples Correlations  
  N Correlation Sig.  
WEMV0 - WEMV1 23 0.810 0.000  
WEMV0 - WEMV2 21 0.563 0.008  
WEMV0 - WEMV3 16 0.687 0.003  
CATV0 - CATV1 22 0.739 0.000  
CATV0 - CATV2 21 0.680 0.001  
CATV0 - CATV3 16 0.685 0.003  
ACQV0 - ACQV1 20 0.772 0.000  
ACQV0 - ACQV2 20 0.688 0.001  
ACQV0 - ACQV3 16 0.622 0.010  
 
 
  Paired Differences t df Sig. (2-
tailed) Mean Std. 
Deviation
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
WEMV0 - 
WEMV1 
-2.836 7.316 1.525 -6.000 0.327 -1.859 22 0.076 
WEMV0 - 
WEMV2 
-6.095 10.720 2.339 -10.975 -1.216 -2.606 20 0.017 
WEMV0 - 
WEMV3 
-8.380 9.362 2.340 -13.368 -3.392 -3.581 15 0.003 
CATV0 - 
CATV1 
2.156 6.451 1.375 -0.704 5.016 1.567 21 0.132 
CATV0 - 
CATV2 
4.755 7.828 1.708 1.192 8.319 2.784 20 0.011 
CATV0 - 
CATV3 
5.036 7.001 1.750 1.305 8.766 2.877 15 0.012 
ACQV0 - 
ACQV1 
1.600 3.979 0.890 -0.262 3.462 1.798 19 0.088 
ACQV0 - 
ACQV2 
2.000 4.449 0.995 -0.082 4.082 2.011 19 0.059 
ACQV0 - 
ACQV3 
2.000 4.648 1.162 -0.477 4.477 1.721 15 0.106 
 
Health and Wellbeing Outcomes – Total Score Analysis 
 
Analysis for per protocol dataset i.e. COPD = 1 and Attendance > 2 sessions 
 
CAT – CAT total score 
WEM – WEMBMS total score 
ACQ – ACQ-5 total score 
 
V0 = Baseline Visit V0 
V1 = Mid-Term Visit V1 
V2 = Follow-Up Visit V2 
V3 = Final Follow-up V3 
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Paired Samples Test: COPD =1 
    Paired Differences t df Sig.  
(2-
tailed) 
    Mean Std. 
Deviat
ion 
Std. 
Error 
Mean 
95% 
Confidence 
Interval of the 
Difference 
    Lower Upper 
Total WEM 
Score 
WEM 
V0-V1 
-2.836 7.316 1.525 -6.000 0.327 -1.859 22 0.076 
Total WEM 
Score  
WEM 
V0-V2 
-6.095 10.72
0 
2.339 -
10.975
-1.216 -2.606 20 0.017 
Total WEM 
Score  
WEM 
V1-V2 
-3.608 7.456 1.627 -7.002 -0.214 -2.218 20 0.038 
Total CAT 
Score  
CATV0 - 
CATV1 
2.156 6.451 1.375 -0.704 5.016 1.567 21 0.132 
Total CAT 
Score  
CATV0 - 
CATV2 
4.755 7.828 1.708 1.192 8.319 2.784 20 0.011 
Total CAT 
Score  
CATV1 - 
CATV2 
2.422 7.869 1.760 -1.261 6.104 1.376 19 0.185 
Total ACQ 
Score  
ACQ 
V0-V1 
1.600 3.979 0.890 -0.262 3.462 1.798 19 0.088 
Total ACQ 
Score  
ACQ 
V0-V2 
2.000 4.449 0.995 -0.082 4.082 2.011 19 0.059 
Total ACQ 
Score  
ACQ 
V1-V2 
-0.050 4.322 0.966 -2.073 1.973 -0.052 19 0.959 
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Group Statistics 
 
Sex/Gender 
 
*COPD = 1 
N Mean Std. 
Deviation 
Std. 
Error 
Mean 
Change WEM 
FU V2 score 
from Baseline 
V0* 
Male 8 2.88 7.717 2.728 
Female 13 8.08 12.068 3.347 
Change CAT 
FU V2 score 
from Baseline 
V0* 
Male 8 -5.66 11.863 4.194 
Female 13 -4.20 4.376 1.214 
Change ACQ 
FU V2 score 
from Baseline 
V0* 
Male 7 -3.14 6.176 2.334 
Female 13 -1.38 3.330 0.924 
SfBB total 
score(All Pts) 
Male 9 10.56 4.667 1.556 
Female 19 17.47 9.851 2.260 
 
 
Independent Samples Test 
 
* COPD = 1 Levene's Test 
for Equality of 
Variances 
t-test for Equality of Means 
Gender F Sig. t df Sig. 
(2-
tailed) 
Mean 
Differen
ce 
Std. 
Error 
Differ
ence 
95% 
Confidence 
Interval of the 
Difference 
 Lower Upper 
Change 
WEM FU 
V2 score 
from 
Baseline 
V0* 
2.292 0.146 -1.085 19 0.292 -5.202 4.796 -15.240 4.836
    -1.205 18.923 0.243 -5.202 4.318 -14.242 3.839
Change 
CAT FU 
V2 score 
from 
Baseline 
V0* 
6.354 0.021 -0.407 19 0.688 -1.464 3.593 -8.984 6.057
    -0.335 8.188 0.746 -1.464 4.366 -11.492 8.565
Change 
ACQ FU 
V2 score 
from 
Baseline 
V0* 
3.609 0.074 -0.836 18 0.414 -1.758 2.102 -6.175 2.658
    -0.700 7.929 0.504 -1.758 2.510 -7.556 4.040
SfBB 
total 
score 
(All Pts) 
2.985 0.096 -1.989 26 0.057 -6.918 3.478 -14.068 0.231
  -2.522 25.977 0.018 -6.918 2.744 -12.558 -1.278
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Appendix E – Weekly Progress Information 
Singing Leader Feedback and Comments 
 
A high-level summary of singing leader comments along with a selection of unsolicited 
participant comments made to the singing leader at the Centre A group (recorded verbatim and 
ad hoc) between Baseline Visit V0 and Follow-Up Visit V3 are described below for illustration 
purposes. No further analysis has been conducted on this data it is presented here to provide 
supportive information. 
 
Session 1 Comments 
 
“Participants were already starting to interact quite quickly after an introduction about 
the study and 45 minutes of exercises and singing.” 
 
Session 2 Comments 
 
“Participants were smiling and starting to mix with each other, exchanging numbers and 
socialising.” 
 
Session 3 Comments 
 
“Participants indicated they were having fun and more relaxed. Starting to discuss what 
will happen when the study ends and whether they can continue.” 
 
Session 4 Comments 
 
“Participants indicated they were having fun some finding it easier and noticing the 
difference to their breathing. Feeling confident enough to say that song was too high for 
them to sing.” 
 
Session 5 Comments 
 
“Participants indicated they felt relaxed and comfortable. They sang songs in two parts 
and rounds. Some mentioned that they are practising in the week and finding songs 
they like at home and looking online e.g. Youtube was mentioned.”  
 
Participant commented “Life has been bad with my heath for the past year but singing 
gives them something to look forward to”, “Thoroughly enjoyed it” and “I downloaded all 
the songs and have been singing along non-stop” 
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Session 6 Comments 
 
“Participants starting to indicate which songs they preferred to sing and asked if they 
could join in and sing with other groups.” 
 
Session 7 Comments 
 
“Visit from Medway healthcare team member and [study] researchers. [Group] 
completed assessments at the beginning of the session. Participants indicated songs 
they preferred to sing and asked if they could join in and sing with other groups.”  
 
Participant [that] missed the last two sessions indicated they had not felt able to come 
out but “Realised that the singing was doing me good - I’m glad that I came back.” 
 
Session 8 Comments 
 
“Weather was warm so warm up was reduced so as not to stress the participants or 
over exert them reminding them to drink and switched on fan.” 
 
“Slightly increased attendee number possibly due to the better weather – led to more 
enthusiasm i.e. humorous chit-chat and anecdotes. Suggested to make the singing 
more operatic/dramatic to increase movement and make things more fun.” 
 
Session 9 Comments 
 
“Attention given to good breathing, then introduced clapping to help with movement.” 
“Community centre staff looked in and made positive comments which lifted the mood 
of the group further. One new attendee joined in for just one session. The door to the 
centre is being left open so that others in the community centre can listen to the singing 
in the foyer.” 
 
“Participant indicated they couldn’t play the DVD but was practising his own songs 
between sessions. 
Participant indicated they had returned to Church “just for singing (I’m not religious just 
go for the singing)” 
One participant indicated she had a bad experience on the way and was deciding 
whether to stay – indicated that she was very glad she stayed as she felt better for it.” 
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Session 10 Comments 
 
“Attention given to good posture and finding space and practising a ‘diving into a pool’ 
position to stretch the core and also working on sitting posture. Discussed attention to 
vowels and putting energy into the singing including singing with arms outstretched.” 
 
“Group seemed confident from the first song today, enthusiastic and they commented 
they had lost inhibitions with each other. Chit-chat and socialising before the session - 
participants are arriving early to meet in the café and stay afterwards to socialise.” 
 
“Participants commented “It was a good day”, “It went exceptionally well”, “It was good 
for us to meet and work together” and “It was lovely to come and sit and relax and sing 
– wonderful.”” 
 
Session 11 Comments 
 
“Good session extra songs sung. Comments [were] raised again about meeting and 
singing with other groups. Laughter and collaboration and all stayed to have 
refreshments together and chat at the end.” 
 
Participants commented “It’s so enjoyable.” and “I’m looking forward to it each week.” 
 
Session 12 Comments 
 
“Participants swapped contact details and discussed the differences between small and 
large sized singing groups.” 
 
Participants commented “we might be a small group but we have done really well.” and 
“It’s really social and we had got to know each other well.” 
 
Session 13 Comments – post-study period 
 
“Group are planning to attend the session of another group tomorrow both to sing and 
discuss sustainability of the groups. All but one participant will be attending." 
 
Participants commented “I’ve never really sung before I used to always mime” and “This 
singing has given me a new lease of life and given me confidence” 
 
 
                                                                          
 
  lxx  
 
Appendix F – SfBB Questionnaire Output Summary 
  
COPD = 1 (COPD Diagnosis) 
COPD = 2 (CRD Diagnosis other than COPD) 
COPD = 3 (Undiagnosed) 
 
ID # Gender Year 
of 
Birth 
COPD Q1 Q2 Q3  Q4  Q5  Q6  Q7  Q8 SfBB 
total 
1001 Female 1948 1 ND 5 ND ND 5 2 1 3 NA 
1002 Female 1948 1 6 1 ND ND 0 0 0 0 NA 
1003 Female 1941 2 2 3 4 6 1 3 5 5 29 
1004 Male 1939 1 4 1 1 1 1 1 1 1 11 
1006 Female 1957 1 2 2 1 3 1 1 1 1 12 
1010 Female 1964 1 0 0 0 0 0 0 0 0 0 
1011 Female 1965 2 3 1 1 3 4 1 3 1 17 
1012 Male 1962 3 0 1 1 1 0 1 1 2 7 
2001 Female 1940 1 3 1 1 2 4 3 1 5 20 
2002 Female 1940 1 3 3 3 2 2 5 2 3 23 
2003 Male 1946 1 3 0 0 3 5 1 0 5 17 
2004 Male 1935 1 3 2 2 1 0 0 0 0 8 
2007 Female 1967 1 2 0 0 0 0 0 0 0 2 
2008 Female 1955 2 3 1 1 5 3 5 1 1 20 
2009 Female 1955 1 3 4 4 0 3 3 3 3 23 
2010 Female 1952 1 5 4 4 2 2 3 3 2 25 
2011 Male 1954 1 1 1 1 1 4 2 1 1 12 
2013 Male 1954 1 3 3 2 2 2 2 2 2 18 
2014 Male 1957 1 3 0 0 0 1 0 0 0 4 
2015 Male 1947 1 3 0 0 0 4 0 0 0 7 
2016 Female 1960 1 2 1 1 1 2 1 1 2 11 
2017 Male 1943 1 3 0 0 2 4 2 0 0 11 
2018 Female 1945 1 6 ND 6 6 6 6 6 6 48 
2019 Female 1953 2 5 1 1 1 3 3 1 3 18 
2020 Female 1959 1 2 0 0 2 2 2 0 0 8 
2022 Female 1957 3 3 0 0 0 5 1 0 5 14 
2023 Female 1937 1 3 3 1 3 4 4 3 2 23 
2025 Female 1952 3 4 3 2 3 3 3 2 2 22 
 
 
 
 
 
 
 
